Search by Patent Identification

---

Patent: (prefix with "US" like US6078908)

Patent	Data	Patent Title	Organization	Deposition	Downloads
US10183937	838	1,3-thiazol-2-yl substituted benzamides	Bayer Aktiengesellschaft	05/16/19	2D 3D TSV
US10179123	89	2-aryl- and 2-arylalkyl-benzimidazoles as mIDH1 inhibitors	BAYER PHARMA AKTIENGESELLSCHAFT	05/16/19	2D 3D TSV
US10174024	77	5H-pyrido[3,2-B]indole compounds as anticancer agents	Bristol-Myers Squibb Company	05/16/19	2D 3D TSV
US10174035	234	6-morpholinyl-2-pyrazolyl-9H-purine derivatives and their use as PI3K inhibitors	Daiichi Sankyo Company, Limited	05/16/19	2D 3D TSV
US10183940	124	Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (SSTR4) agonists	Boehringer Ingelheim International GmbH	05/16/19	2D 3D TSV
US10183025	206	Autotaxin inhibitors	Novartis AG	05/16/19	2D 3D TSV
US10174049	36	Compounds as diacylglycerol acyltransferase inhibitors	Glaxosmithkline LLC	05/16/19	2D 3D TSV
US10179761	52	Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases	UNIVERSITE DE LILLE 2 DROIT ET SANTE; CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE (CHRU)	05/16/19	2D 3D TSV
US10174030	116	Cyclopropylamines as LSD1 inhibitors	Incyte Corporation	05/16/19	2D 3D TSV
US10174037	579	Dihydropyrazolopyrimidinone compounds as PDE2 inhibitors	Merck Sharp & Dohme Corp.	05/16/19	2D 3D TSV
US10183939	56	Fused bicyclic (hetero)aromatic compounds useful for the treatment of cancers	Redx Pharma PLC	05/16/19	2D 3D TSV
US10174044	63	Fused pyridines as kinase inhibitors	Bristol-Myers Squibb Company	05/16/19	2D 3D TSV
US10183938	448	Geminal substituted quinuclidine amide compounds as agonists of α-7 nicotonic acetylcholine receptors	Axovant Sciences GmbH	05/16/19	2D 3D TSV
US10174023	22	Heterocyclic-imidazole compounds, pharmaceutical compositions thereof, preparation method therefor and use thereof	SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY CO., LTD	05/16/19	2D 3D TSV
US10174026	297	Histone demethylase inhibitors	CELGENE QUANTICEL RESEARCH, INC.	05/16/19	2D 3D TSV
US10179769	211	Histone demethylase inhibitors	Celgene Quanticel Research, Inc.	05/16/19	2D 3D TSV
US10183928	8	Inhibitors of RET	BLUEPRINT MEDICINES CORPORATION	05/16/19	2D 3D TSV
US10179773	10	Isoxazole carboxamides as irreversible SMYD inhibitors	EPIZYME, INC.	05/16/19	2D 3D TSV
US10183942	112	JAK kinase inhibitor compounds for treatment of respiratory disease	THERAVANCE BIOPHARMA R&D IP, LLC	05/16/19	2D 3D TSV
US10179804	132	Melanocortin receptor-specific peptides	Palatin Technologies, Inc.	05/16/19	2D 3D TSV
US10183954	14	Oxathiolane carboxylic acids and derivatives for the treatment and prophylaxis of virus infection	Hoffmann-La Roche Inc.	05/16/19	2D 3D TSV
US10183913	128	Pyrazole compound	SUMITOMO DAINIPPON PHARMA CO., LTD.	05/16/19	2D 3D TSV
US10183947	51	Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors	ASTRAZENECA AB	05/16/19	2D 3D TSV
US10174020	10	Pyridone or pyrimidone derivative, preparation method therefor and application thereof	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.	05/16/19	2D 3D TSV
US10183944	614	Pyrimido-pyridazinone compounds and methods of use thereof	Asana BioSciences, LLC	05/16/19	2D 3D TSV
US10174040	143	Pyrrolopyrimidine compound or salt thereof and compositions containing the pyrrolopyrimidine compound or salt thereof	Taiho Pharmaceutical Co., Ltd.	05/16/19	2D 3D TSV
US10183931	91	Rho kinase inhibitors	Kadmon Corporation, LLC	05/16/19	2D 3D TSV
US10179791	122	Spiro-cyclic amine derivatives as S1P modulators	AbbVie B.V.; AbbVie, Inc.	05/16/19	2D 3D TSV
US10183953	990	Substituted 2-azabicycles and their use as orexin receptor modulators	Janssen Pharmaceutica NV	05/16/19	2D 3D TSV
US10183932	357	Substituted oxopyridine derivatives and use thereof cardiovascular disorders	Bayer Pharma Aktiengesellschaft	05/16/19	2D 3D TSV
US10174028	1162	Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors	Array BioPharma Inc.	05/16/19	2D 3D TSV
US10174027	1162	Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors	Array BioPharma Inc.	05/16/19	2D 3D TSV
US10183009	122	Therapeutic compounds and uses thereof	GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC.	05/16/19	2D 3D TSV
US10183946	92	Triazolo[4,5-D]pyrimidines	HOFFMANN-LA ROCHE INC.	05/16/19	2D 3D TSV
US10183917	18	Tricyclic compounds and uses thereof in medicine	SUNSHINE LAKE PHARMA CO., LTD.	05/16/19	2D 3D TSV
US10183021	388	sGC stimulators	Ironwood Pharmaceuticals, Inc.	05/16/19	2D 3D TSV
US10174016	873	1,3-thiazol-2-yl substituted benzamides	BEYER AKTIENGESELLSCHAFT	05/15/19	2D 3D TSV
US9624197	30	2-pyridylamino-4-nitrile-piperidinyl orexin receptor antagonists	MERCK SHARP & DOHME CORP.	05/15/19	2D 3D TSV
US9624210	3	Amino-pyrimidine-containing spleen tyrosine kinase (Syk) inhibitors	MERCK SHARP & DOHME CORP.	05/15/19	2D 3D TSV
US10173985	34	Aminoindazole derivatives as sodium channel inhibitors	Almirall, S.A.	05/15/19	2D 3D TSV
US9624159	8	Aniline derivatives, their preparation and their therapeutic application	SANOFI	05/15/19	2D 3D TSV
US10174013	42	Benzimidazole derivatives as kinase inhibitors	SELVITA S.A.	05/15/19	2D 3D TSV
US10174000	62	Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators	Pfizer Inc.	05/15/19	2D 3D TSV
US9624235	20	Compounds and methods for inhibition of AP endonuclease-1/redox factor-1 (HAPE1) activity	University of Pittsburgh—Of the Commonwealth System of Higher Education	05/15/19	2D 3D TSV
US9624213	207	Compounds and methods for kinase modulation, and indications therefor	Plexxikon Inc.	05/15/19	2D 3D TSV
US9624217	159	Dihydropyrrolopyridine inhibitors of ROR-gamma	Vitae Pharmaceuticals, Inc.	05/15/19	2D 3D TSV
US9624175	82	Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors	FORMA THERAPEUTICS, INC.	05/15/19	2D 3D TSV
US9624194	25	Heteroaryl compounds as sodium channel blockers	Purdue Pharma L.P.	05/15/19	2D 3D TSV
US9624234	25	Heterocyclic compounds and methods for their use	NOVARTIS AG	05/15/19	2D 3D TSV
US9624243	85	Heterocyclic compounds and methods of their use	NOVARTIS AG	05/15/19	2D 3D TSV
US10174011	307	Heterocyclic compounds, process for preparation of the same and use thereof	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES; SUZHOU VIGONVITA LIFE SCIENCES CO., LTD.; TOPHARMAN SHANDONG CO., LTD.	05/15/19	2D 3D TSV
US10173996	511	Histone demethylase inhibitors	Celgene Quanticel Research, Inc.	05/15/19	2D 3D TSV
US10174003	329	Histone demethylase inhibitors	Celgene Quanticel Research, Inc.	05/15/19	2D 3D TSV
US9624188	12	IDO inhibitors	Bristol-Myers Squibb Company	05/15/19	2D 3D TSV
US9624228	377	Inhibitors of ERK and methods of use	Kura Oncology, Inc.	05/15/19	2D 3D TSV
US9624201	20	Inhibitors of bruton's tyrosine kinase	HOFFMANN-LA ROCHE INC.; CHUGAI PHARMACEUTICAL CO.	05/15/19	2D 3D TSV
US9623028	67	Methods of treating a cancer using substituted pyrrolopyrimidine compounds, compositions thereof	Signal Pharmaceuticals, LLC	05/15/19	2D 3D TSV
US10173988	15	N2-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,4-diamine	GLUCOX BIOTECH AB	05/15/19	2D 3D TSV
US9623021	24	Nuclear receptor binding agents	GTX, Inc.	05/15/19	2D 3D TSV
US9624247	107	Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease	NOVARTIS AG	05/15/19	2D 3D TSV
US9624246	30	Pyridazinone macrocycles as IRAK inhibitors and uses thereof	Merck Patent GmbH	05/15/19	2D 3D TSV
US10173995	7	Pyridine compounds used as PI3 kinase inhibitors	Teligene Ltd.	05/15/19	2D 3D TSV
US9624218	112	Pyrido[2,3-d]pyrimidin-4-one compounds as tankyrase inhibitors	Eli Lilly and Company	05/15/19	2D 3D TSV
US10174007	40	Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors	Pfizer Inc.	05/15/19	2D 3D TSV
US9624205	12	Substituted 6,5-fused bicyclic heteroaryl compounds	Epizyme, Inc.	05/15/19	2D 3D TSV
US9624199	21	Substituted bipiperidinyl derivatives	Bayer Pharma Aktiengesellschaft	05/15/19	2D 3D TSV
US10174015	92	Substituted heterocyclic derivative, preparation method and use thereof	Xiamen University	05/15/19	2D 3D TSV
US9624198	15	Substituted piperidinyltetrahydroquinolines	Bayer Pharma Aktiengesellschaft	05/15/19	2D 3D TSV
US10172868	103	Substituted quinazolines for inhibiting kinase activity	NEUPHARMA, INC.	05/15/19	2D 3D TSV
US10173991	590	Sulfone amide linked benzothiazole inhibitors of endothelial lipase	Bristol-Myers Squibb Company	05/15/19	2D 3D TSV
US9624241	574	Tricyclic heterocycles as BET protein inhibitors	Incyte Corporation; Incyte Holdings Corporation	05/15/19	2D 3D TSV
US10173990	17	URAT1 inhibitor	Nippon Chemiphar Co., Ltd.; J-Pharma Co., Ltd.; DeThree Res. Lab. Inc.	05/15/19	2D 3D TSV
US9617246	74	Thioether-piperidinyl orexin receptor antagonists	MERCK SHARP & DOHME CORP.	05/10/19	2D 3D TSV
US9617225	165	4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity	VIROSTATICS SRL	05/08/19	2D 3D TSV
US9617262	62	Antibacterial cyclopental[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones	Janssen Sciences Ireland UC	05/08/19	2D 3D TSV
US9617267	761	Compounds and methods for kinase modulation, and indications therefor	Plexxikon Inc.	05/08/19	2D 3D TSV
US9617226	45	Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases	AbbVie Deutschland GmbH & Co. KG	05/08/19	2D 3D TSV
US9617273	122	Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors	BeiGene, Ltd.	05/08/19	2D 3D TSV
US9617259	45	Histone deacetylase inhibitors and compositions and methods of use thereof	CHDI Foundation, Inc.	05/08/19	2D 3D TSV
US9617242	237	Histone demethylase inhibitors	CELGENE QUANTICEL RESEARCH, INC.	05/08/19	2D 3D TSV
US9617281	8	Imidazo[2,1-b]thiazole derivatives, their preparation and use as medicaments	LABORATORIES DEL DR. ESTEVE S.A.	05/08/19	2D 3D TSV
US9617260	34	Inhibitors of bruton's tyrosine kinase	Hoffmann-La Roche Inc.	05/08/19	2D 3D TSV
US9617282	218	Macrocyclic compounds as IRAK4 inhibitors for the treatment of inflammatory diseases	BIOGEN MA INC.	05/08/19	2D 3D TSV
US9617269	97	N-substituted pyrazolo [3,4-D] pyrimidine ketone compound, and preparation process and use thereof	Sun Yat-Sen University; University of North Carolina at Chapel Hill	05/08/19	2D 3D TSV
US9617239	89	Phenoxy thiophene sulfonamides and their use as inhibitors of glucuronidase	North Carolina Central University; The University of North Carolina at Chapel Hill	05/08/19	2D 3D TSV
US9617250	26	Pyridin-4-yl derivatives	ACTELION PHARMACEUTICALS LTD.	05/08/19	2D 3D TSV
US9617258	611	Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides	Pfizer Inc.	05/08/19	2D 3D TSV
US9617261	11	Substituted pyridinone compounds as MEK inhibitors	CMG PHARMACEUTICAL CO., LTD.	05/08/19	2D 3D TSV
US9617271	72	Triazolo compounds	Hoffmann-La Roche Inc.	05/08/19	2D 3D TSV
US9617272	20	Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization	NewLink Genetics Corporation	05/08/19	2D 3D TSV
US9616063	30	1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidase	AstraZeneca AB	05/07/19	2D 3D TSV
US9617222	48	Alkynyl indazole derivative and use thereof	SENJU PHARMACEUTICAL CO., LTD.	05/07/19	2D 3D TSV
US9616064	137	Rho kinase inhibitors and methods of use	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.	05/07/19	2D 3D TSV
US9616059	12	Substituted indazole derivatives active as kinase inhibitors	NERVIANO MEDICAL SCIENCES S.R.L.	05/07/19	2D 3D TSV
US10172856	122	2,4-diaminopyrimidine derivatives as histamine H4 modulators	Janssen Pharmaceutica NV	04/30/19	2D 3D TSV
US10172859	919	Arylquinazolines	Merck Patent GmbH	04/30/19	2D 3D TSV
US9611269	84	Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors	Incyte Corporation; Incyte Holdings Corporation	04/30/19	2D 3D TSV
US10172858	368	Combination pharmaceutical compositions and uses thereof	INTELLIKINE LLC	04/30/19	2D 3D TSV
US9611270	21	Inhibitors of CYP17A1	UNIVERSITY OF KANSAS	04/30/19	2D 3D TSV
US10172837	11	Insulin sensitisers and methods of treatment	Naia Metabolic, Inc.	04/30/19	2D 3D TSV
US9611275	61	Permeable glycosidase inhibitors and uses thereof	ALECTOS THERAPEUTICS, INC.; MERCK SHARP & DOHME CORP.	04/30/19	2D 3D TSV
US10172843	81	Piperidine derivatives	Hoffmann-La Roche Inc.	04/30/19	2D 3D TSV
US9611277	990	Substituted 2-azabicycles and their use as orexin receptor modulators	Janssen Pharmaceutica NV	04/30/19	2D 3D TSV
US10172845	2116	Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors	Array BioPharma Inc.	04/30/19	2D 3D TSV
US10172851	1229	Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors	Array BioPharma Inc.	04/30/19	2D 3D TSV
US10172814	213	Substituted pyridyl-cycloalkyl-carboxylic acids, compositions containing them and medical uses thereof	BAYER PHARMA AKTIENGESELLSCHAFT	04/30/19	2D 3D TSV
US10172864	1070	Therapeutically active compounds and their methods of use	Agios Pharmaceuticals, Inc.	04/30/19	2D 3D TSV
US9611229	39	1,2,3-triazole-4-amine derivatives for the treatment of sigma receptor related diseases and disorders	LABORATORIOS DEL DR. ESTEVE S.A.	04/29/19	2D 3D TSV
US9611249	35	1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors	AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A.	04/29/19	2D 3D TSV
US9611224	350	Antiproliferative benzo [B] azepin-2-ones	HOFFMANN-LA ROCHE INC.	04/29/19	2D 3D TSV
US9610264	16	Compounds for the treatment and prevention of retroviral infections	KFLP BIOTECH, LLC	04/29/19	2D 3D TSV
US9610299	42	Compounds for the treatment of addiction	Gilead Sciences, Inc.	04/29/19	2D 3D TSV
US9611221	199	Histone demethylase inhibitors	Celgene Quanticel Research, Inc.	04/29/19	2D 3D TSV
US9610322	10	Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof	President and Fellows of Harvard College	04/29/19	2D 3D TSV
US9611232	8	Oxazolidinone and imidazolidinone compounds	Hoffmann-La Roche Inc.	04/29/19	2D 3D TSV
US9611261	846	Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use	Amgen Inc.	04/29/19	2D 3D TSV
US9611222	152	Pyridine compounds and the uses thereof	Purdue Pharma L.P.	04/29/19	2D 3D TSV
US9611262	489	Substituted 2-azabicycles and their use as orexin receptor modulators	Janssen Pharmaceutica NV	04/29/19	2D 3D TSV
US9611251	546	Substituted piperidine compounds and their use as orexin receptor modulators	Janssen Pharmaceutica NV	04/29/19	2D 3D TSV
US9611259	3	Substituted pyridine derivatives useful as C-FMS kinase inhibitors	Janssen Pharmaceutica NV	04/29/19	2D 3D TSV
US9611267	699	Substituted tricyclic compounds as FGFR inhibitors	Incyte Holdings Corporation; Incyte Corporation	04/29/19	2D 3D TSV
US9611252	146	Therapeutic inhibitory compounds	LIFESCI PHARMACEUTICALS, INC.	04/29/19	2D 3D TSV
US9611265	241	Tropomyosin-related kinase (TRK) inhibitors	GENZYME CORPORATION	04/29/19	2D 3D TSV
US10167299	125	1-(3-aminopropyl) substituted cyclic amine compounds, preparation method therefor, and pharmaceutical compositions and uses thereof	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES	04/24/19	2D 3D TSV
US10167282	14	1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido [2, 3-B]pyrazin- 8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer	CANCER RESEARCH TECHNOLOGY LIMITED; INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE)	04/24/19	2D 3D TSV
US9605007	135	2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides	Pfizer Inc.	04/24/19	2D 3D TSV
US10167261	20	2-oxo-3,4-dihydroquinolin-6-yl sulphonamide CPDS and their use as plant growth regulators	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA; SYNGENTA PARTICIPATIONS AG	04/24/19	2D 3D TSV
US9605006	15	5-aryl-1-imino-1-oxo-[1,2,4]thiadiazines	Hoffmann-La Roche Inc.	04/24/19	2D 3D TSV
US9605005	199	Alkynyl alcohols and methods of use	Genentech, Inc.	04/24/19	2D 3D TSV
US10167292	172	Benzodiazepines as bromodomain inhibitors	Catalyst Therapeutics Pty Ltd.	04/24/19	2D 3D TSV
US9605008	21	Benzyl-1H-pyrazolo[3,4-b]pyridines and use thereof	BAYER PHARMA AKTIENGESELLSCHAFT	04/24/19	2D 3D TSV
US10167279	409	Compounds and compositions as RAF kinase inhibitors	Novartis AG	04/24/19	2D 3D TSV
US10167276	207	Compounds and methods for inhibiting JAK	Dizal (Jiangsu) Pharmaceutical Co., Ltd.	04/24/19	2D 3D TSV
US9604998	109	Inhibitors of the renal outer medullary potassium channel	Merck Sharp & Dohme Corp.	04/24/19	2D 3D TSV
US9605022	39	Macrocyclic compounds for inhibition of inhibitors of apoptosis	Ensemble Therapeutics Corporation	04/24/19	2D 3D TSV
US9605024	9	PAR4 agonist peptides	Bristol-Myers Squibb Company	04/24/19	2D 3D TSV
US10167256	8	Psychotrophic agents and uses thereof	LB PHARMACEUTICALS INC.	04/24/19	2D 3D TSV
US10167313	102	Selective caspase inhibitors and uses thereof	Genesis Technologies Limited	04/24/19	2D 3D TSV
US10167285	48	Small-molecule HSP90 inhibitors	Memorial Sloan Kettering Cancer Center	04/24/19	2D 3D TSV
US10166249	952	Substituted bicyclic compounds	Bristol-Myers Squibb Company	04/24/19	2D 3D TSV
US10167280	108	Substituted oxopyridine derivatives	BAYER PHARMA AKTIENGESELLSCHAFT	04/24/19	2D 3D TSV
US10167264	10	Substituted pyrimidines useful as EGFR-T790M kinase inhibitors	Jiangsu Medolution Ltd	04/24/19	2D 3D TSV
US10167270	175	Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activity	Northwestern University	04/24/19	2D 3D TSV
US10167281	213	Substituted thiazole or oxazole P2X7 receptor antagonists	Axxam S.P.A.	04/24/19	2D 3D TSV
US10166216	151	Substituted triazoles useful as Axl inhibitors	Rigel Pharmaceuticals, Inc.	04/24/19	2D 3D TSV
US10167273	111	Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases	Takeda Pharmaceutical Company Limited	04/24/19	2D 3D TSV
US10167296	99	Sulfoximine substituted quinazolines for pharmaceutical compositions	EVOTEC INTERNATIONAL GMBH	04/24/19	2D 3D TSV
US10166239	241	Tropomyosin-related kinase (Trk) inhibitors	Genzyme Corporation	04/24/19	2D 3D TSV
US10167293	76	[8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones	BAYER PHARMA AKTIENGESELLSCHAFT	04/24/19	2D 3D TSV
US9603834	27	1,2- bis-sulfonamide derivatives as chemokine receptor modulators	ALLERGAN, INC.	04/23/19	2D 3D TSV
US9604984	934	5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof	Genentech, Inc.	04/23/19	2D 3D TSV
US9604960	81	Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof	Albany Molecular Research, Inc.	04/23/19	2D 3D TSV
US9604944	6	Arylpiperazine derivatives and methods of utilizing same	REVIVA PHARMACEUTICALS, INC.	04/23/19	2D 3D TSV
US9603833	88	Benzene or thiophene derivative and use thereof as VAP-1 inhibitor	R-Tech Ueno, Ltd.	04/23/19	2D 3D TSV
US9604977	516	Bicyclic thiophenylamide compounds	Hoffman-La Roche Inc.	04/23/19	2D 3D TSV
US9604926	226	Highly selective sigma receptor radioligands	THE UNIVERSITY OF MISSISSIPPI	04/23/19	2D 3D TSV
US9604961	509	Histone demethylase inhibitors	Celgene Quanticel Research, Inc.	04/23/19	2D 3D TSV
US9603889	86	IAP antagonists	Bristol-Myers Squibb Company	04/23/19	2D 3D TSV
US9604989	159	Imidazopyridazines as Akt kinase inhibitors	BAYER INTELLECTUAL PROPERTY GMBH; BAYER PHARMA AKTIENGESELLSCHAFT	04/23/19	2D 3D TSV
US9603854	119	Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them	LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD	04/23/19	2D 3D TSV
US9604931	24	Nuclear receptor binding agents	GTx, Inc.; THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS	04/23/19	2D 3D TSV
US9604982	678	P2X7 modulators	Janssen Pharmaceutica NV	04/23/19	2D 3D TSV
US9603836	28	Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for use as IDO1 inhibitors	ITEOS THERAPEUTICS	04/23/19	2D 3D TSV
US9603819	13	Substituted aminobutyric derivatives as neprilysin inhibitors	NOVARTIS AG	04/23/19	2D 3D TSV
US9604945	7	Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders	Caliper Life Sciences, Inc.	04/23/19	2D 3D TSV
US10166226	9	CGRP receptor antagonists	Heptares Therapeutics Limited	04/11/19	2D 3D TSV
US10166229	10	Compounds and methods for the treatment of cancer	The Board of Trustees of the University of Illinois	04/11/19	2D 3D TSV
US10155763	7	2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors	TIUMBIO CO., LTD.	04/10/19	2D 3D TSV
US10155750	76	Amidoethyl azole orexin receptor antagonists	Merck Sharp & Dohme Corp.	04/10/19	2D 3D TSV
US10155760	237	Biaryl kinase inhibitors	Bristol-Myers Squibb Company	04/10/19	2D 3D TSV
US10155765	66	Carboxamide inhibitors of IRAK4 activity	Merck Sharp & Dohme Corp.	04/10/19	2D 3D TSV
US10155769	91	Fused azaheterocyclic compounds and their use as AMPA receptor modulators	Janssen Pharmaceutica NV	04/10/19	2D 3D TSV
US10155768	520	Fused pyrimidine compound or salt thereof	Taiho Pharmaceutical Co., Ltd.	04/10/19	2D 3D TSV
US10155752	16	Indazoles and use thereof	Purdue Pharma L.P.	04/10/19	2D 3D TSV
US10155733	27	N-aralkylcarbonyl-piperazine and -homopiperazine compounds and personal care compositions comprising the same	Conopco, Inc.	04/10/19	2D 3D TSV
US10155731	131	Nitrogen-containing saturated heterocyclic compound	MITSUBISHI TANABE PHARMA CORPORATION; SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.	04/10/19	2D 3D TSV
US10155751	81	Pyrazolyl-substituted heteroaryls and their use as medicaments	Boehringer Ingelheim International GmbH	04/10/19	2D 3D TSV
US10155732	5	Ribonucleotide reductase inhibitors and methods of use	City of Hope	04/10/19	2D 3D TSV
US10155972	10	Screening method	Iomet Pharma Ltd.	04/10/19	2D 3D TSV
US10166214	284	Somatostatin receptor subtype 4 (SSTR4) agonists	Centrexion Therapeutics Corporation	04/10/19	2D 3D TSV
US10155775	8	Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitors	Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.	04/10/19	2D 3D TSV
US10155764	114	Therapeutic compounds and uses thereof	GENENTECH, INC; CONSTELLATION PHARMACEUTICALS, INC.	04/10/19	2D 3D TSV
US10150759	3	1,4-pyridone bicycic heteroaryl compounds	Epizyme, Inc.	04/09/19	2D 3D TSV
US10150755	127	ASK1 inhibitor compounds and uses thereof	SEAL ROCK THERAPEUTICS, INC.	04/09/19	2D 3D TSV
US9657003	40	Androgen receptor modulating compounds	ORION CORPORATION	04/09/19	2D 3D TSV
US10155722	20	Antitumor compound targeting IDH2 mutation and method of use thereof	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.; Centaurus Biopharma Co., Ltd.	04/09/19	2D 3D TSV
US10155002	334	Aryl- or heteroaryl-substituted benzene compounds	Epizyme, Inc.	04/09/19	2D 3D TSV
US9657001	65	Compounds and uses	ASTRAZENECA AB	04/09/19	2D 3D TSV
US10150760	390	Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor	AMGEN INC.	04/09/19	2D 3D TSV
US9656996	17	Fused heterocyclic compound, preparation method therefor, pharmaceutical composition, and uses thereof	SHANGHAI YINGLI PHARMACEUTICAL CO., LTD.	04/09/19	2D 3D TSV
US9657009	168	Heteroaryl substituted pyridyl compounds useful as kinase modulators	Bristol-Myers Squibb Company	04/09/19	2D 3D TSV
US10150763	76	Histone deacetylase inhibitors and their use in therapy	Karus Therapeutics Limited	04/09/19	2D 3D TSV
US9656988	1351	Inhibitors of Bruton's tyrosine kinase	PHARMACYCLICS LLC	04/09/19	2D 3D TSV
US9656991	121	Inhibitors of glutaminyl cyclase	PROBIODRUG AG	04/09/19	2D 3D TSV
US10150765	843	P2X7 modulators	Janssen Pharmaceutica NV	04/09/19	2D 3D TSV
US10150766	102	P2X7 modulators	Janssen Pharmaceutica NV	04/09/19	2D 3D TSV
US10150758	30	PRMT5 inhibitors and uses thereof	Epizyme, Inc.	04/09/19	2D 3D TSV
US10155727	217	Pyrazoles	JANSSEN PHARMACEUTICALS, INC.	04/09/19	2D 3D TSV
US9657007	36	Substituted aminopyrimidine compounds and methods of use	CALITOR SCIENCES, LLC; SUNSHINE LAKE PHARMA CO., LTD.	04/09/19	2D 3D TSV
US10150764	139	Substituted benzene compounds	Epizyme, Inc.	04/09/19	2D 3D TSV
US9657015	73	Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity	Boehringer Ingelheim International GmbH	04/09/19	2D 3D TSV
US10150787	10	TC-PTP inhibitors as APC activators for immunotherapy	TBA	04/09/19	2D 3D TSV
US9657033	112	Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease	Lycera Corporation; Merck Sharp & Dohme Corp.	04/09/19	2D 3D TSV
US10150767	46	Therapeutic compounds and uses thereof	Genentech, Inc.; Constellation Pharmaceuticals Inc.	04/09/19	2D 3D TSV
US10150762	178	Trifluoromethyl alcohols as modulators of RORγt	Janssen Pharmaceutica, NV	04/09/19	2D 3D TSV
US9656975	20	Bicyclo[3.2.1]octyl amide derivatives and uses of same	H. Lundbeck A/S	04/08/19	2D 3D TSV
US9655879	188	Heteroarylcarboxylic acid ester derivative	EA Pharma Co., Ltd.	04/08/19	2D 3D TSV
US9656961	158	Methods for treating depressive symptoms	ALKERMES PHARMA IRELAND LIMITED	04/08/19	2D 3D TSV
US9656968	122	Pyrimidines as sodium channel blockers	TBA	04/08/19	2D 3D TSV
US9656955	808	Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy	AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG	04/08/19	2D 3D TSV
US9656962	87	Ring-contracted morphinans and the use thereof	Purdue Pharma L.P.	04/08/19	2D 3D TSV
US9656959	90	Substituted pyridines as sodium channel blockers	Purdue Pharma L.P.	04/08/19	2D 3D TSV
US9649308	246	Benzamide-containing compounds and their use in the treatment of pain	H. Lundbeck A/S	04/03/19	2D 3D TSV
US9650377	368	Diazepinone derivatives	Novartis AG	04/03/19	2D 3D TSV
US9650366	16	Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors	ALLERGAN, INC.	04/03/19	2D 3D TSV
US9650362	20	Inhibitors	PROBIODRUG AG	04/03/19	2D 3D TSV
US9650336	11	Mono-fluoro beta-secretase inhibitors	ASTRAZENECA AB	04/03/19	2D 3D TSV
US9650358	339	Pyridine CDK9 kinase inhibitors	AbbVie Inc.	04/03/19	2D 3D TSV
US9650371	37	Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity	Shionogi & Co., Ltd.	04/03/19	2D 3D TSV
US9649309	1394	Therapeutic uses of selected pyrimidine compounds with anti-Mer tyrosine kinase activity	The University of North Carolina at Chapel Hill	04/03/19	2D 3D TSV
US10150740	15	6,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infection	Hoffmann-La Roche Inc.	03/31/19	2D 3D TSV
US10150728	704	Alkylene derivatives	SHIONOGI & CO., LTD.	03/31/19	2D 3D TSV
US10144746	350	Bridged bicyclic kallikrein inhibitors	Global Blood Therapeutics, Inc.	03/31/19	2D 3D TSV
US10150743	28	Carboxylic acid compounds	Sumitomo Dainippon Pharma Co., Ltd.	03/31/19	2D 3D TSV
US10149839	156	Chemical compounds	AstraZeneca AB	03/31/19	2D 3D TSV
US10149841	6	Compound of 3-hydroxyl pyridine, preparation method thereof and pharmaceutical use thereof	SHENYANG SUNSHINE PHARMACEUTICAL CO. LTD.	03/31/19	2D 3D TSV
US10150747	65	Compounds for the treatment of hepatitis C	Bristol-Myers Squibb Company	03/31/19	2D 3D TSV
US10149835	7	Isoxazole derivatives as FXR agonists and methods of use thereof	Elmore Patent Law Group, P.C.	03/31/19	2D 3D TSV
US10149840	3	OCT3 activity inhibitor containing imidazopyridine derivative as active component, and OCT3 detection agent	SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.	03/31/19	2D 3D TSV
US10150751	82	Pyrrolidine orexin receptor antagonists	Merck Sharp & Dohme Corp.	03/31/19	2D 3D TSV
US10143681	183	Factor XIa inhibitors	Merck Sharp & Dohme Corp.	03/30/19	2D 3D TSV
US10138245	14	Fused triazole derivatives as phosphodiesterase 10A inhibitors	CELON PHARMA S.A.	03/30/19	2D 3D TSV
US10143668	5	Hydroxy-substituted amino and ammonium derivatives and their medical use	GRI BIO, INC.	03/30/19	2D 3D TSV
US10138253	38	Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication	ViiV HEALTHCARE UK (NO.5) LIMITED	03/30/19	2D 3D TSV
US10143746	28	Immunomodulators	Bristol-Myers Squibb Company	03/30/19	2D 3D TSV
US10144729	8	Isoxazole analogs as FXR agonists and methods of use thereof	ENANTA PHARMACEUTICALS, INC.	03/30/19	2D 3D TSV
US10143704	1	Methods for treating cancer	Epizyme, Inc.	03/30/19	2D 3D TSV
USRE47141	78	Methods of treating fibrosis, cancer and vascular injuries	EWHA UNIVERSITY—INDUSTRY COLLABORATION FOUNDATION	03/30/19	2D 3D TSV
US10144731	519	Nrf2 regulators	GlaxoSmithKline Intellectual Property Development Limited; Astex Therapeutics, Ltd	03/30/19	2D 3D TSV
US10144715	925	Piperazine derivatives as liver X receptor modulators	Vitae Pharmaceuticals, Inc.	03/30/19	2D 3D TSV
US10144738	148	Pyrazolo[1,5-A]PYRAZIN-4-YL derivatives	Pfizer Inc.	03/30/19	2D 3D TSV
US10138242	229	Pyrazolopyridine derivatives and their use in therapy	TBA	03/30/19	2D 3D TSV
US10143695	130	Pyrrolobenzodiazepines and conjugates thereof	Mersana Therapeutics, Inc.	03/30/19	2D 3D TSV
US10144742	520	Quinoxaline compounds and uses thereof	Millennium Pharmaceuticals, Inc.	03/30/19	2D 3D TSV
US10144734	2116	Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors	Array BioPharma Inc.	03/30/19	2D 3D TSV
US10138249	20	Triazolopyridines and triazolopyrazines as LSD1 inhibitors	Incyte Corporation	03/30/19	2D 3D TSV
US10137110	81	1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors	Bayer Pharma Aktiengesellschaft	03/29/19	2D 3D TSV
US9597318	7	2-oxothiazole compounds and method of using same for chronic inflammatory disorders	Avexxin AS	03/29/19	2D 3D TSV
US9598446	65	Amino compounds for treatment of complement mediated disorders	ACHILLION PHARMACEUTICALS, INC.	03/29/19	2D 3D TSV
US10138212	111	Aminoquinazoline compounds as A2A antagonist	Merck Sharp & Dohme Corp.	03/29/19	2D 3D TSV
US9598407	41	Antibacterial piperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinones	Janssen Sciences Ireland UC	03/29/19	2D 3D TSV
US10137202	11	Antibody-drug conjugates and immunotoxins	Oncomatryx Biopharma, S.L.	03/29/19	2D 3D TSV
US10138230	125	Autotaxin inhibitors	Cancer Research Technology Limited	03/29/19	2D 3D TSV
US9597333	160	Benzazepine dicarboxamide compounds	Hoffmann-La Roche Inc.	03/29/19	2D 3D TSV
US10138226	44	Benzimidazol-2-amines as MIDH1 inhibitors	Bayer Pharma Aktiengesellschaft	03/29/19	2D 3D TSV
US9597326	26	Benzonapthyridine compositions and uses thereof	GlaxoSmithKline Biologicals SA; U.S. Army Medical Research and Materiel Command	03/29/19	2D 3D TSV
US10131670	108	Bicyclic heteroaryl derivatives as CFTR potentiators	CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC.	03/29/19	2D 3D TSV
US10131663	194	Chemical compounds	AstraZeneca AB	03/29/19	2D 3D TSV
US9598415	265	Compounds as modulators of RORγ	Boehringer Ingelheim International GmbH	03/29/19	2D 3D TSV
US9598431	15	Compounds useful for inhibiting ROR-gamma-t	Eli Lilly and Company	03/29/19	2D 3D TSV
US10138240	2	Crystal of 5-hydroxy-4-(trifluoromethyl)pyrazolopyridine derivative	Daiichi Sankyo Company, Limited	03/29/19	2D 3D TSV
US9597330	60	Drugs for treating respiratory diseases	Daiichi Sankyo Company, Limited	03/29/19	2D 3D TSV
US10138236	66	Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives	BAYER PHARMA AKTIENGESELLSCHAFT	03/29/19	2D 3D TSV
US10138229	156	Heteroaromatic compounds as BTK inhibitors	Boehringer Ingelheim International GmbH	03/29/19	2D 3D TSV
US9598421	372	Imidazopyridazine compounds	Pfizer Inc.	03/29/19	2D 3D TSV
US9597310	65	Indanyloxydihydrobenzofuranylacetic acids	Boehringer Ingelheim International GmbH	03/29/19	2D 3D TSV
US9598440	159	Inhibitors of IRAK4 activity	MERCK SHARP & DOHME CORP.	03/29/19	2D 3D TSV
US10131664	178	Inhibitors of lysine specific demethylase-1	Celgene Quanticel Research, Inc.	03/29/19	2D 3D TSV
US10138228	4	Isoxazole derivatives as FXR agonists and methods of use therof	ENANTA PHARMACEUTICALS, INC.	03/29/19	2D 3D TSV
US10137122	244	Kinase inhibitors and methods of use thereof	The Broad Institute, Inc.; Dana-Farber Cancer Institute, Inc.; The General Hospital Corporation	03/29/19	2D 3D TSV
US9598426	8	Organic compounds	INTRA-CELLULAR THERAPIES, INC.	03/29/19	2D 3D TSV
US9598447	72	Phosphorus-substituted quinoxaline-type piperidine compounds and uses thereof	Purdue Pharma L.P.	03/29/19	2D 3D TSV
US10131673	42	Piperidine substituted tricyclic pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (RSV)	Janssen Sciences Ireland UC	03/29/19	2D 3D TSV
US9598370	55	Prolyl hydroxylase inhibitors and methods of use	Akebia Therapeutics, Inc.	03/29/19	2D 3D TSV
US9598381	18	SMYD2 inhibitors	AbbVie Inc.	03/29/19	2D 3D TSV
US9598410	68	Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, their use as medicament, and pharmaceutical preparations comprising them	SANOFI	03/29/19	2D 3D TSV
US9598423	827	Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitors	Bristol-Myers Squibb Company	03/29/19	2D 3D TSV
US10138222	122	Substituted benzamides as RIPK2 inhibitors	Boehringer Ingelheim International GmbH	03/29/19	2D 3D TSV
US10138241	97	Substituted benzamides as RIPK2 inhibitors	Boehringer Ingelheim International GmbH	03/29/19	2D 3D TSV
US9598411	172	Substituted benzimidazole-type piperidine compounds and uses thereof	Purdue Pharma L.P.	03/29/19	2D 3D TSV
US9598416	159	Substituted benzothienyl-pyrrolotriazines and uses thereof in the treatment cancer	BAYER INTELLECTUAL PROPERTY GMBH	03/29/19	2D 3D TSV
US9598436	18	Substituted bicyclic heteroaryl compounds	Bristol-Myers Squibb Company	03/29/19	2D 3D TSV
US9598401	63	Substituted heteroaryl compounds and methods of use thereof	SUNSHINE LAKE PHARMA CO., LTD.	03/29/19	2D 3D TSV
US9597317	74	Substituted indazole derivatives active as kinase inhibitiors	NERVIANO MEDICAL SCIENCES S.R.L.	03/29/19	2D 3D TSV
US10137124	1229	Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors	Array BioPharma Inc.	03/29/19	2D 3D TSV
US10131667	699	Substituted tricyclic compounds as FGFR inhibitors	Incyte Corporation	03/29/19	2D 3D TSV
US9598396	39	Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors	Janssen Pharmaceutica NV	03/29/19	2D 3D TSV
US9598405	52	Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors	Merck Sharp & Dohme Corp.	03/29/19	2D 3D TSV
US10137210	9	Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition	The University of Pittsburgh—Of the Commonwealth System of Higher Education	03/29/19	2D 3D TSV
US10131675	153	Tricyclic DLK inhibitors and uses thereof	Genentech, Inc.	03/29/19	2D 3D TSV
US9598387	260	Urea and amide derivatives of aminoalkylpiperazines and use thereof	Southern Research Institute	03/29/19	2D 3D TSV
US10131692	88	Vasopressin-2 receptor agonists	Ferring B.V.	03/29/19	2D 3D TSV
US10130619	70	Amido thiadiazole derivatives as NADPH oxidase inhibitors	GENKYOTEX SUISSE SA	03/28/19	2D 3D TSV
US10131658	37	Anti-alphavbeta1 integrin compounds and methods	The Regents of the University of California	03/28/19	2D 3D TSV
US10131645	33	Benzofurans substituted with primary benzamide as HCV inhibitors	Bristol-Myers Squibb Company	03/28/19	2D 3D TSV
US10130617	18	Chemical compounds	AstraZeneca AB	03/28/19	2D 3D TSV
US10130633	700	Compounds	BAYER PHARMA AKTIENGESELLSCHAFT	03/28/19	2D 3D TSV
US10130622	11	Compounds for treatment of cystic fibrosis	AbbVie S.á.r.l.; Galapagos NV	03/28/19	2D 3D TSV
US10130642	65	Neprilysin inhibitors	THERAVANCE BIOPHARMA R&D IP, LLC	03/28/19	2D 3D TSV
US10131648	98	Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes	Janssen Pharmaceutica NV	03/28/19	2D 3D TSV
US10131651	13	[7,6]-fused bicyclic antidiabetic compounds	Merck Sharp & Dohme Corp.	03/28/19	2D 3D TSV
US9593097	435	Axl inhibitors	Pfizer Inc.	03/15/19	2D 3D TSV
US9593099	22	Compounds and compositions as protein kinase inhibitors	Array BioPharma, Inc.	03/15/19	2D 3D TSV
US9593100	23	Compounds and compositions as protein kinase inhibitors	Array BioPharma, Inc.	03/15/19	2D 3D TSV
US9593127	20	Heterocyclylalkyne derivatives and their use as modulators of mGluR5 receptors	RECORDATI IRELAND LTD.	03/15/19	2D 3D TSV
US9593123	194	Triazolo[4,5-D]pyrimidine derivatives	Hoffmann-La Roche Inc.	03/15/19	2D 3D TSV
US9592235	219	Aminoquinazoline and pyridopyrimidine derivatives	Genentech, Inc.	03/14/19	2D 3D TSV
US9593105	223	Cyclic amines	H. Lundbeck A/S	03/14/19	2D 3D TSV
US9593110	201	Neprilysin inhibitors	Theravence Biopharma R&D IP, LLC	03/14/19	2D 3D TSV
US9592230	125	Substituted imidazoles as PDE10A inhibitors	H. Lundbeck A/S	03/14/19	2D 3D TSV
US10125145	31	5-HT3 receptor antagonists	Takeda Pharmaceutical Company Limited	03/12/19	2D 3D TSV
US10125150	26	Crystalline forms of a PI3K inhibitor	Incyte Corporation	03/12/19	2D 3D TSV
US9593113	85	Imide and acylurea derivatives as modulators of the glucocorticoid receptor	Bristol-Myers Squibb Company	03/12/19	2D 3D TSV
US9593121	14	Indole substituted pyrrolopyrimidinyl inhibitors of Uba6	Millennium Pharmaceuticals, Inc.	03/12/19	2D 3D TSV
US9593129	497	Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer	Amgen, Inc.	03/12/19	2D 3D TSV
US10125148	28	Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication	ViiV HEALTHCARE UK (NO. 5) LIMITED	03/12/19	2D 3D TSV
US10125097	18	1- [1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives	UNIVERSITAT DE BARCELONA; FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA); IPROTEOS S.L.	03/11/19	2D 3D TSV
US10125111	99	Benzofuran compounds for the treatment of hepatitis C	Bristol-Myers Squibb Company	03/11/19	2D 3D TSV
US10125137	10	Benzofurans substituted with bicyclic secondary benzamide as HCV inhibitors	Bristol-Myers Squibb Company	03/11/19	2D 3D TSV
US10124009	14	Bromodomain inhibitors	Tensha Therapeutics, Inc.	03/11/19	2D 3D TSV
US10125135	51	Chemical compounds	AstraZeneca AB	03/11/19	2D 3D TSV
US10123995	32	Factor XIa inhibitors	Merck Sharp & Dohme Corp.	03/11/19	2D 3D TSV
US10125118	458	Heteroaryl compounds and their use as therapeutic drugs	Dong-A Socio Holdings Co., Ltd.	03/11/19	2D 3D TSV
US10117875	20	Immune system modulators	JANUS BIOTHERAPEUTICS, INC.	03/11/19	2D 3D TSV
US10125101	123	Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof	Boehringer Ingelheim International GmbH	03/11/19	2D 3D TSV
US10112968	7	Inhibitors of protein methyltransferase DOT1L and methods of use thereof	Epizyme, Inc.	03/11/19	2D 3D TSV
US10112955	73	Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2	eFFECTOR Therapeutics, Inc.	03/11/19	2D 3D TSV
US10118894	7	Isoindolinone derivatives useful as antiviral agents	ViiV HEALTHCARE UK LIMITED	03/11/19	2D 3D TSV
US10118915	563	Kappa opioid ligands	The Scripps Research Institute	03/11/19	2D 3D TSV
US10125100	197	Kinase inhibitors	Topivert Pharma Limited	03/11/19	2D 3D TSV
US10125125	58	N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors	Active Biotech AB	03/11/19	2D 3D TSV
US10123984	50	Neprilysin inhibitors	THERAVANCE BIOPHARMA R&D IP, LLC	03/11/19	2D 3D TSV
US10118929	6	Nonanoic and decanoic acid derivatives and uses thereof	SciFluor Life Sciences, Inc.	03/11/19	2D 3D TSV
US10118918	49	PRMT5 inhibitors and uses thereof	Epizyme, Inc.	03/11/19	2D 3D TSV
US10118930	465	Piperidinylpyrazolopyrimidinones and their use	BAYER PHARMA AKTIENGESELLSCHAFT	03/11/19	2D 3D TSV
US10117858	15	Pyridine and pyrazine derivative for the treatment of CF	Novartis AG	03/11/19	2D 3D TSV
US10125144	60	Rho kinase inhibitors	KADMON CORPORATION, LLC	03/11/19	2D 3D TSV
US10118902	223	Small molecule agonists of neurotensin receptor 1	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE	03/11/19	2D 3D TSV
US10117864	67	Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof	BAYER PHARMA AKTIENGESELLSCHAFT	03/11/19	2D 3D TSV
US10125133	13	Substituted [1,2,4]triazolo[1,5-a]pyridines and substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors	Incyte Corporation	03/11/19	2D 3D TSV
US10117944	14	Targeted therapeutics	MADRIGAL PHARMACEUTICALS, INC.	03/11/19	2D 3D TSV
US10124003	52	Therapeutic agent for FGFR inhibitor-resistant cancer	Taiho Pharmaceutical Co., Ltd.	03/11/19	2D 3D TSV
US10112941	441	Tricyclic compounds as anticancer agents	Bristol-Myers Squibb Company	03/11/19	2D 3D TSV
US10111866	2	Compounds as rearranged during transfection (RET) inhibitors	GlaxoSmithKline Intellectual Property Development Limited	03/10/19	2D 3D TSV
US10112934	40	(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles	Centrexion Therapeutics Corporation	03/04/19	2D 3D TSV
US10112931	783	3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH	NOVARTIS AG	03/04/19	2D 3D TSV
US10112932	62	Benzoxazepin oxazolidinone compounds and methods of use	Genentech, Inc.	03/04/19	2D 3D TSV
US10112944	41	Heterocyclic compounds useful as inhibitors of TNF	Bristol-Myers Squibb Company	03/04/19	2D 3D TSV
US10112940	116	Histone demethylase inhibitors	Celgene Quanticel Research, Inc.	03/04/19	2D 3D TSV
US10112935	516	Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease	Lycera Corporation	03/04/19	2D 3D TSV
US10112928	32	Inhibitors of SYK	HOFFMANN-LA ROCHE INC.	03/04/19	2D 3D TSV
US10112929	379	Lactams as inhibitors of rock	Bristol-Myers Squibb Company	03/04/19	2D 3D TSV
US10112937	1877	P2X7 modulators and methods of use	Janssen Pharmaceutica NV	03/04/19	2D 3D TSV
US10112950	116	Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors	Incyte Corporation	03/04/19	2D 3D TSV
US10112942	1229	Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors	Array BioPharma Inc.	03/04/19	2D 3D TSV
US10112939	112	Tied-back benzamide derivatives as potent rock inhibitors	Bristol-Myers Squibb Company	03/04/19	2D 3D TSV
US9586925	22	1-(dimethylamino)ethyl-substituted 6H-benzo[C]chromen-6-ones against senile dementia	NOBEL ILAÇ SANAYII VE TICARET A.S.	03/02/19	2D 3D TSV
US9586950	104	2-pyridyloxy-3-ester-4-nitrile orexin receptor antagonists	MERCK SHARP & DOHME CORP.	03/02/19	2D 3D TSV
US10112926	1455	Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors	Novartis AG	03/02/19	2D 3D TSV
US9586945	38	Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy	AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.	03/02/19	2D 3D TSV
US9586942	17	Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy	AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.	03/02/19	2D 3D TSV
US10112895	14	Antivirals against molluscum contagiosum virus	The Trustees of the University of Pennsylvania	03/02/19	2D 3D TSV
US9586949	157	Aza-heteroaryl compounds as PI3K-gamma inhibitors	Incyte Corporation	03/02/19	2D 3D TSV
US9586962	903	Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators	Janssen Pharmaceutica NV	03/02/19	2D 3D TSV
US9585879	28	Heterocyclic GSK-3 allosteric modulators	Consejo Superior de Investigaciones Cientificas (CSIC)	03/02/19	2D 3D TSV
US9586970	27	Imidazole derivatives	Hoffmann-La Roche Inc.	03/02/19	2D 3D TSV
US10112922	40	Inhibitor of bruton's tyrosine kinase	Centaurus BioPharma Co., Ltd.	03/02/19	2D 3D TSV
US9586948	51	Inhibitors of IRAK4 activity	MERCK SHARP & DOHME CORP.	03/02/19	2D 3D TSV
US10112899	326	Isoindoline derivatives for use in the treatment of a viral infection	ViiV HEALTHCARE UK LIMITED	03/02/19	2D 3D TSV
US9586965	16	Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases	ACEA BIOSCIENCES INC.	03/02/19	2D 3D TSV
US9586900	121	Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists	Bristol-Myers Squibb Company	03/02/19	2D 3D TSV
US10111875	18	Pyrrolopyrimidine compounds and uses thereof	HUTCHINSON MEDIPHARMA LIMITED	03/02/19	2D 3D TSV
US10112911	75	Substituted cyanoguanidines as oral anti-virals	ABBVIE INC.	03/02/19	2D 3D TSV
US10112907	52	Substituted indazoles for treating tendon and/or ligament injuries	NOVARTIS AG	03/02/19	2D 3D TSV
US9585881	56	Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases	ONO PHARMACEUTICAL CO., LTD.	03/02/19	2D 3D TSV
US9586959	169	Substituted tricyclic heterocycles as histamine 4 receptor inhibitors	C&C RESEARCH LABORATORIES	03/02/19	2D 3D TSV
US10106550	6	Aza-phenalene-3-ketone derivative, preparation method thereof, and its application as PARP inhibitor	SUZHOU KANGRUN PHARMACEUTICALS INC.	02/24/19	2D 3D TSV
US10106522	12	Benzimidazole derivatives as antihistamine agents	Faes Farma, S.A.	02/24/19	2D 3D TSV
US10106552	43	Compounds inhibiting eukaryotic elongation factor 2 kinase activity	Longevica Pharmaceuticals, Inc.	02/24/19	2D 3D TSV
US10106521	18	Eckol derivatives, methods of synthesis and uses thereof	Phloronol, Inc.	02/24/19	2D 3D TSV
US10106571	23	HCV polymerase inhibitors	MEDIVIR AB	02/24/19	2D 3D TSV
US10106535	45	Histone deacetylase inhibitors and compositions and methods of use thereof	CHDI FOUNDATION, INC.	02/24/19	2D 3D TSV
US10106534	274	Histone demethylase inhibitors	Celgene Quanticel Research, Inc.	02/24/19	2D 3D TSV
US10106527	488	Isoquinolin-3-yl carboxamides and preparation and use thereof	Samumed, LLC	02/24/19	2D 3D TSV
US10106501	428	Nuclear receptor modulators	AbbVie Inc.	02/24/19	2D 3D TSV
US10106557	26	Preparation method for benzoxazoleoxazine ketone compound and intermediate and crystal form thereof	NORTH CHINA PHARMACEUTICAL NEW DRUG R&D CO., LTD.	02/24/19	2D 3D TSV
US10106504	83	Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication	ViiV HEALTHCARE UK (NO.5) LIMITED	02/24/19	2D 3D TSV
US10106508	94	Quinazoline heterocyclic compound as EGFR kinase inhibitor and preparation and application thereof	BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED	02/24/19	2D 3D TSV
US10106553	70	Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes	Janssen Pharmaceutica NV	02/24/19	2D 3D TSV
US10106510	60	Substituted isoxazoles for treating cancer	EPIZYME, INC.	02/24/19	2D 3D TSV
US10106559	152	Substituted tetrahydrocarbazole and carbazole carboxamide compounds	Bristol-Myers Squibb Company	02/24/19	2D 3D TSV
US10100045	36	3-aryl-2H-pyrazolo[4,3-b]pyridine compounds and their use as AMPA receptor modulators	Janssen Pharmaceutica NV	02/21/19	2D 3D TSV
US10100030	25	Carboxymethyl piperidine derivative	KISSEI PHARMACEUTICAL CO., LTD.	02/21/19	2D 3D TSV
US10100051	14	Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryloxy or heteroaryloxy, preparation method thereof and pharmaceutical use thereof	SHENYANG SUNSHINE PHARMACEUTICAL CO. LTD.	02/21/19	2D 3D TSV
US10100058	717	Fused heterocyclic compounds as CaM kinase inhibitors	Gilead Sciences, Inc.	02/21/19	2D 3D TSV
US10100048	7	Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors	ABBVIE DEUTSCHLAND GMBH & CO. KG	02/21/19	2D 3D TSV
US10100057	199	Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same	SK BIOPHARMACEUTICALS CO., LTD.	02/21/19	2D 3D TSV
US10100046	31	Inhibitors of lysine specific demethylase-1	CELGENE QUANTICEL RESEARCH, INC.	02/21/19	2D 3D TSV
US10100049	112	JAK kinase inhibitor compounds for treatment of respiratory disease	THERAVANCE BIOPHARMA R&D IP, LLC	02/21/19	2D 3D TSV
US10100019	177	N2-(2-methoxyphenyl)pyrimidine derivative, method for preparing same, and pharmaceutical composition for cancer prevention or treatment containing same as active ingredient	Korea Research Institute of Chemical Technology	02/21/19	2D 3D TSV
US10105349	6	Organic compounds	INTRA-CELLULAR THERAPIES, INC.	02/21/19	2D 3D TSV
US10105367	304	Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-ones	DART NEUROSCIENCE (CAYMAN) LTD.	02/21/19	2D 3D TSV
US9580437	709	Triazolopyrimidine compounds and uses thereof	Novartis AG	02/21/19	2D 3D TSV
US10100042	12	[5,6]—fused bicyclic antidiabetic compounds	Merck Sharp & Dohme Corp.	02/21/19	2D 3D TSV
US9580418	156	Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors	Incyte Corporation	02/19/19	2D 3D TSV
US9580423	200	Bicyclic heterocycles as FGFR4 inhibitors	Incyte Corporation	02/19/19	2D 3D TSV
US9580396	112	C6-spiro iminothiadiazine dioxides as BACE inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	02/19/19	2D 3D TSV
US9580449	298	Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity	Merck Patent GmbH	02/19/19	2D 3D TSV
US9580415	36	Compounds	Proximagen Limited	02/19/19	2D 3D TSV
US9580412	102	Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases	GALDERMA RESEARCH & DEVELOPMENT	02/19/19	2D 3D TSV
US9580432	134	Fused pyrimidine compound or salt thereof	TAIHO PHARMACEUTICAL CO., LTD.	02/19/19	2D 3D TSV
US9579320	492	Inhibitors of syk and JAK protein kinases	Portola Pharmaceuticals, Inc.	02/19/19	2D 3D TSV
US9579407	4	Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals	TAKEDA PHARMACEUTICAL COMPANY LIMITED	02/19/19	2D 3D TSV
US9580411	11	Substituted sulfonamide compounds	Hoffmann-La Roche Inc.	02/19/19	2D 3D TSV
US9580442	52	Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors	Karus Therapeutics Limited	02/19/19	2D 3D TSV
US10098883	105	(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use	BAYER PHARMA AKTIENGESELLSCHAFT	02/18/19	2D 3D TSV
US10100018	136	Amide derivatives as lysophosphatidic acid receptor antagonists	Takeda Pharmaceutical Company Limited	02/18/19	2D 3D TSV
US10098902	131	Arginase inhibitors as therapeutics	Mars, Incorporated	02/18/19	2D 3D TSV
US10100016	53	Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof	SHANGHAI YINGLI PHARMACEUTICAL CO., LTD.	02/18/19	2D 3D TSV
US10099993	358	Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof	SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE	02/18/19	2D 3D TSV
US10098900	5	Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases	ZHEJIANG DTRM BIOPHARMA CO. LTD.	02/18/19	2D 3D TSV
US10098888	22	Substituted benzene compounds	Epizyme, Inc.	02/18/19	2D 3D TSV
US10093671	40	2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection	Hoffmann-La Roche Inc.	01/23/19	2D 3D TSV
US9573958	74	Benzimidazole derivatives as ITK inhibitors	PRINCIPIA BIOPHARMA, INC.	01/23/19	2D 3D TSV
US9572792	5	Coumarin compounds as receptor modulators with therapeutic utility	Allergan, Inc.	01/23/19	2D 3D TSV
US9572802	96	Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity	Theravance Respiratory Company LLC	01/23/19	2D 3D TSV
US10093683	74	Factor XIa inhibitors	Merck Sharp & Dohme Corp.	01/23/19	2D 3D TSV
US10093697	12	IBAT inhibitors for the treatment of liver diseases	TBA	01/23/19	2D 3D TSV
US9573957	151	Inhibitors of leukotriene production	Boehringer Ingelheim International GmbH	01/23/19	2D 3D TSV
US9573930	122	Inhibitors of lysine specific demethylase-1	Celgene Quanticel Research, Inc.	01/23/19	2D 3D TSV
US9573961	95	Inhibitors of the renal outer medullary potassium channel	Merck Sharp & Dohme Corp.	01/23/19	2D 3D TSV
US9573943	86	Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use	Genentech, Inc.	01/23/19	2D 3D TSV
US10092575	221	Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compounds	Dart NeuroScience (Cayman) Ltd.	01/23/19	2D 3D TSV
US10093673	15	Tetracyclic pyridone compounds as antivirals	Novartis AG	01/23/19	2D 3D TSV
US9572811	103	Treatment of dry eye	PRINCIPIA BIOPHARMA INC.	01/23/19	2D 3D TSV
US10093646	286	1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2	Novartis AG	01/22/19	2D 3D TSV
US10093664	74	Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease	Board of Regents, The University of Texas System	01/22/19	2D 3D TSV
US10093631	12	Bifunctional compounds and use for reducing uric acid levels	Acquist LLC	01/22/19	2D 3D TSV
US10093658	29	Bifunctional compounds and use for reducing uric acid levels	Acquist LLC	01/22/19	2D 3D TSV
US10093651	5	Ghrelin O-acyl transferase inhibitors	Eli Lilly and Company	01/22/19	2D 3D TSV
US10093655	81	Heteroaromatic compounds and their use as dopamine D1 ligands	Pfizer Inc.	01/22/19	2D 3D TSV
US10093635	56	MAGL inhibitors	ABIDE THERAPEUTICS, INC.	01/22/19	2D 3D TSV
US10093663	110	Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof	Novartis AG	01/22/19	2D 3D TSV
US10093660	261	Sulfoximine substituted quinazolines for pharmaceutical compositions	EVOTEC INTERNATONAL GMBH	01/22/19	2D 3D TSV
US10093650	24	Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors	Bristol-Myers Squibb Company	01/22/19	2D 3D TSV
US10092570	368	Heterocyclylamines as PI3K inhibitors	Incyte Holdings Corporation; Incyte Corporation	01/18/19	2D 3D TSV
US10092529	7	Necrosis inhibitors	National Institute of Biological Sciences, Beijing	01/18/19	2D 3D TSV
US10092563	408	Phosphatidylinositol 3-kinase inhibitors	Gilead Sciences, Inc.	01/18/19	2D 3D TSV
US10092556	28	Piperidine compound or salt thereof	TAIHO PHARMACEUTICAL CO., LTD.	01/18/19	2D 3D TSV
US10087191	87	Piperidine derivative and preparation method and pharmaceutical use thereof	Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd.	01/18/19	2D 3D TSV
US10092551	173	Spiro-thiazolones	Hoffmann-LaRoche Inc.	01/18/19	2D 3D TSV
US10087144	18	Agents for use in the treatment of cardiovascular and inflammatory diseases structurally based on 4(1 H)-quinolone	UCL Business PLC	01/17/19	2D 3D TSV
US10085988	5	Aglaroxin C and derivatives as HCV entry inhibitors	SRI International; Trustees of Boston University	01/17/19	2D 3D TSV
US10085983	38	Azabicyclo derivatives, process for preparation thereof and medical use thereof	Shanghai Haiyan Pharmaceutical Technology Co., Ltd.; Yangtze River Pharmaceutical Group Co., Ltd.	01/17/19	2D 3D TSV
US10087188	204	Benzamide imidazopyrazine Btk inhibitors	Merck Sharp & Dohme Corp.	01/17/19	2D 3D TSV
US10087167	32	Benzofurans substituted with secondary benzamide as HCV inhibitors	Bristol-Myers Squibb Company	01/17/19	2D 3D TSV
US10087181	30	Compound as WNT signaling inhibitor, composition, and use thereof	CUREGENIX, INC.	01/17/19	2D 3D TSV
US10087185	125	Fused bicylic pyridine compounds and their use as AMPA receptor modulators	Janssen Pharmaceutica NV	01/17/19	2D 3D TSV
US10087187	510	Imidazopyridazine derivatives as PI3KB inhibitors	Janssen Pharmaceutica NV	01/17/19	2D 3D TSV
US10085984	272	Metalloenzyme inhibitor compounds	Viamet Pharmaceuticals (Bermuda), Ltd.	01/17/19	2D 3D TSV
US10087143	160	Pyridone amides as modulators of sodium channels	VERTEX PHARMACEUTICALS INCORPORATED	01/17/19	2D 3D TSV
US10085986	20	Pyrimidinone compounds and their use	Takeda Pharmaceutical Company Limited	01/17/19	2D 3D TSV
US9567341	72	Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonists	Rugen Holdings (Cayman) Limited	01/17/19	2D 3D TSV
US10087148	49	Quinazolines as biogenic amine transport modulators	THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTE OF HEALTH; SOUTHERN RESEARCH INSTITUTE	01/17/19	2D 3D TSV
US9567334	150	Quinolone derivatives as fibroblast growth factor receptor inhibitors	Principia Biopharma, Inc.	01/17/19	2D 3D TSV
US9567324	34	Substituted nicotinamide derivatives as kinase inhibitors	ALLERGAN, INC.	01/17/19	2D 3D TSV
US10087178	163	Substituted spiropyrido[1,2-a]pyrazine derivative and medicinal use thereof as HIV integrase inhibitor	JAPAN TOBACCO INC.	01/17/19	2D 3D TSV
US10086000	131	Tricyclic compounds as inhibitors of mutant IDH enzymes	Merck Sharp & Dohme Corp.	01/17/19	2D 3D TSV
US10085990	88	Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors	vTv Therapeutics LLC	01/17/19	2D 3D TSV
US9518026	206	5-aminopyrazole-4-carboxamide inhibitors of CDPK1 from T. gondii and C. parvum	University of Washington Through its Center For Commercialization	01/14/19	2D 3D TSV
US9518000	100	Bicyclo [2.2.1] acid GPR120 modulators	Bristol-Myers Squibb Company	01/14/19	2D 3D TSV
US9517228	8	Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes	Jenrin Discovery, Inc.	01/14/19	2D 3D TSV
US9566312	321	Cyclic peptides and use as medicines	Novartis AG	01/14/19	2D 3D TSV
US9567327	3	Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto	Arena Pharmaceuticals, Inc.	01/14/19	2D 3D TSV
US9518055	38	Imidazopyridyl compounds as aldosterone synthase inhibitors	Merck Sharp & Dohme	01/14/19	2D 3D TSV
US9518064	131	Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation	Bristol-Myers Squibb Company; Universite De Montreal	01/14/19	2D 3D TSV
US9566277	5	Methods of using phthalazinone ketone derivatives	Jiangsu Hansoh Pharmaceutical Co., Ltd.	01/14/19	2D 3D TSV
US9567339	358	Primary carboxamides as BTK inhibitors	AbbVie Inc.	01/14/19	2D 3D TSV
US9567338	61	Pyrazolo[3,4-d]pyrimidine compounds, their preparation and use as sigma ligands	LABORATORIOS DEL DR. ESTEVE S.A.	01/14/19	2D 3D TSV
US9518052	676	Pyrazolopyridines and pyrazolopyrimidines	Pfizer Inc.	01/14/19	2D 3D TSV
US9567320	29	Pyridazinone-amides derivatives	MERCK PATENT GmbH	01/14/19	2D 3D TSV
US9567304	358	Quinazolinedione derivative	Chugai Seiyaku Kabushiki Kaisha	01/14/19	2D 3D TSV
US9518060	98	Substituted pyrrolo[3,4-c]pyrazoles as PKC kinase inhibitors	PFIZER INC.	01/14/19	2D 3D TSV
US9567333	14	Triazolopyridyl compounds as aldosterone synthase inhibitors	Merck Sharp & Dohme Corp.	01/14/19	2D 3D TSV
US10081635	20	Substituted N-(pyrrolidine-3-yl)-7H-pyrrolo[2,3-D]pyrimidine-4-amine as janus kinase inhibitor	YANG JI CHEMICAL CO., LTD.; HAN WHA PHARMA CO., LTD.	01/13/19	2D 3D TSV
US10081632	21	Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-α]pyrazine-2-carboxamides as RSK inhibitors	PHOENIX MOLECULAR DESIGNS	01/13/19	2D 3D TSV
US10081629	107	Amide derivatives and pharmaceutically acceptable salts thereof, preparation method thereof and medicinal application thereof	Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd.	01/12/19	2D 3D TSV
US10081623	35	Diamide macrocycles that are FXIa inhibitors	Bristol-Myers Squibb Company	01/12/19	2D 3D TSV
US10081617	134	Factor XIa inhibitors	Merck Sharp & Dohme Corp.	01/12/19	2D 3D TSV
US10081606	46	Heteroaryl compounds and uses thereof	Celgene CAR LLC	01/12/19	2D 3D TSV
US10081602	42	Opioid agonists and uses thereof	Nektar Therapeutics	01/12/19	2D 3D TSV
US10081622	12	Substituted indazole derivatives active as kinase inhibitors	NERVIANO MEDICAL SCIENCES S.R.L.	01/12/19	2D 3D TSV
US10080750	243	Aminopyrimidine derivatives for use as modulators of kinase activity	Merck Patent GmbH	01/11/19	2D 3D TSV
US10077277	38	Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors	Incyte Corporation	01/11/19	2D 3D TSV
US10023583	56	Bicyclic pyridine compound	Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.	01/11/19	2D 3D TSV
US10023592	505	Bromodomain inhibitors	Celgene Quanticel Research, Inc.	01/11/19	2D 3D TSV
US10077289	76	Cyclosporins modified on the MeBmt sidechain by heterocyclic rings	Allergan, Inc.	01/11/19	2D 3D TSV
US10081601	41	Glucocerebrosidase modulators and uses thereof	Alectos Therapeutics Inc.	01/11/19	2D 3D TSV
US10077272	23	Heteroaromatic compounds and their use as dopamine D1 ligands	Pfizer Inc.	01/11/19	2D 3D TSV
US10023576	117	Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors	Bristol-Myers Squibb Company	01/11/19	2D 3D TSV
US10077269	372	Imidazopyridazine compounds	Pfizer Inc.	01/11/19	2D 3D TSV
US10077273	54	SHMT inhibitors	The Trustees of Princeton University	01/11/19	2D 3D TSV
US10077265	28	Substituted oxopyridine derivatives	BAYER PHARMA AKTIENGESELLSCHAFT	01/11/19	2D 3D TSV
US10077266	142	Substituted pyrido[3,4-b]pyrazines as GPR6 modulators	TAKEDA PHARMACEUTICAL COMPANY LIMITED	01/11/19	2D 3D TSV
US10080744	176	Thiazoles as modulators of RORγt	Janssen Pharmaceutica NV	01/11/19	2D 3D TSV
US10077247	54	Tricyclic spiro compound	ONO PHARMACEUTICAL CO., LTD.	01/11/19	2D 3D TSV
US10023575	202	Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide	Boehringer Ingelheim International GmbH	01/10/19	2D 3D TSV
US10023564	139	G protein-coupled receptor kinase 2 inhibitors and methods for use of the same	THE REGENTS OF THE UNIVERSITY OF MICHIGAN	01/10/19	2D 3D TSV
US10023562	168	Heteroaryl substituted pyridyl compounds useful as kinase modulators	Bristol-Myers Squibb Company	01/10/19	2D 3D TSV
US10023570	1162	Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors	Array BioPharma Inc.	01/10/19	2D 3D TSV
US10023539	107	Aryl-cyanoguanidine compounds	Bayer Pharma Aktiengesellschaft	01/06/19	2D 3D TSV
US10023561	74	Fumagillol heterocyclic compounds and methods of making and using same	Zafgen, Inc.	01/06/19	2D 3D TSV
US10023543	122	Inhibitors of lysine specific demethylase-1	CELGENE QUANTICEL RESEARCH, INC.	01/06/19	2D 3D TSV
US10023559	262	Substituted azetidine derivatives	Hoffman-La Roche Inc.	01/06/19	2D 3D TSV
US10023557	451	Therapeutic inhibitory compounds	LIFESCI PHARMACEUTICALS, INC.	01/06/19	2D 3D TSV
US9884865	4	Azaspiro[4.5] decane derivatives and use thereof	Purdue Pharma L.P.	01/05/19	2D 3D TSV
US9884874	18	Bromodomain-inhibiting compounds and pharmaceutical composition comprising same for preventing or treating a cancer	KAINOS MEDICINE, INC.	01/05/19	2D 3D TSV
US9884843	140	Cyclic sulfone and sulfoximine analogs and uses thereof	PELOTON THERAPEUTICS, INC.	01/05/19	2D 3D TSV
US9884878	845	FLAP modulators	JANSSEN PHARMACEUTICA NV	01/05/19	2D 3D TSV
US9884860	365	Fused pyrroledicarboxamides and their use as pharmaceuticals	Sanofi	01/05/19	2D 3D TSV
US9884850	16	Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors	ACETYLON PHARMACEUTICALS, INC.	01/05/19	2D 3D TSV
US9884828	117	Substituted cinnolines as inhibitors of LRRK2 kinase activity	Imago Pharmaceuticals, Inc.	01/05/19	2D 3D TSV
US9884868	605	TGF-beta inhibitors	Rigel Pharmaceuticals, Inc.; Bristol-Myers Squibb Company	01/05/19	2D 3D TSV
US10022387	157	Aza-heteroaryl compounds as PI3K-gamma inhibitors	Incyte Corporation	12/31/18	2D 3D TSV
US10023528	16	Branched 3-phenylpropionic acid derivatives and their use	BAYER PHARMA AKTIENGESELLSCHAFT	12/31/18	2D 3D TSV
US10023534	22	Carbazole and tetrahydrocarbazole compounds useful as inhibitors of BTK	Bristol-Myers Squibb Company	12/31/18	2D 3D TSV
US10023519	68	Cyclobutane containing carboxylic acid GPR120 modulators	Bristol-Myers Squibb Company	12/31/18	2D 3D TSV
US10030026	52	Difluoroethylpyridine derivatives as NR2B NMDA receptor antagonists	Rugen Holdings (Cayman) Limited	12/31/18	2D 3D TSV
US10030016	798	Heterocyclic compounds useful as PDK1 inhibitors	Sunesis Pharmaceuticals, Inc.; Millenium Pharmaceuticals, Inc.	12/31/18	2D 3D TSV
US10022352	15	Modulators of ATP-binding cassette transporters	Vertex Pharmaceuticals Incorporated	12/31/18	2D 3D TSV
US10030047	55	Peptide macrocycles against acinetobacter baumannii	HOFFMANN-LA ROCHE INC.	12/31/18	2D 3D TSV
US10022376	676	Pyrazolopyridines and pyrazolopyrimidines	Pfizer Inc.	12/31/18	2D 3D TSV
US10022354	246	Pyrrolidine amide compounds as histone demethylase inhibitors	GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS INC.	12/31/18	2D 3D TSV
US10022461	105	Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrilary tangles	Merck Sharp & Dohme Corp.	12/31/18	2D 3D TSV
US10030027	248	Soluble guanylate cyclase stimulators	Merck Sharp & Dohme Corp.	12/31/18	2D 3D TSV
US10030020	677	Spirocycle compounds and methods of making and using same	ABIDE THERAPEUTICS, INC.	12/31/18	2D 3D TSV
US10030025	205	Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists	OGEDA SA	12/31/18	2D 3D TSV
US10030004	207	Compounds and methods of use	Medivation Technologies LLC	12/30/18	2D 3D TSV
US10029993	68	Disubstituted 1, 2, 4-triazine compound	MITSUBISHI TANABE PHARMA CORPORATION	12/30/18	2D 3D TSV
US10030012	100	Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists	Heptares Therapeutics Limited	12/30/18	2D 3D TSV
US10028961	1070	Therapeutically active compounds and their methods of use	Agios Pharmaceuticals, Inc.	12/30/18	2D 3D TSV
US10034864	21	1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase	Incyte Holdings Corporation; Incyte Corporation	12/25/18	2D 3D TSV
US10034861	606	1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors	H. Lundbeck A/S	12/25/18	2D 3D TSV
US10035761	33	Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives	Revivia Pharmaceuticals, Inc.	12/25/18	2D 3D TSV
US10035797	73	Fused amino pyridine as HSP90 inhibitors	Curis, Inc.	12/25/18	2D 3D TSV
US10035814	18	Guanine analogs as telomerase substrates and telomere length affectors	Geron Corporation	12/25/18	2D 3D TSV
US10035794	139	Heterocyclic derivatives and their use in the treatment of neurological disorders	Novartis AG	12/25/18	2D 3D TSV
US10035777	109	Heterocyclic kinase inhibitors	Bristol-Myers Squibb Company	12/25/18	2D 3D TSV
US10035760	349	Inhibitors of human immunodeficiency virus replication	ViiV HEALTHCARE UK (NO. 5) LIMITED	12/25/18	2D 3D TSV
US10035778	119	Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists	Saint Louis University	12/25/18	2D 3D TSV
US10028960	106	Pyrimidine compounds as JAK kinase inhibitors	THERAVANCE BIOPHARMA R&D IP, LLC	12/25/18	2D 3D TSV
US10035780	9	Quinazoline scaffold based compounds, pharmaceutical compositions and methods of use thereof	TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD.	12/25/18	2D 3D TSV
US10035792	71	Resorcinol derivative as HSP90 inhibitor	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.	12/25/18	2D 3D TSV
US10035804	122	Spirodiamine derivatives as aldosterone synthase inhibitors	Hoffman-La Roche Inc.	12/25/18	2D 3D TSV
US10028934	74	Substituted indazole derivatives active as kinase inhibitiors	NERVIANO MEDICAL SCIENCES S.R.L.	12/25/18	2D 3D TSV
US10034939	22	Synergistic combination of immunologic inhibitors for the treatment of cancer	The University of Chicago	12/25/18	2D 3D TSV
US10040788	63	1,3,4-thiadiazole compounds and their use in treating cancer	AstraZeneca AB; Cancer Research Technology Limited	12/22/18	2D 3D TSV
US10040789	28	1,3,4-thiadiazole compounds and their use in treating cancer	AstraZeneca AB; Cancer Research Technology Limited	12/22/18	2D 3D TSV
US10040815	21	3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection	Hoffmann-La Roche Inc.	12/22/18	2D 3D TSV
US10040790	162	Bicyclic heterocycles as FGFR inhibitors	Incyte Holdings Corporation; Incyte Corporation	12/22/18	2D 3D TSV
US10040791	334	Isoxazole derivative as mutant isocitrate dehydrogenase 1 inhibitor	Daiichi Sankyo Company, Limited; National Cancer Center	12/22/18	2D 3D TSV
US10040798	117	Pyrrolopyridazine inhibitors of IRAK4 activity	Merck Sharp & Dohme Corp.	12/22/18	2D 3D TSV
US10040805	19	Substituted imidazo[1,5-a]pyrazines as Btk inhibitors	Merck Sharp & Dohme Corp.	12/22/18	2D 3D TSV
US10040802	109	Thienopyrazine inhibitors of IRAK4 activity	Merck Sharp & Dohme Corp.	12/22/18	2D 3D TSV
US10071086	115	1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof	Samumed, LLC	12/21/18	2D 3D TSV
US10072005	105	4-azaindole derivatives	Eisai R&D Management Co., Ltd.	12/21/18	2D 3D TSV
US10072026	1144	Crystalline form of 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile	THERAVANCE BIOPHARMA R&D IP, LLC	12/21/18	2D 3D TSV
US10071992	17	Diacylglycerol acyl transferase 2 inhibitors	Pfizer Inc.	12/21/18	2D 3D TSV
US10072025	140	Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitors	Merck Sharp & Dohme Corp.	12/21/18	2D 3D TSV
US10071984	129	Histone demethylase inhibitors	Celgene Quanticel Research, Inc.	12/21/18	2D 3D TSV
US10040779	237	Histone demethylase inhibitors	Celgene Quanticel Research, Inc.	12/21/18	2D 3D TSV
US10071998	58	Iminothiadiazine dioxides bearing an amine-linked substituent as BACE inhibitors, compositions, and their use	TBA	12/21/18	2D 3D TSV
US10072034	37	Kinase inhibitors	Respivert Limited; Topivert Pharma Limited	12/21/18	2D 3D TSV
US10071974	169	Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists	Boehringer Ingelheim International GmbH	12/21/18	2D 3D TSV
US10071957	138	N-substituted benzamides and methods of use thereof	GENENTECH, INC.; XENON PHARMACEUTICALS INC.	12/21/18	2D 3D TSV
US10071994	3	N-sulfonyl homoserine lactone derivatives, preparation method and use thereof	Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China	12/21/18	2D 3D TSV
US10071110	33	Phosphonate compounds	The Regents of the University of California	12/21/18	2D 3D TSV
US10071965	42	Pyridone FabI inhibitors and uses thereof	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK	12/21/18	2D 3D TSV
US10072008	7	Spiro-isoquinoline-3,4′-piperidine compounds having activity against pain	ESTEVE PHARMACEUTICALS S.A.	12/21/18	2D 3D TSV
US10071988	647	Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators	JANSSEN PHARMACEUTICA NV	12/21/18	2D 3D TSV
US10072016	247	Substituted 4-phenylpiperidines, their preparation and use	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK	12/21/18	2D 3D TSV
US10071995	38	Substituted oxopyridine derivatives	BAYER PHARMA AKTIENGESELLSCHAFT	12/21/18	2D 3D TSV
US10071991	18	Substituted pyridine derivatives useful as c-fms kinase inhibitors	Janssen Pharmaceutica NV	12/21/18	2D 3D TSV
US10072001	527	Tank-binding kinase inhibitor compounds	Gilead Sciences, Inc.	12/21/18	2D 3D TSV
US10040781	1854	Tank-binding kinase inhibitor compounds	Gilead Sciences, Inc.	12/21/18	2D 3D TSV
US10072003	130	Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use	TBA	12/21/18	2D 3D TSV
US9878996	42	2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase	Northwestern University	12/12/18	2D 3D TSV
US9884814	277	Acylguanidines for treating osteoarthritis	MERCK PATENT GMBH	12/12/18	2D 3D TSV
US10065972	193	Bicyclic or tricyclic heterocyclic compound	MITSUBISHI TANABE PHARMA CORPORATION	12/12/18	2D 3D TSV
US9884048	326	ERK inhibitors	MERCK SHARP & DOHME CORP.	12/12/18	2D 3D TSV
US9556117	95	Indole carboxamide derivatives as P2X7 receptor antagonists	ACTELION PHARMACEUTICALS LTD.	12/12/18	2D 3D TSV
US9556190	94	Piperidinyloxy lactone orexin receptor antagonists	MERCK SHARP & DOHME CORP.	12/12/18	2D 3D TSV
US9879013	12	Purinone derivative	ONO PHARMACEUTICAL CO., LTD.	12/12/18	2D 3D TSV
US9879032	46	Pyridine compounds	Daiichi Sankyo Company, Limited; Sandford Burnham Prebys Medical Discovery Institute	12/12/18	2D 3D TSV
US9550796	455	Pyrrolopyrrolone derivatives and their use as BET inhibitors	NOVARTIS AG	12/12/18	2D 3D TSV
US9951047	4	Salt of monocyclic pyridine derivative and crystal thereof	Eisai R&D Management Co., Ltd.	12/12/18	2D 3D TSV
US9556188	218	Substituted imidazo[1,2-b]pyrazoles as bruton'S tyrosine kinase modulators	BeiGene, Ltd.	12/12/18	2D 3D TSV
US9556179	949	Substituted imidazoles as casein kinase 1 D/E inhibitors	Bristol-Myers Squibb Company	12/12/18	2D 3D TSV
US9556187	1933	Substituted pyrrolo[3′,2′:5,6]pyrido[4,3-d]pyrimidines and JAK inhibitors comprising the same	NISSAN CHEMICAL INDUSTRIES, LTD.	12/12/18	2D 3D TSV
US9879026	27	Substituted spirocycles	Boehringer Ingelheim International GmbH	12/12/18	2D 3D TSV
US9878991	226	TRPV1 antagonists including dihydroxy substituent and uses thereof	Purdue Pharma L.P.	12/12/18	2D 3D TSV
US9877957	81	Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2	Merck Sharp & Dohme Corp.	12/12/18	2D 3D TSV
US10059669	24	2-amino-3,5-difluoro-3,6-dimethyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treating alzheimer's disease	H. Lundbeck A/S	12/11/18	2D 3D TSV
US10058540	19	2-amino-5,5-difluoro-6-(fluoromethyl)-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors	H. Lundbeck A/S	12/11/18	2D 3D TSV
US10059713	296	3-substituted 2-amino-indole derivatives	TAKEDA PHARMACEUTICAL COMPANY LIMITED	12/11/18	2D 3D TSV
US10059705	452	Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors	Merck Sharp & Dohme Corp.	12/11/18	2D 3D TSV
US10065941	574	Aminotriazine derivative and pharmaceutical composition comprising the same	SHIONOGI & CO., LTD.	12/11/18	2D 3D TSV
US10059667	216	Antidiabetic compounds	Merck Sharp & Dohme Corp.	12/11/18	2D 3D TSV
US10058534	230	Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders	Novartis AG	12/11/18	2D 3D TSV
US10065961	90	Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof	Ogeda SA.	12/11/18	2D 3D TSV
US10059709	84	Compounds	Elanco Tiergesundheit AG	12/11/18	2D 3D TSV
US10064873	147	Compounds and compositions for treating HIV with derivatives of Betulin	GLAXOSMITHKLINE LLC	12/11/18	2D 3D TSV
US10064853	26	Compounds for use in methods for treating diseases or conditions mediated by protein disulfide isomerase	Beth Israel Deaconess Medical Center, Inc.; The Broad Institute, Inc.	12/11/18	2D 3D TSV
US10065967	43	Compounds that are ERK inhibitors	Merck, Sharp & Dohme Corp.	12/11/18	2D 3D TSV
US10059695	67	Cot modulators and methods of use thereof	GILEAD SCIENCES, INC.	12/11/18	2D 3D TSV
US10065963	620	Heterocyclic compounds as PI3K-γ inhibitors	Incyte Corporation	12/11/18	2D 3D TSV
US10065948	96	Histone deacetylase inhibitors and compositions and methods of use thereof	CHDI Foundation, Inc.	12/11/18	2D 3D TSV
US10059687	128	Histone demethylase inhibitors	Celgene Quanticel Research, Inc.	12/11/18	2D 3D TSV
US10058549	3	Imidazo[1,2-α]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto	Arena Pharmaceuticals, Inc.	12/11/18	2D 3D TSV
US10065953	19	Imidazo[1,2-A]pyridine derivatives for use as inhibitors of human immunodeficiency virus replication	ViiV HEALTHCARE UK (NO.5) LIMITED	12/11/18	2D 3D TSV
US10065945	9	Isoquinoline derivatives as MGAT2 inhibitors	Merck Sharp & Dohme Corp.	12/11/18	2D 3D TSV
US10059668	41	LSD1 inhibitors	Mirati Therapeutics, Inc.	12/11/18	2D 3D TSV
US10064861	81	Macrocyclic pyridazinone derivatives	Merck Patent GmbH	12/11/18	2D 3D TSV
US10058550	788	Methods of treating heart failure	AMGEN INC.	12/11/18	2D 3D TSV
US10059688	43	Protein tyrosine kinase modulators and methods of use	BETTA PHARMACEUTICALS CO., LTD.	12/11/18	2D 3D TSV
US10059720	288	Pyridine derivative	Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.	12/11/18	2D 3D TSV
US10065928	42	Quinolinone compound and use thereof	SUNSHINE LAKE PHARMA CO., LTD.	12/11/18	2D 3D TSV
US10065973	23	Substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection	Hoffmann-La Roche Inc.	12/11/18	2D 3D TSV
US10065950	358	Substituted thiazoles as HIV integrase inhibitors	Japan Tobacco Inc.	12/11/18	2D 3D TSV
US10065970	215	Tricyclic PI3K inhibitor compounds and methods of use	Genentech, Inc.	12/11/18	2D 3D TSV
US10071079	2922	[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds	Bristol-Myers Squibb Company	12/11/18	2D 3D TSV
US9718813	168	Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer	Janssen Pharmaceutica NV	12/10/18	2D 3D TSV
US9718825	648	N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals	SANOFI	12/10/18	2D 3D TSV
US9549932	488	2-(morpholin-4-yl)-1,7-naphthyridines	Bayer Pharma Aktiengesellschaft	11/29/18	2D 3D TSV
US9718828	489	BTK Inhibitors	MERCK SHARP & DOHME CORP.; MERCK SHARP & DOHME B.V.	11/29/18	2D 3D TSV
US9550771	93	Keto-imidazopyridine derivatives as RORc modulators	Genentech, Inc.	11/29/18	2D 3D TSV
US9718822	68	Macrocyclic compounds as Trk kinase inhibitors	Array BioPharma, Inc.	11/29/18	2D 3D TSV
US9718854	20	Selective glycosidase inhibitors and uses thereof	Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.	11/29/18	2D 3D TSV
US9718820	90	Substituted aza-bicyclic imidazole derivatives useful TRPM8 receptor modulators	JANSSEN PHARMACEUTICA NV	11/29/18	2D 3D TSV
US9550775	130	Substituted triazolopyridines and methods of use thereof	GENENTECH, INC.; XENON PHARMACEUTICALS INC.	11/29/18	2D 3D TSV
US9718814	375	Cyclopropanamine compound and use thereof	Takeda Pharmaceutical Company Limited	11/28/18	2D 3D TSV
US9718819	182	Non-nucleoside reverse transcriptase inhibitors	Merck Sharp & Dohme Corp.	11/28/18	2D 3D TSV
US9718812	213	Substituted thiazole or oxazole P2X7 receptor antagonists	Axxam S.P.A.	11/28/18	2D 3D TSV
US9718809	87	Bisarylsulfonamides useful in the treatment of inflammation and cancer	Kancera AB	11/27/18	2D 3D TSV
US9718800	115	Chromenone derivatives	ASTRAZENECA AB	11/27/18	2D 3D TSV
US9718808	144	Inhibitors of the renal outer medullary potassium channel	Merck Sharp & Dohme Corp.	11/27/18	2D 3D TSV
US9718793	138	Isoxazole compounds as inhibitors of heat shock proteins	Vernalis (R&D) Ltd.; Cancer Research Technology Limited; The Institute of Cancer Research	11/27/18	2D 3D TSV
US9718792	101	Isoxazoline hydroxamic acid derivatives as LpxC inhibitors	Novartis AG	11/27/18	2D 3D TSV
US9718790	2250	Triazine derivative and pharmaceutical composition having an analgesic activity comprising the same	SHIONOGI & CO., LTD.	11/27/18	2D 3D TSV
US9718803	375	Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors	Amgen Inc.	11/27/18	2D 3D TSV
US9718771	48	Aniline derivative, pharmaceutical composition containing same, and use thereof	KISSEI PHARMACEUTICAL CO., LTD.	11/16/18	2D 3D TSV
US9718787	9	Poly (ADP-ribose) polymerase inhibitor	CHENGDU DIAO PHARMACEUTICAL GROUP CO., LTD.	11/16/18	2D 3D TSV
US9718780	6	Substituted pyridines as sodium channel blockers	TBA	11/16/18	2D 3D TSV
US9714242	13	Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists	Bayer Intellectual Property GmbH	11/15/18	2D 3D TSV
US9714234	70	Carbazole carboxamide compounds	Bristol-Myers Squibb Company	11/15/18	2D 3D TSV
US9713651	56	Compositions, methods, and systems for the synthesis and use of imaging agents	Lantheus Medical Imaging, Inc.	11/15/18	2D 3D TSV
US9714236	207	Compounds and methods for inhibiting JAK	ASTRAZENECA AB	11/15/18	2D 3D TSV
US9713612	30	Compounds for treatment of cancer	CUREGENIX, INC.	11/15/18	2D 3D TSV
US9714252	7	Cyclic sulfonamides as sodium channel blockers	Purdue Pharma L.P.	11/15/18	2D 3D TSV
US9714241	375	Cyclopropanamine compound and use thereof	Takeda Pharmaceutical Company Limited	11/15/18	2D 3D TSV
US9714266	46	Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (AKR1C3)	BAYER PHARMA AKTIENGESELLSCHAFT	11/15/18	2D 3D TSV
US9714224	8	Heterocyclic compounds and methods of their use	NOVARTIS AG	11/15/18	2D 3D TSV
US9714230	511	Histone demethylase inhibitors	Celgene Quantical Research, Inc.	11/15/18	2D 3D TSV
US9713606	584	Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C	Boehringer Ingelheim International GmbH	11/15/18	2D 3D TSV
US9714247	452	Multiple kinase pathway inhibitors	Tolero Pharmaceuticals, Inc.; Mannkind Corporation	11/15/18	2D 3D TSV
US9717745	5	Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases	ZHEJIANG DTRM BIOPHARMA CO. LTD.	11/15/18	2D 3D TSV
US9718760	257	Plasminogen activator inhibitor-1 inhibitors and methods of use thereof	THE REGENTS OF THE UNIVERSITY OF MICHIGAN; EASTERN MICHIGAN UNIVERSITY	11/15/18	2D 3D TSV
US9714249	134	Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease	Novartis AG	11/15/18	2D 3D TSV
US9714235	40	Quinazoline derivatives, compositions thereof, and use as pharmaceuticals	Shanghai Fochon Pharmaceutical Co., Ltd.	11/15/18	2D 3D TSV
US9717714	14	Spirocyclic CETP inhibitors	Merck Sharp & Dohme Corp.	11/15/18	2D 3D TSV
US9714221	654	Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof	SANOFI	11/15/18	2D 3D TSV
US9714232	72	Substituted piperazine compounds and methods of use thereof	SUNSHINE LAKE PHARMA CO., LTD.	11/15/18	2D 3D TSV
US9714244	46	Substituted pyrido[4,3-d]pyrimidines as Wee-1 inhibitors	ALMAC DISCOVERY LIMITED	11/15/18	2D 3D TSV
US9556130	73	4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139	Takeda Pharmaceutical Company Limited	11/08/18	2D 3D TSV
US9550741	612	Benzoisothiazole compounds and methods of treating schizophrenia	Shanghai Institute of Pharmaceutical Industry	11/08/18	2D 3D TSV
US9556150	59	Inhibitors of bruton's tyrosine kinase	Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co.	11/08/18	2D 3D TSV
US9708370	88	Azapeptides as CD36 binding compounds	VALORISATION-RECHERCHE, LIMITED PARTNERSHIP; VALORISATION HSJ, LIMITED PARTNERSHIP	11/07/18	2D 3D TSV
US9546162	91	Compounds and methods for skin repair	ALLERGAN, INC.	11/07/18	2D 3D TSV
US9533987	230	Heterocyclic derivates	Kalvista Pharmaceuticals Limited	11/07/18	2D 3D TSV
US9546164	648	Substituted benzamides and methods of use thereof	GENENTECH, INC.; XENON PHARMACEUTICALS INC.	11/07/18	2D 3D TSV
US9708337	36	Aryl amide-based kinase inhibitors	Bristol-Myers Squibb Company	11/05/18	2D 3D TSV
US9708336	2511	Metallo-beta-lactamase inhibitors	Merck Sharp & Dohme Corp.	11/05/18	2D 3D TSV
US9708359	143	Pyrrolopyrimidine nucleosides and analogs thereof	Chimerix, Inc.; The Regents of the University of Michigan	11/05/18	2D 3D TSV
US9708340	96	Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors	Hoffmann-La Roche Inc.	11/05/18	2D 3D TSV
US9708333	86	Fused bicyclic 1,2,4-triazine compounds as TAM inhibitors	Incyte Corporation	11/01/18	2D 3D TSV
US9708309	24	Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use	ORYZON GENOMICS, S.A.	10/31/18	2D 3D TSV
US9708311	143	Benzimidazole derivatives as EP4 antagonists	BAYER PHARMA AKTIENGESELLSCHAFT	10/31/18	2D 3D TSV
US9708318	856	Bicyclic heterocycles as FGFR4 inhibitors	Incyte Corporation	10/31/18	2D 3D TSV
US9708302	46	Flouro-naphthyl derivatives	HOFFMANN-LA-ROCHE INC.	10/31/18	2D 3D TSV
US9708313	142	Substituted pyrido[3,4-b]pyrazines as GPR6 modulators	Takeda Pharmaceutical Company Limited	10/31/18	2D 3D TSV
US9708325	62	Sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection	Hoffmann-La Roche Inc.	10/31/18	2D 3D TSV
US9708279	100	2-acylaminothiazoles for the treatment of cancer	UNIVERSITÁ DEGLI STUDI DI MILANO—BICOCCA; UNIVERSITÈ DE GENÈVE; UNIVERSITÈ CLAUDE BERNARD LYON 1	10/30/18	2D 3D TSV
US10053471	17	Azabenzimidazole derivatives	Boehringer Ingelheim International GmbH	10/30/18	2D 3D TSV
US9708266	40	Cyclohexyl pyridine derivative	KISSEI PHARMACEUTICAL CO., LTD.	10/30/18	2D 3D TSV
US9708253	135	Cyclohexyl sulfone RORγ modulators	Bristol-Myers Squibb Company	10/30/18	2D 3D TSV
US9701672	77	Dihydropyridinone MGAT2 inhibitors for use in the treatment of metabolic disorders	Bristol-Myers Squibb Company	10/30/18	2D 3D TSV
US9708275	12	Heterocyclic compounds and methods for their use	NOVARTIS AG	10/30/18	2D 3D TSV
US9707233	368	Heterocyclylamines as PI3K inhibitors	Incyte Holdings Corporation; Incyte Corporation	10/30/18	2D 3D TSV
US9708272	22	Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylase	TES Pharma S.r.l.	10/30/18	2D 3D TSV
US9700563	3	Kappa opioid receptor compounds	MediSynergies, LLC	10/30/18	2D 3D TSV
US10053462	195	P2X7 modulators	Janssen Pharmaceutica NV	10/30/18	2D 3D TSV
US9701669	34	Preparation and use of 7a-amide substituted- 6,6-difluoro bicyclic himbacine derivatives as PAR-1 receptor antagonists	Merck Sharp & Dohme Corp.	10/30/18	2D 3D TSV
US9708269	7	Process for making isoquinoline compounds	FibroGen, Inc.	10/30/18	2D 3D TSV
US9701670	374	Pyrazolyl-ureas as kinase inhibitors	RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED	10/30/18	2D 3D TSV
US10053465	286	Pyrrolopyrimidine derivatives as TAM inhibitors	Incyte Corporation	10/30/18	2D 3D TSV
US9708268	42	ROR modulators and their uses	INNOV17 LLC	10/30/18	2D 3D TSV
US9707205	16	S1P receptors modulators and their use thereof	AKAAL PHARMA PTY LTD.	10/30/18	2D 3D TSV
US9701693	4	Selective glycosidase inhibitors and uses thereof	Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.	10/30/18	2D 3D TSV
US9701685	18	Spiropyrrolidines as MDM2 inhibitors	Hudson Biopharma Inc.	10/30/18	2D 3D TSV
US9708295	51	Substituted 2-aminopyridine protein kinase inhibitor	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.; Centaurus Biopharma Co., Ltd.; LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD.	10/30/18	2D 3D TSV
US10053463	422	Substituted [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulators	Janssen Pharmaceutica NV	10/30/18	2D 3D TSV
US9708270	91	Substituted spiropiperidinyl compounds useful as GPR120 agonists	Merck Sharp & Dohme Corp.	10/30/18	2D 3D TSV
US9701663	37	Sulfonamide retinoic acid receptor-related orphan receptor modulators and uses thereof	INNOV17 LLC	10/30/18	2D 3D TSV
US9708274	328	Sulfoximine substituted quinazolines for pharmaceutical compositions	EVOTEC INTERNATIONAL GMBH	10/30/18	2D 3D TSV
US10053461	41	Tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection	Hoffmann-La Roche Inc.	10/30/18	2D 3D TSV
US9701638	16	Therapeutic hydroxyquinolones	Rutgers, The State University of New Jersey	10/30/18	2D 3D TSV
US9701691	25	Thienopyrimidine compounds	Hoffman-La Roche Inc.	10/30/18	2D 3D TSV
US9550763	437	Heterocyclic ring and carbocyclic derivative	SHIONOGI & CO., LTD.	10/19/18	2D 3D TSV
US9546173	190	Substituted pyrrolo[3,4-d]pyrimidines as kinase inhibitors	Novartis AG	10/19/18	2D 3D TSV
US10053433	20	Androgen receptor antagonists	The Regents of the University of California	10/18/18	2D 3D TSV
US10053454	88	Carbazole compounds useful as bromodomain inhibitors	Bristol-Myers Squibb Company	10/18/18	2D 3D TSV
US10053456	375	Cyclopropanamine compound and use thereof	Takeda Pharmaceutical Company Limited	10/18/18	2D 3D TSV
US10053455	22	Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors	AB SCIENCE	10/18/18	2D 3D TSV
US10053434	24	Histone deacetylase inhibitors and compositions and methods of use thereof	CHDI FOUNDATION, INC.	10/18/18	2D 3D TSV
US10053458	216	Pyrimidine-2,4-diamine derivative and anticancer pharmaceutical composition comprising same as effective ingredient	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY	10/18/18	2D 3D TSV
US10053431	514	Tetrahydro-benzodiazepinones	Hoffmann-La Roche Inc.	10/18/18	2D 3D TSV
US9556139	260	6-substituted phenoxychroman carboxylic acid derivatives	Array BioPharma Inc.	10/17/18	2D 3D TSV
US9556135	339	Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use	Amgen, Inc.	10/17/18	2D 3D TSV
US10047118	7	C17-aryl substituted betulinic acid analogs	ViiV HEALTHCARE UK (NO.5) LIMITED	10/17/18	2D 3D TSV
US10047086	158	Imidazopyridines and imidazopyrazines as LSD1 inhibitors	Incyte Corporation	10/17/18	2D 3D TSV
US9556143	18	Metalloenzyme inhibitor compounds	Viamet Pharmaceuticals, Inc.	10/17/18	2D 3D TSV
US9556168	60	N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof	Merck Sharp & Dohme Corp.	10/17/18	2D 3D TSV
US9556148	86	N-cyanomethylamides as inhibitors of janus kinase	Cadila Healthcare Limited	10/17/18	2D 3D TSV
US10052306	333	Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B	CADENT THERAPEUTICS, INC.	10/17/18	2D 3D TSV
US9555024	35	Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors	University of Utah Research Foundation	10/17/18	2D 3D TSV
US9555022	102	Substituted triazolopyridines	Bayer Intellectual Property GmbH	10/17/18	2D 3D TSV
US10047080	42	(R)-2-methyl-piperazine derivatives as CXCR3 receptor modulators	IDORSIA PHARMACEUTICALS LTD.	10/10/18	2D 3D TSV
US10045974	14	2-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors	H. Lundbeck A/S	10/10/18	2D 3D TSV
US9556175	46	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and thier use as pharmaceutical compositions	Boehringer Ingelheim International GmbH	10/10/18	2D 3D TSV
US10047073	12	Histone deacetylase inhibitors and compositions and methods of use thereof	CHDI FOUNDATION, INC	10/10/18	2D 3D TSV
US10047084	43	Imidazolone derivatives, pharmaceutical compositions and uses thereof	BEIJING FORELANDPHARMA CO. LTD.	10/10/18	2D 3D TSV
US10047093	120	Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors	TOLERO PHARMACEUTICALS, INC.	10/10/18	2D 3D TSV
US9556191	8	Aminoquinazoline derivatives and their salts and methods of use thereof	SUNSHINE LAKE PHARMA CO., LTD.	10/05/18	2D 3D TSV
US9556160	76	Guanidine compound	Astellas Pharma Inc.	10/03/18	2D 3D TSV
US9562012	23	PPAR-sparing compounds for the treatment of metabolic diseases	Metabolic Solutions Development Company, LLC	10/03/18	2D 3D TSV
US9561238	6	Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy	Donesta Bioscience B.V.	10/03/18	2D 3D TSV
US10047098	188	C5-C6-oxacyclic fused iminopyrimidinone compounds as bace inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	10/02/18	2D 3D TSV
US10047103	384	Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation	Bristol-Myers Squibb Company; Universite de Montreal	10/02/18	2D 3D TSV
US10047097	105	Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds	Array BioPharma Inc.	10/02/18	2D 3D TSV
US10047092	276	Substituted [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulators	Janssen Pharmaceutica NV	10/02/18	2D 3D TSV
US10047096	454	Substituted pyridobenzodiazepinone-derivatives and use thereof	Bayer Pharma Aktiengesellschaft	10/02/18	2D 3D TSV
US9556181	21	Substituted pyrazolopyrimidinylamino-indazoles	BAYER PHARMA AKTIENGESELLSCHAFT	09/30/18	2D 3D TSV
US9540377	1285	2,6,7,8 substituted purines as HDM2 inhibitors	Merck Sharp & Dohme Corp.	09/26/18	2D 3D TSV
US9556157	6	Enhancer of zeste homolog 2 inhibitors	GlaxoSmithKline Intellectual Property (No.2) Limited	09/26/18	2D 3D TSV
US9556170	3	Substituted-1H-benzo[d]imidazole series compounds as lysine-specific demethylase 1 (LSD1) inhibitors	University of Utah Research Foundation	09/26/18	2D 3D TSV
US9546152	448	2-pyridyloxy-3-substituted-4-nitrile orexin receptor antagonists	MERCK SHARP & DOHME CORP.	09/18/18	2D 3D TSV
US9546153	514	Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators	Bristol-Myers Squibb Company	09/18/18	2D 3D TSV
US9533992	75	PDE9 inhibitors with imidazo triazinone backbone	TBA	09/18/18	2D 3D TSV
US9550778	52	Substituted 6-aryl-imidazopyridine and 6-aryl-triazolopyridine carboxamide analogs as negative allosteric modulators of mGluR5	Vanderbilt University	09/18/18	2D 3D TSV
US9556111	23	Tertiary amines for use in the treatment of cardiac disorders	UNIVERSITETET I OSLO	09/18/18	2D 3D TSV
US9556145	22	2-pyridyloxy-4-ester orexin receptor antagonists	MERCK SHARP & DOHME CORP.	09/07/18	2D 3D TSV
US9540359	15	Dihydrooxazine or oxazepine derivatives having BACE1 inhibitory activity	Shionogi & Co., Ltd.	09/07/18	2D 3D TSV
US9556147	7	Inhibitors of bruton's tyrosine kinase	HOFFMANN-LA INC.	09/07/18	2D 3D TSV
US9550781	26	Kinase modulating compounds, compositions containing the same and use thereof	Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	09/07/18	2D 3D TSV
US9556132	41	Tetrazole derivatives and their use as potassium channel modulators	Saniona A/S	09/07/18	2D 3D TSV
US9540396	38	6-arylamino pyridone carboxamide as MEK inhibitors	Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	08/28/18	2D 3D TSV
US9550755	5	Complement pathway modulators and uses thereof	NOVARTIS AG	08/28/18	2D 3D TSV
US9546168	29	ERK inhibitors	Merck Sharp & Dohme Corp.	08/28/18	2D 3D TSV
US9550774	2	Dihydropyrido pyrimidine compounds as autotaxin inhibitors	Eli Lilly and Company	08/25/18	2D 3D TSV
US9527857	211	HSPC-sparing treatments for RB-positive abnormal cellular proliferation	GI Therapeutics, Inc.	08/25/18	2D 3D TSV
US9540379	222	(1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases	Boehringer Ingelheim International GmbH	08/24/18	2D 3D TSV
US9539260	567	Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives	NOVARTIS AG	08/24/18	2D 3D TSV
US9540357	74	15-aryl prostaglandins as EP4 agonists, and methods of use thereof	Allergan, Inc.	08/16/18	2D 3D TSV
US9540323	274	7-hydroxy-indolinyl antagonists of P2Y1 receptor	Bristol-Myers Squibb Company	08/16/18	2D 3D TSV
US9540388	197	P2X7 modulators	Janssen Pharmaceutica NV	08/16/18	2D 3D TSV
US9527851	130	Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof	Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd.	08/16/18	2D 3D TSV
US9540352	14	Substituted 1,7-naphthyridines as dopamine D1 ligands	Pfizer Inc.	08/16/18	2D 3D TSV
US9670229	31	5-HT3 receptor antagonists	Takeda Pharmaceutical Company Limited	08/07/18	2D 3D TSV
US9522914	174	Azole derivative	TAISHO PHARMACEUTICAL CO., LTD	08/07/18	2D 3D TSV
US9540364	19	Benzimidazole tetrahydrofuran derivatives	Merck Sharp & Dohme Corp.	08/07/18	2D 3D TSV
US9676777	3	Compounds useful for producing an optically active diazabicyclooctane compound	MEIJI SEIKA PHARMA CO., LTD.	08/07/18	2D 3D TSV
US9533999	64	Fused thiazin-3-ones as KCA3.1 inhibitors	Boehringer Ingelheim International GmbH	08/07/18	2D 3D TSV
US9670231	368	Fused tricyclic amide compounds as multiple kinase inhibitors	BeiGene, Ltd.	08/07/18	2D 3D TSV
US9670230	12	Heteroaryl compounds and methods of use thereof	Sunovion Pharmaceuticals Inc.	08/07/18	2D 3D TSV
US9676783	105	Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds	Array BioPharma, Inc.	08/07/18	2D 3D TSV
US9670255	3	Modified biotin, mutant streptavidin, and use thereof	SAVID THERAPEUTICS INC.	08/07/18	2D 3D TSV
US9676786	4	Pharmacologically active compounds	THE UNIVERSITY OF LIVERPOOL	08/07/18	2D 3D TSV
US9676792	4	Pyrimido-diazepinone compounds and methods of treating disorders	Dana-Farber Cancer Institute, Inc.	08/07/18	2D 3D TSV
US9540384	58	Pyrrolidino heterocycles	Hoffmann-La Roche, Inc.	08/07/18	2D 3D TSV
US9533995	14	Substituted N-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof	Sanofi	08/07/18	2D 3D TSV
US9676782	342	Substituted pyrazolo[1,5-a]pyrazines as negative allosteric modulators of metabotropic glutamate receptor 3	Vanderbilt University	08/07/18	2D 3D TSV
US9540373	27	Substituted spirocycles	Boehringer Ingelheim International GmbH	08/07/18	2D 3D TSV
US9676818	32	Toll-like receptor 2-agonistic lipopeptides, and method of making the same	University of Kansas	08/07/18	2D 3D TSV
US9670211	45	Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection	HOFFMANN-LA ROCHE INC.	07/07/18	2D 3D TSV
US9670216	58	Cannabinoid-2 agonists	ALLERGAN, INC.	07/07/18	2D 3D TSV
US9670204	211	Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders	GALAPAGOS NV	07/07/18	2D 3D TSV
US9670210	116	Cyclopropylamines as LSD1 inhibitors	Incyte Corporation	07/07/18	2D 3D TSV
US9670220	66	Fused heterocyclic derivatives as S1P modulators	Abbvie B.V.; AbbiVie Inc.	07/07/18	2D 3D TSV
US9670203	142	Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors	BeiGene, Ltd.	07/07/18	2D 3D TSV
US9670212	191	Inhibitors of PI3K-delta and methods of their use and manufacture	Exelixis, Inc.	07/07/18	2D 3D TSV
US9670209	69	Muscarinic agonists	ACADIA PHARMACEUTICALS INC.; ALLERGAN, INC.	07/07/18	2D 3D TSV
US9670213	175	Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitor	East China University of Science and Technology	07/07/18	2D 3D TSV
US9670208	48	Serine/threonine kinase inhibitors	Array BioPharma Inc.; Genentech, Inc.	07/07/18	2D 3D TSV
US9670214	404	Small molecule myristate inhibitors of Bcr-abl and methods of use	DANA-FARBER CANCER INSTITUTE, INC.; THE SCRIPPS RESEARCH INSTITUTE	07/07/18	2D 3D TSV
US9670136	210	(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors	ORYZON GENOMICS S.A.	05/19/18	2D 3D TSV
US9670142	171	1,3-diaminocyclopentane carboxamide derivatives	Merck Patent GmbH	05/19/18	2D 3D TSV
US9669034	227	4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group	BAYER INTELLECTUAL PROPERTY GMBH	05/19/18	2D 3D TSV
US9670161	20	5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group	BAYER PHARMA AKTIENGESELLSCHAFT	05/19/18	2D 3D TSV
US9670157	271	Benzylamine derivatives	Kalvista Pharmaceuticals Limited	05/19/18	2D 3D TSV
US9669035	66	Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disorders	JANSSEN PHARMACEUTICA NV	05/19/18	2D 3D TSV
US9669095	13	Cyclosporin analogues for preventing or treating hepatitis C infection	ENANTA PHARMACEUTICALS, INC.	05/19/18	2D 3D TSV
US9670195	3	Glycosidase inhibitors and uses thereof	Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.	05/19/18	2D 3D TSV
US9669029	114	Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors	H. Lundbeck A/S	05/19/18	2D 3D TSV
US9669031	313	MNK inhibitors and methods related thereto	eFFECTOR THERAPEUTICS, INC.	05/19/18	2D 3D TSV
US9670201	104	Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof	Pfizer Inc.	05/19/18	2D 3D TSV
US9670191	116	Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors	NERVIANO MEDICAL SCIENCES S.R.L.	05/19/18	2D 3D TSV
US9669028	175	Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors	ARRIEN PHARMACEUTICALS LLC	05/19/18	2D 3D TSV
US9670181	87	Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)	ALLERGAN, INC.; EXONHIT THERAPEUTICS SA	05/19/18	2D 3D TSV
US9670194	71	Substituted aminopyrimidine compounds and methods of use	CALITOR SCIENCES, LLC; SUNSHINE LAKE PHARMA CO., LTD.	05/19/18	2D 3D TSV
US9670166	297	Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity	Boehringer Ingelheim International GmbH	05/19/18	2D 3D TSV
US9670202	22	Substituted triazolopyridines	BAYER PHARMA AKTIENGESELLSCHAFT	05/19/18	2D 3D TSV
US9670196	13	Thiazole-substituted aminoheteroaryls as Spleen Tyrosine Kinase inhibitors	Merck Sharp & Dohme Corp.	05/19/18	2D 3D TSV
US9670193	138	Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease	Novartis AG	05/19/18	2D 3D TSV
US9676728	19	2-benzyl-benzimidazole complement factor B inhibitors and uses thereof	Novartis AG	04/16/18	2D 3D TSV
US9675697	203	BET bromodomain inhibitors and therapeutic methods using the same	THE REGENTS OF THE UNIVERSITY OF MICHIGAN	04/16/18	2D 3D TSV
US9676721	112	Compounds and compositions for the inhibition of NAMPT	FORMA TM, LLC	04/16/18	2D 3D TSV
US9676701	287	Cyclopropylamine derivatives useful as LSD1 inhibitors	ORYZON GENOMICS, S.A.	04/16/18	2D 3D TSV
US9676732	74	Ethynyl derivatives	HOFFMANN-LA ROCHE INC.	04/16/18	2D 3D TSV
US9676712	15	Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions	CAYMAN CHEMICAL COMPANY, INC.	04/16/18	2D 3D TSV
US9676720	29	Substituted biaryl compound	UBE INDUSTRIES, LTD.	04/16/18	2D 3D TSV
US9675616	13	Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-C]quinolines	BAYER INTELLECTUAL PROPERTY GMBH	04/12/18	2D 3D TSV
US9688710	328	Inhibitors of sodium glucose cotransporter 1	Lexicon Pharmaceuticals, Inc.	04/12/18	2D 3D TSV
US9675614	334	PRMT5 inhibitors and uses thereof	Epizyme, Inc.	04/12/18	2D 3D TSV
US9688696	116	Piperidine/piperazine derivatives	Janssen Pharmaceutica N.V.	04/12/18	2D 3D TSV
US9688816	46	Polyetherimide compositions and methods for the manufacture and use thereof	SABIC GLOBAL TECHNOLOGIES B.V.	04/12/18	2D 3D TSV
US9675612	45	Substituted thiazolopyrimidines	BAYER PHARMA AKTIENGESELLSCHAFT	04/12/18	2D 3D TSV
US9688680	950	Compositions useful for treating disorders related to kit	BLUEPRINT MEDICINES CORPORATION	03/27/18	2D 3D TSV
US9688695	384	Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation	BRISTOL-MYERS SQUIBB COMPANY	03/27/18	2D 3D TSV
US9688678	37	Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof for treating vasopressin-related diseases	AbbVie Deutschland GmbH & Co. KG	03/27/18	2D 3D TSV
US9688683	31	Substituted condensed pyrimidine compounds	Dalhousie University	03/27/18	2D 3D TSV
US9688684	278	Substituted tetrazolo[1,5-a]pyrazines as ROR-gamma inhibitors	Merck Patent GmbH	03/27/18	2D 3D TSV
US9688676	65	Tyrosine kinase inhibitors	PRINCIPIA BIOPHARMA INC.	03/27/18	2D 3D TSV
US9688672	450	3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH	NOVARTIS AG	03/19/18	2D 3D TSV
US9688668	150	Long chain base sphingosine kinase inhibitors	University of Virginia Patent Foundation	03/19/18	2D 3D TSV
US9688664	8	Modulators of fatty acid amide hydrolase	Janssen Pharmaceutica NV	03/19/18	2D 3D TSV
US9688669	125	Oxazolidinones as modulators of mGluR5	Bristol-Myers Squibb Company	03/19/18	2D 3D TSV
US9688661	139	Substituted pyrroles active as kinases inhibitors	NERVIANO MEDICAL SCIENCES S.R.L.	03/19/18	2D 3D TSV
US9675593	518	Anti-fibrotic pyridinones	INTERMUNE, Inc.	03/16/18	2D 3D TSV
US9675594	46	Arylpyrrolopyridine derived compounds as LRRK2 inhibitors	H. Lundbeck A/S	03/16/18	2D 3D TSV
US9675539	2	Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives	Duke University	03/16/18	2D 3D TSV
US9675571	28	Inhibitors of indoleamine 2,3-dioxygenase (IDO)	Bristol-Myers Squibb Company	03/16/18	2D 3D TSV
US9688645	25	Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa	SANOFI	03/16/18	2D 3D TSV
US9675591	9	Methods for treating seizure disorders and pain	SRMLSC	03/16/18	2D 3D TSV
US9675605	83	Substituted naphthyridine and quinoline compounds as MAO inhibitors	Dart NeuroScience (Cayman) Ltd.	03/16/18	2D 3D TSV
US9688642	96	Substituted pyrazines as GPR40 agonists	Janssen Pharmaceutica NV	03/12/18	2D 3D TSV
US9688643	325	Triazine derivative and pharmaceutical composition comprising the same	SHIONOGI & CO., LTD.	03/12/18	2D 3D TSV
US9688638	35	Opioid agonists and uses thereof	Nektar Therapeutics	03/11/18	2D 3D TSV
US9682995	359	Amino-substituted isothiazoles	BAYER PHARMA AKTIENGESELLSCHAFT	03/10/18	2D 3D TSV
US9682993	22	Anticancer compounds	St. Jude Children's Research Hospital	03/10/18	2D 3D TSV
US9682983	326	BMP inhibitors and methods of use thereof	The Brigham and Women's Hospital, Inc.; Dept. of Health and Human Services, National Institutes of Health	03/10/18	2D 3D TSV
US9688615	706	Benzimidazole inhibitors of the sodium channel	DEGIACOMO, INTERIM TRUSTEE, MARK G.	03/10/18	2D 3D TSV
US9688624	12	DP2 antagonist and uses thereof	Brickell Biotech, Inc.	03/10/18	2D 3D TSV
US9687494	21	Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use	Ambit Biosciences	03/10/18	2D 3D TSV
US9688629	262	Indole carboxamide compounds	Bristol-Myers Squibb Company	03/10/18	2D 3D TSV
US9687479	520	Multisubstituted aromatic compounds as serine protease inhibitors	VERSEON CORPORATION	03/10/18	2D 3D TSV
US9687478	34	Quinuclidine derivatives and medicinal compositions containing the same	ALMIRALL, S.A.	03/10/18	2D 3D TSV
US9687483	5	Treatment of cerebral cavernous malformations and cerebral aneurysms with Rho kinase inhibitors	BIOAXONE BIOSCIENCES, INC.	03/10/18	2D 3D TSV
US9682991	198	Tricyclic compounds for use as kinase inhibitors	FUNDACIÓN CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III	03/10/18	2D 3D TSV
US9682971	220	1,2,5-Substituted benzimidazoles as flap modulators	JANSSEN PHARMACEUTICA NV	02/14/18	2D 3D TSV
US9682980	85	Positive allosteric modulators of mGluR2	Bristol-Myers Squibb Company	02/14/18	2D 3D TSV
US9682976	324	Protein kinase C inhibitors and uses thereof	Rigel Pharmaceuticals, Inc.	02/14/18	2D 3D TSV
US9682959	6	Ethynyl derivatives	HOFFMANN-LA ROCHE INC.	02/13/18	2D 3D TSV
US9682965	75	Fumagillol heterocyclic compounds and methods of making and using same	Zafgen, Inc.	02/13/18	2D 3D TSV
US9682966	563	Kappa opioid ligands	The Scripps Research Institute	02/13/18	2D 3D TSV
US9682967	50	N-substituted-5-substituted phthalamic acids as sortilin inhibitors	H. Lundbeck A/S	02/13/18	2D 3D TSV
US9682960	137	Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety	ENDORECHERCHE, INC.	02/13/18	2D 3D TSV
US9682969	31	Phthalazinone compounds and methods for the treatment of cystic fibrosis	Flatley Discovery Lab, LLC	02/13/18	2D 3D TSV
US9682968	110	Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof	Novartis AG	02/13/18	2D 3D TSV
US9682963	28	Pyridine derivatives as soft rock inhibitors	Redx Pharma PLC	02/13/18	2D 3D TSV
US9682961	26	Quinazoline derivative	CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER	02/13/18	2D 3D TSV
US9682953	166	Amide compounds, compositions and applications thereof	ADVINUS THERAPEUTICS LIMITED	02/07/18	2D 3D TSV
US9687476	60	Bisaryl-bonded aryltriazolones and use thereof	Bayer Intellectual Property GmbH	02/07/18	2D 3D TSV
US9682141	2516	Combination of kinase inhibitors and uses thereof	Intellikine LLC	02/07/18	2D 3D TSV
US9682957	192	Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity	Theravance Respiratory Company, LLC	02/07/18	2D 3D TSV
US9682940	502	Indazole derivatives useful as CB-1 inverse agonists	Janssen Pharmaceutica NV	02/07/18	2D 3D TSV
US9682955	280	Quinazoline derivatives useful as CB-1 inverse agonists	Janssen Pharmaceutica NV	02/07/18	2D 3D TSV
US9682910	35	Series of skin-whitening (lightening) compounds	Unigen, Inc.	02/07/18	2D 3D TSV
US9695195	162	5-HT3 receptor antagonists	Takeda Pharmaceutical Company Limited	02/06/18	2D 3D TSV
US9695205	53	Amide compounds for treatment of complement mediated disorders	Achillion Pharmaceuticals, Inc.	02/06/18	2D 3D TSV
US9695197	11	Glycosidase inhibitors and uses thereof	Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.	02/06/18	2D 3D TSV
US9695200	175	Heterocyclic ITK inhibitors for treating inflammation and cancer	Confluence Life Sciences, Inc.	02/06/18	2D 3D TSV
US9695151	90	3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds	Hoffmann-La Roche Inc.	01/26/18	2D 3D TSV
US9695152	84	3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds	Hoffmann-La Roche Inc.	01/26/18	2D 3D TSV
US9695194	126	Benzoxazinone derivatives for treatment of skin diseases	SIXERA PHARMA AB	01/26/18	2D 3D TSV
US9695172	15	Diazepane derivatives and uses thereof	Dana-Farber Cancer Institute, Inc.	01/26/18	2D 3D TSV
US9695175	51	Highly selective c-Met inhibitors as anticancer agents	CB THERAPEUTICS INC.	01/26/18	2D 3D TSV
US9695181	15	Hydroximic acid derivatives and medical applications therof	DOUBLE RIDER MEDICINE CO., LTD.	01/26/18	2D 3D TSV
US9695174	21	Inhibitor of breast cancer resistance protein (BCRP)	Millennium Pharmaceuticals, Inc.	01/26/18	2D 3D TSV
US9695165	82	Inhibitors of the fibroblast growth factor receptor	BLUEPRINT MEDICINES CORPORATION	01/26/18	2D 3D TSV
US9695179	17	Methods and compositions for inhibition of bromodomain-containing proteins	ConverGene LLC	01/26/18	2D 3D TSV
US9695170	217	Naphthyridine derivatives as inhibitors of Hypoxia inducible factor (HIF) hydroxylase	FibroGen, Inc.	01/26/18	2D 3D TSV
US9695160	36	Piperazine derivatives for treating disorders	The University of Nottingham; NewSouth Innovations PTY Limited	01/26/18	2D 3D TSV
US9695183	702	Substituted 7-azabicycles and their use as orexin receptor modulators	JANSSEN PHARMACEUTICA NV	01/26/18	2D 3D TSV
US9695180	119	Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors	Incyte Corporation	01/26/18	2D 3D TSV
US9695168	158	Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors	Incyte Corporation	01/26/18	2D 3D TSV
US9695176	4	Substituted imidazo[1,5-a]pyrazines as CGRP receptor antagonists	Bristol-Myers Squibb Company	01/26/18	2D 3D TSV
US9695167	13	Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors	Incyte Corporation	01/26/18	2D 3D TSV
US9695185	5	Synthetic methods for spiro-oxindole compounds	Xenon Pharmaceuticals Inc.	01/26/18	2D 3D TSV
US9695163	76	Thiazole orexin receptor antagonists	MERCK SHARP & DOHME CORP	01/26/18	2D 3D TSV
US9695149	235	1,2,6-substituted benzimidazoles as flap modulators	JANSSEN PHARMACEUTICA NV	01/19/18	2D 3D TSV
US9695118	394	Benzamide derivative	Chugai Seiyaku Kabushiki Kaisha	01/19/18	2D 3D TSV
US9694016	2555	Biaryl amide compounds as kinase inhibitors	NOVARTIS AG	01/19/18	2D 3D TSV
US9695128	13	Ethynyl derivatives	Hoffmann-La Roche Inc.	01/19/18	2D 3D TSV
US9695132	194	Heteroaryl compounds and uses thereof	Celgene CAR LLC; Sanofi	01/19/18	2D 3D TSV
US9694018	12	IBAT inhibitors for the treatment of liver disease	Albireo AB	01/19/18	2D 3D TSV
US9694015	59	Methods for the treatment of locally advanced breast cancer	Celgene Corporation	01/19/18	2D 3D TSV
US9694024	17	Methods of treating retroviral infections and related dosage regimes	Chimerix, Inc.	01/19/18	2D 3D TSV
US9694012	76	Pyrazol derivatives	Hoffmann-La Roche Inc.	01/19/18	2D 3D TSV
US9694011	6	Substituted pyrazolopyrimidines as kinases inhibitors	Jiangsu Medolution Ltd	01/19/18	2D 3D TSV
US9695131	56	Substituted uracils as chymase inhibitors	Bayer Pharma Aktiengesellschaft	01/19/18	2D 3D TSV
US9693997	356	Antiviral compounds	HOFFMANN-LA ROCHE INC.	01/14/18	2D 3D TSV
US9693992	251	IRE-1α inhibitors	MannKind Corporation	01/14/18	2D 3D TSV
US9694002	648	Substituted benzamides and methods of use thereof	GENENTECH, INC.; XENON PHARMACEUTICALS INC.	01/14/18	2D 3D TSV
US9527838	54	2-pyridinecarboxamide derivatives, compositions containing such compounds, and methods of treatment	Merck Sharp & Dohme Corp.	12/04/17	2D 3D TSV
US9527839	25	Benzimidazole tetrahydropyran derivatives	Merck Sharp & Dohme Corp.	12/04/17	2D 3D TSV
US9533969	6	Materials and method for inhibiting replication protein A and uses thereof	Indiana University Research and Technology Corporation	12/04/17	2D 3D TSV
US9532990	119	Polyfluorinated compounds acting as bruton tyrosine kinase inhibitors	Zhejiang DTRM Biopharma Co. Ltd.	12/04/17	2D 3D TSV
US9504692	48	Selective inhibition of MALT1 protease by phenothiazine derivatives	HELMHOLTZ ZENTRUM MUNCHEN, DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT (GMBH)	12/04/17	2D 3D TSV
US9533989	123	Substituted pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitors	Ziarco Pharma Ltd.	12/04/17	2D 3D TSV
US9533985	193	Sulfonamide derivative and medicinal use thereof	EA Pharma Co., Ltd.	12/04/17	2D 3D TSV
US9522881	71	Hydroxyindole carboxylic acid based inhibitors for oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)	Indiana University Research and Technology Corporation	11/27/17	2D 3D TSV
US9512115	58	Inhibitors	PROBIODRUG AG	11/27/17	2D 3D TSV
US9505766	158	Kinase inhibitors	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA	11/27/17	2D 3D TSV
US9522910	16	Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon	OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYOU “FUSION PHARMA”	11/27/17	2D 3D TSV
US9505762	338	Purine derivatives as CB2 receptor agonists	HOFFMANN-LA ROCHE INC.	11/27/17	2D 3D TSV
US9512141	84	Pyrazine derivatives as CB2 receptor agonists	HOFFMANN-LA ROCHE INC.	11/27/17	2D 3D TSV
US9512132	76	Pyrazole compounds as CB2 agonists	Hoffmann-La Roche Inc.	11/27/17	2D 3D TSV
US9522886	195	Pyridine derivatives	HOFFMANN-LA ROCHE INC.	11/27/17	2D 3D TSV
US9505749	527	Quinazolinone compounds and derivatives thereof	AMGEN INC.	11/27/17	2D 3D TSV
US9505780	114	Thienopyranones as kinase and epigenetic inhibitors	SignalRx Pharmaceuticals, Inc.	11/27/17	2D 3D TSV
US9512121	47	[1,2,4] triazol [4,3-A] pyridine derivative, preparation method therefor or medical application thereof	Jiangsu Hansoh Pharmaceutical Co., Ltd.	11/27/17	2D 3D TSV
US9499492	130	4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group	Bayer Pharma Aktiengesellschaft	11/20/17	2D 3D TSV
US9499502	733	5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	11/20/17	2D 3D TSV
US9512084	40	Amino pyrimidine derivatives	Novartis AG	11/20/17	2D 3D TSV
US9499547	110	Amino-substituted imidazopyridazines	BAYER INTELLECTUAL PROPERTY GMBH	11/20/17	2D 3D TSV
US9493490	60	Boron-containing small molecules	Anacor Pharmaceuticals, Inc.	11/20/17	2D 3D TSV
US9493486	113	Diazaspirocycloalkane and azaspirocycloalkane	Hoffmann-La Roches Inc.	11/20/17	2D 3D TSV
US9505745	110	Enhancer of zeste homolog 2 inhibitors	GlaxoSmithKline Intellectual Property (No. 2) Limited	11/20/17	2D 3D TSV
US9526727	30	Inhibitors of beta-secretase	Vitae Pharmaceutical, Inc.	11/20/17	2D 3D TSV
US9499482	247	Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists	Bristol-Myers Squibb Company	11/20/17	2D 3D TSV
US9512114	52	Substituted aminopyrimidine compounds and methods of use	CALITOR SCIENCES, LLC; SUNSHINE LAKE PHARMA CO., LTD.	11/20/17	2D 3D TSV
US9512126	25	Substituted imidazopyridazines	Bayer Intellectual Property GmbH	11/20/17	2D 3D TSV
US9512169	23	3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments	BAYER PHARMA AKTIENGESELLSCHAFT	11/13/17	2D 3D TSV
US9512068	14	Augmenting moieties for anti-inflammatory compounds	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY; LEHIGH UNIVERSITY	11/13/17	2D 3D TSV
US9493448	168	Cycloalkane derivatives	DAIICHI SANKYO COMPANY, LIMITED	11/13/17	2D 3D TSV
US9511061	6	Incontinence treatment methods	IXALTIS	11/13/17	2D 3D TSV
US9505753	69	Inhibitors of D-amino acid oxidase	THE JOHNS HOPKINS UNIVERSITY	11/13/17	2D 3D TSV
US9512082	7	Inhibitors of glutaminyl cyclase	PROBIODRUG AG	11/13/17	2D 3D TSV
US9493446	1134	Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives	ACTELION PHARMACEUTICALS LTD.	11/13/17	2D 3D TSV
US9512065	5	Polymorphs of N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide hydrochloride	Kalvista Pharmaceuticals Limited	11/13/17	2D 3D TSV
US9493485	178	Spirocyclic dihydro-thiazine and dihydro-oxazine BACE inhibitors, and compositions and uses thereof	Imago Pharmaceuticals, Inc.	11/13/17	2D 3D TSV
US9505786	59	Substituted annulated triazines and use thereof	BAYER PHARMA AKTIENGESELLSCHAFT; BAYER INTELLECTUAL PROPERTY GMBH	11/13/17	2D 3D TSV
US9522888	952	Substituted bicyclic compounds	Bristol-Myers Squibb Company	11/13/17	2D 3D TSV
US9512130	4	Substituted imidazopyridazines	BAYER PHARMA AKTIENGESELLSCHAFT	11/13/17	2D 3D TSV
US9493441	222	Acyclic cyanoethylpyrazoles as janus kinase inhibitors	Merck Sharp & Dohme Corp.	11/06/17	2D 3D TSV
US9489013	194	C6-azaspiro iminothiadiazine dioxides as bace inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	11/06/17	2D 3D TSV
US9493440	239	Compounds inhibiting leucine-rich repeat kinase enzyme activity	Merck Sharp & Dohme Corp.	11/06/17	2D 3D TSV
US9493432	214	Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders	Takeda Pharmaceuticals Company Limited	11/06/17	2D 3D TSV
US9487511	375	Cyclopropanamine compound and use thereof	Takeda Pharmaceutical Company Limited	11/06/17	2D 3D TSV
US9522883	1	Glycosidase inhibitors and uses thereof	Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.	11/06/17	2D 3D TSV
US9505736	16	Histone deacetylase inhibitors and compositions and methods of use thereof	CHDI Foundation, Inc.	11/06/17	2D 3D TSV
US9493435	182	IRE-1α inhibitors	MannKing Corporation	11/06/17	2D 3D TSV
US9492453	77	Protein kinase B inhibitors	AstraZeneca AB	11/06/17	2D 3D TSV
US9505773	18	Rapamycin analogues and their pharmaceutical use	Isomerase Therapeutics Ltd.	11/06/17	2D 3D TSV
US9504684	11	Syk inhibitors	Gilead Sciences, Inc.	11/06/17	2D 3D TSV
US9487512	159	(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors	Oryzon Genomics S.A.	10/30/17	2D 3D TSV
US9487490	63	3-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereof	Merck Sharp & Dohme Corp.	10/30/17	2D 3D TSV
US9481672	253	Bicyclically substituted uracils and the use thereof	Bayer Pharma Aktiengesellschaft	10/30/17	2D 3D TSV
US9487483	128	Complement pathway modulators and uses thereof	Novartis AG	10/30/17	2D 3D TSV
US9505754	4	Compound useful for the treatment of degenerative and inflammatory diseases	GALAPAGOS NV	10/30/17	2D 3D TSV
US9487462	114	Inhibitors of matrix metalloproteinases	PharmaHungary 2000 Kft.; TargetEx Kft.	10/30/17	2D 3D TSV
US9481648	347	Kinase inhibitors	Respivert Limited; Topivert Pharma Limited	10/30/17	2D 3D TSV
US9505743	3	Matrix metalloproteinase inhibitors and methods for the treatment of pain and other diseases	TBA	10/30/17	2D 3D TSV
US9487501	114	Pyrazole carboxamide compounds and uses thereof	Hoffmann-La Roche Inc.	10/30/17	2D 3D TSV
US9475815	228	Substituted benzothienyl-pyrrolotriazines and uses thereof	BAYER INTELLETUAL PROPERTY GMBH	10/30/17	2D 3D TSV
US9487488	60	Sulfonamide compound	MITSUBISHI TANABE PHARMA CORPORATION	10/30/17	2D 3D TSV
US9481688	24	(Thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT2A antagonists	Eli Lilly and Company	10/23/17	2D 3D TSV
US9499493	51	2,4-pyrimidinediamine compounds and their uses	Rigel Pharmaceuticals, Inc.	10/23/17	2D 3D TSV
US9499570	14	Boron containing small molecules	Anacor Pharmaceuticals, Inc.	10/23/17	2D 3D TSV
US9499561	46	Fused pyrimidine compound, and preparation method, intermediate, composition, and uses thereof	Shanghai Yingli Pharmaceutical Co., Ltd.	10/23/17	2D 3D TSV
US9499486	7	Kinase inhibitor	Respivert Limited; Topivert Pharma Limited	10/23/17	2D 3D TSV
US9499523	63	Phosphatidylinositol 3-kinase inhibitors	GILEAD SCIENCES, INC.	10/23/17	2D 3D TSV
US9475817	402	Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitors	Bristol-Myers Squibb Company	10/23/17	2D 3D TSV
US9475819	702	Substituted 7-azabicycles and their use as orexin receptor modulators	Janssen Pharmaceutica NV	10/23/17	2D 3D TSV
US9481682	221	Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors	MERCK SHARP & DOHME CORP.	10/23/17	2D 3D TSV
US9499534	42	Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors	Merck Sharp & Dohme Corp.	10/23/17	2D 3D TSV
US9475813	268	Tricyclic pyrrolopyridine compound, and JAK inhibitor	Nissan Chemical Industries, Ltd.	10/23/17	2D 3D TSV
US9469597	210	(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors	Oryzon Genomics S.A.	10/16/17	2D 3D TSV
US9505765	36	4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatment	CONFLUENCE LIFE SCIENCES INC.	10/16/17	2D 3D TSV
US9499542	46	Arylpyrrolopyridine derived compounds as LRRK2 inhibitors	H. Lundbeck A/S; Vernalis (R&D) Ltd.	10/16/17	2D 3D TSV
US9475775	160	Benzazepine dicarboxamide compounds	Hoffmann-La Roche Inc.	10/16/17	2D 3D TSV
US9493483	6	Benzo [C] isoxazoloazepine bromodomain inhibitors and uses thereof	Constellation Pharmaceuticals, Inc.	10/16/17	2D 3D TSV
US9487554	62	Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, processes for their preparation, pharmaceutical preparations comprising them and their use for preparing medicaments	Bayer Intellectual Property GmbH; Bayer Pharma Aktiengesellschaft	10/16/17	2D 3D TSV
US9469631	130	N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them, and uses thereof	Boehringer Ingelheim International GmbH	10/16/17	2D 3D TSV
US9464084	843	P2X7 modulators	Janssen Pharmaceutica NV	10/16/17	2D 3D TSV
US9505734	2	Phenyl C-glucoside derivative containing deoxyglucose structure, preparation method and use thereof	Tianjin Institute of Pharmaceutical Research	10/16/17	2D 3D TSV
US9468661	123	Pyrrolidine derivatives and their use as complement pathway modulators	Novartis AG	10/16/17	2D 3D TSV
US9493412	34	Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors	Bristol-Myers Squibb Company	10/16/17	2D 3D TSV
US9493472	34	Substituted benzoxazoles	Bayer Pharma Aktiengesellschaft	10/16/17	2D 3D TSV
US9481677	37	Biaryl ether sulfonamides and their use as therapeutic agents	XENON PHARMACEUTICALS INC.	10/10/17	2D 3D TSV
US9493457	3	4,5,6,7-tetrahyroimidazo[4,5-c]pyridine compounds	Proximagen Limited	10/09/17	2D 3D TSV
US9481673	141	6-alkynyl-pyridine derivatives	Boehringer ingelheim International GmbH	10/09/17	2D 3D TSV
US9493431	44	Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases	ABBVIE INC.	10/09/17	2D 3D TSV
US9493430	41	Biaryl- or heterocyclic biaryl-substituted cyclohexene derivative compounds as CETP inhibitors	Chong Kun Dang Pharmaceutical Corp.	10/09/17	2D 3D TSV
US9493474	60	Inhibitors of the renal outer medullary potassium channel	Merck Sharp & Dohme Corp.	10/09/17	2D 3D TSV
US9458201	162	Melanocortin receptor-specific heptapeptides	Palatin Technologies, Inc.	10/09/17	2D 3D TSV
US9458171	572	Pyrrolidinyl sulfone RORγ modulators	Bristol-Myers Squibb Company	10/09/17	2D 3D TSV
US9505739	11	Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease	Merck Sharp & Dohme Corp.	10/09/17	2D 3D TSV
US9464092	229	Transient protection of normal cells during chemotherapy	G1 Therapeutics, Inc.	10/09/17	2D 3D TSV
US9459250	254	Use of T1R3 venus flytrap region polypeptide to screen for taste modulators	SENOMYX, INC.	10/09/17	2D 3D TSV
US9464076	131	Benzothiophene derivative	Daiichi Sankyo Company, Limited	10/02/17	2D 3D TSV
US9487494	9	Cyclic hydrocarbon compounds for the treatment of diseases	LEO PHARMA A/S	10/02/17	2D 3D TSV
US9481685	8	Imaging neuroinflammation	GE Healthcare Limited	10/02/17	2D 3D TSV
US9493447	14	Optically active PDE10 inhibitor	Omeros Corporation	10/02/17	2D 3D TSV
US9480684	35	Orvinol and thevinol derivatives useful in the treatment of anxiety or a compulsive disorder	The University of Bath	10/02/17	2D 3D TSV
US9458110	632	Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors	Bristol-Myers Squibb Company	10/02/17	2D 3D TSV
US9458172	180	Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives	TBA	10/02/17	2D 3D TSV
US9493429	9	Substituted benzoxazoles and methods of use thereof	GENENTECH, INC.; XENON PHARMACEUTICALS INC.	10/02/17	2D 3D TSV
US9458113	187	Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity	Boehringer Ingelheim International GmbH	10/02/17	2D 3D TSV
US9458176	245	Tetrahydroimidazo(1,5-D)[1,4]oxazepine derivative	Eisai R&D Management Co., Ltd.	10/02/17	2D 3D TSV
US9469608	44	Thrombin inhibitors	Merck Sharp & Dohme Corp.	10/02/17	2D 3D TSV
US9452986	683	6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use	AbbVie Inc.	09/25/17	2D 3D TSV
US9453031	272	Chemical entities	Fundación Centro Nacional de Investigaciones Oncológicas Carlos III	09/25/17	2D 3D TSV
US9475814	83	Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof	Euroscreen S.A.	09/25/17	2D 3D TSV
US9475806	21	Complement factor B inhibitors and uses there of	Novartis AG	09/25/17	2D 3D TSV
US9452990	131	Complement pathway modulators and uses thereof	NOVARTIS AG	09/25/17	2D 3D TSV
US9464060	136	Compounds	Takeda Pharmaceutical Company Limited	09/25/17	2D 3D TSV
US9468642	46	Imidazopyrazines	BAYER INTELLECTUAL PROPERTY GMBH	09/25/17	2D 3D TSV
US9447148	197	Melanocortin-1 receptor-specific cyclic peptides	Palatin Technologies, Inc.	09/25/17	2D 3D TSV
US9469653	23	Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY	09/25/17	2D 3D TSV
US9452998	274	Protein kinase C inhibitors and methods of their use	NOVARTIS AG	09/25/17	2D 3D TSV
US9481668	1	Quinoline inhibitor of the macrophage stimulating 1 receptor MSTR1	Merck Patent GmbH	09/25/17	2D 3D TSV
US9475779	63	Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity	Boehringer Ingelheim International GmbH	09/25/17	2D 3D TSV
US9475809	16	Substituted oxopyridine derivatives and use thereof as factor xia/plasma	Bayer Pharma Aktiengesellschaft	09/25/17	2D 3D TSV
US9469613	4	(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide	GILEAD SCIENCES, INC.	09/18/17	2D 3D TSV
US9464044	101	Compound having ability to inhibit 11Beta-HSD1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient	AHN-GOOK PHARMACEUTICAL CO., LTD.; BAMICHEM CO., LTD; INCHEON UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION	09/18/17	2D 3D TSV
US9447087	91	Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders	UNIVERSITY OF UTAH RESEARCH FOUNDATION	09/18/17	2D 3D TSV
US9469644	7	Inhibitors of Bruton's tyrosine kinase	Hoffmann-La Roche Inc.	09/18/17	2D 3D TSV
US9469639	14	Naphthylurea derivatives and medical applications thereof	Radiant Pharma & Tech. Co., Ltd.	09/18/17	2D 3D TSV
US9469627	3	Phenyloxadiazole derivatives as PGDS inhibitors	Sanofi	09/18/17	2D 3D TSV
US9434697	144	Pyrimidine FGFR4 inhibitors	EISAI R&D MANAGEMENT CO., LTD.	09/18/17	2D 3D TSV
US9464103	12	Spirocyclic sulfones as gamma secretase inhibitors	MERCK SHARP & DOHME CORP.	09/18/17	2D 3D TSV
US9434727	247	Substituted 4-phenylpiperidines, their preparation and use	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK	09/18/17	2D 3D TSV
US9447038	205	Substituted B-amino acid derivatives as CXCR3 receptor antagonists	Sanofi	09/18/17	2D 3D TSV
US9452980	625	Substituted benzamides	Hoffmann-La Roche Inc.	09/18/17	2D 3D TSV
US9447106	218	Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators	BeiGene, Ltd.	09/18/17	2D 3D TSV
US9475795	111	Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases	Takeda Pharmaceutical Company Limited	09/18/17	2D 3D TSV
US9457039	24	2′-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases	Merck Sharp & Dohme Corp.	09/11/17	2D 3D TSV
US9434725	762	5-azaindazole compounds and methods of use	F. HOFFMANN-LA ROCHE AG	09/11/17	2D 3D TSV
US9458145	111	Benzimidazole derivatives as bromodomain inhibitors	Gilead Sciences, Inc.	09/11/17	2D 3D TSV
US9453034	72	C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	09/11/17	2D 3D TSV
US9458136	1	Crystalline forms and processes for the preparation of cannabinoid receptor modulators	Arena Pharmaceuticals, Inc.	09/11/17	2D 3D TSV
US9458135	60	Dihydroquinoline-2-one derivatives	Hoffmann-La Roche Inc.	09/11/17	2D 3D TSV
US9464062	6	Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2B activity modulators	TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	09/11/17	2D 3D TSV
US9458140	29	Furanone compounds as kinase inhibitors	Eternity Bioscience Inc.	09/11/17	2D 3D TSV
US9453038	42	Glucokinase activator compounds, compositions containing such compounds, and methods of treatment	Merck Sharp & Dohme Corp.	09/11/17	2D 3D TSV
US9453048	38	IAP antagonists	Bristol-Myers Squibb Company	09/11/17	2D 3D TSV
US9458105	10	Inhibitors of Bruton's tyrosine kinase	Hoffmann-La Roche Inc.	09/11/17	2D 3D TSV
US9464073	16	Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors	Acetylon Pharmaceuticals, Inc.	09/11/17	2D 3D TSV
US9464081	23	Pyrrolidine derivatives and their use as complement pathway modulators	Novartis AG	09/11/17	2D 3D TSV
US9434711	709	Sulfonamides as TRPM8 modulators	Janssen Pharmaceutica, N.V.	09/11/17	2D 3D TSV
US9463192	43	Trk-inhibiting compound	ONO PHARMACEUTICAL CO., LTD.	09/11/17	2D 3D TSV
US9434719	783	3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH	NOVARTIS AG	09/05/17	2D 3D TSV
US9453017	12	Antiviral therapies with phospholipase D inhibitors	Vanderbilt University	09/05/17	2D 3D TSV
US9447029	38	Fluorinated arylalkylaminocarboxamide derivatives	NEWRON PHARMACEUTICALS S.P.A.	09/05/17	2D 3D TSV
US9447090	34	Imidazopyridine compounds	Astellas Pharma Inc.	09/05/17	2D 3D TSV
US9447085	33	Iminothiadiazine dioxides containing a thioamide, amidine, or amide oxime group as BACE inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	09/05/17	2D 3D TSV
US9446026	20	Ocular formulations for drug-delivery to the posterior segment of the eye	PanOptica, Inc.	09/05/17	2D 3D TSV
US9434733	75	PDE9 inhibitors with imidazo triazinone backbone	H. LUNDBECK A/S	09/05/17	2D 3D TSV
US9447092	48	Pharmaceutically active compounds	CANCER RESEARCH TECHNOLOGY LIMITED	09/05/17	2D 3D TSV
US9447091	40	Protein kinase inhibitors	ORION CORPORATION	09/05/17	2D 3D TSV
US9447095	30	Pyrimidine derivatives as phosphodiesterase 10 inhibitors (PDE-10)	PALOBIOFARMA S.L.	09/05/17	2D 3D TSV
US9453018	22	Pyrimidinones as factor XIa inhibitors	Bristol-Myers Squibb Company	09/05/17	2D 3D TSV
US9453021	17	Pyrimidodiazepinone compound	Kyowa Hakko Kirin Co., Ltd.	09/05/17	2D 3D TSV
US9434724	377	Quinuclidines for modulating alpha 7 activity	ALPHARMAGEN, LLC	09/05/17	2D 3D TSV
US9453023	39	Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof	Sanofi	09/05/17	2D 3D TSV
US9452985	8	Tau imaging probe	GE Healthcare Limited	09/05/17	2D 3D TSV
US9428508	324	2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors	Centaurus BioPharma Co., Ltd.	08/28/17	2D 3D TSV
US9446130	25	BTK inhibitors	Merck Sharp & Dohme Corp.	08/28/17	2D 3D TSV
US9433609	144	Benzimidazole-imidazole derivatives	Janssen Sciences Ireland UC	08/28/17	2D 3D TSV
US9428514	208	Bromodomain inhibitors	AbbVie Inc.	08/28/17	2D 3D TSV
US9446044	107	DYRK1 inhibitors and uses thereof	DIAXONHIT	08/28/17	2D 3D TSV
US9447132	2	Highly active nucleoside derivative for the treatment of HCV	Achillion Pharmaceuticals, Inc.	08/28/17	2D 3D TSV
US9428503	315	Imidazo[4,5-c]quinolin-2-one compounds and their use in treating Cancer	AstraZeneca AB	08/28/17	2D 3D TSV
US9428511	152	Imidazopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases	Bristol-Myers Squibb Company	08/28/17	2D 3D TSV
US9434692	4	Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto	Arena Pharmaceuticals, Inc.	08/28/17	2D 3D TSV
US9433622	330	Pyrimidine compounds useful in the treatment of diseases mediated by IKKE and/or TBK1 mechanisms	Case Western Reserve University	08/28/17	2D 3D TSV
US9447057	29	Schiff bases of thiazoles: a new class of ureases inhibitors	TBA	08/28/17	2D 3D TSV
US9434690	357	Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders	Bayer Pharma Aktiengesellschaft	08/28/17	2D 3D TSV
US9434693	45	Substituted pyrazoles as N-type calcium channel blockers	Janssen Pharmaceutica NV	08/28/17	2D 3D TSV
US9447114	29	Thieno- and furo[2,3-d]pyrimidine-2,4[1H,3H]-dione derivatives	Hydra Biosciences, Inc.	08/28/17	2D 3D TSV
US9428513	29	Triazolopyrazine	Boehringer Ingelheim International GmbH	08/28/17	2D 3D TSV
US9428505	22	Hydantoin derivative	Chugai Seiyaku Kabushiki Kaisha	08/24/17	2D 3D TSV
US9428469	30	Antiviral compounds	HOFFMANN-LA ROCHE	08/22/17	2D 3D TSV
US9447055	2	α-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof	Merck Serono S.A.	08/21/17	2D 3D TSV
US9428456	501	1-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivatives	ACTELION PHARMACEUTICALS LTD	08/21/17	2D 3D TSV
US9428504	172	7-hydroxy-spiropipiperidine indolinyl antagonists of P2Y1 receptor	Bristol-Myers Squibb Company	08/21/17	2D 3D TSV
US9428500	117	Alpha-carbolines for the treatment of cancer	UNIVERSITA DEGLI STUDI DI MILANO—BICOCCA; UNIVERSITE DE GENEVE; UNIVERSITE CLAUDE BERNARD—LYON	08/21/17	2D 3D TSV
US9427428	138	Benzimidazole-imidazole derivatives	Janssen Sciences Ireland UC	08/21/17	2D 3D TSV
US9428501	53	Bicyclic nitrogen-containing aromatic heterocyclic amide compound	Astellas Pharma Inc.	08/21/17	2D 3D TSV
US9446064	9	Combination therapy for treating cancer	Epizyme, Inc.	08/21/17	2D 3D TSV
US9428502	338	Heterocyclic modulators of lipid synthesis	3-V Biosciences, Inc.	08/21/17	2D 3D TSV
US9427440	69	Macrocyclic indole derivatives useful as hepatitis C virus inhibitors	Janssen Sciences Ireland UC	08/21/17	2D 3D TSV
US9428460	40	N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products	BAYER PHARMA AKTIENGESELLSCHAFT	08/21/17	2D 3D TSV
US9428478	66	Piperazine derivatives, compositions, and uses related thereto	Emory University	08/21/17	2D 3D TSV
US9428476	17	S-imino-S-oxo-iminothiadiazine compounds as BACE inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	08/21/17	2D 3D TSV
US9428492	54	Secondary alcohol substituted triazoles as PDE10 inhibitors	Merck Sharp & Dohme Corp.	08/21/17	2D 3D TSV
US9428491	12	Substituted azoles, antiviral active component, pharmaceutical composition, method for preparation and use thereof	TBA	08/21/17	2D 3D TSV
US9422293	771	Tetrahydro-pyrimidoazepines as modulators of TRPV1	Janssen Pharmaceutica NV	08/21/17	2D 3D TSV
US9422331	108	2-oxo-2,3,4,5-tetrahydro-1 H-benzo[B]diazepines and their use in the treatment of cancer	HOFFMANN-LA ROCHE INC.	08/14/17	2D 3D TSV
US9422332	92	Azaheterocycles as BIR2 and/or BIR3 inhibitors	HOFFMANN-LA ROCHE INC.	08/14/17	2D 3D TSV
US9428447	29	Bis-(aryl/heteroaryl)-methylene compounds, pharmaceutical compositions containing same and their use for treating cancer	The Royal Institution for the Advancement of Learning/McGill University	08/14/17	2D 3D TSV
US9415055	223	Cyclic amines	H. Lundbeck A/S	08/14/17	2D 3D TSV
US9422318	37	Epoxyeicosatrienoic acid analogs and methods of making and using the same	The Medical College of Wisconsin, Inc.; The Board of Regents of the University of Texas System	08/14/17	2D 3D TSV
US9427442	58	Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds	Bristol-Myers Squibb Company	08/14/17	2D 3D TSV
US9422240	52	Partially saturated nitrogen-containing heterocyclic compound	TAISHO PHARMACEUTICAL CO., LTD	08/14/17	2D 3D TSV
US9422255	40	S-imino-S-oxo-iminothiazine compounds as BACE inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	08/14/17	2D 3D TSV
US9422299	205	Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists	EUROSCREEN SA	08/14/17	2D 3D TSV
US9416132	120	Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors	Tolero Pharmaceuticals, Inc.	08/14/17	2D 3D TSV
US9422235	171	Sulfonamide derivatives with therapeutic indications	Pharmos Corporation	08/14/17	2D 3D TSV
US9422290	38	Triazolopyridazine	Boehringer Ingelheim International GmbH	08/14/17	2D 3D TSV
US9422297	65	Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof	Duquesne University of the Holy Ghost	08/14/17	2D 3D TSV
US9416129	244	Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use	Merck Sharp & Dohme Corp.	08/14/17	2D 3D TSV
US9422277	170	Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use	Merck Sharp & Dohme Corp.	08/14/17	2D 3D TSV
US9394331	44	2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections	Gilead Pharmasset LLC	08/07/17	2D 3D TSV
US9409892	368	4-hydroxy-isoquinoline compounds as HIF hydroxylase inhibitors	FibroGen, Inc.	08/07/17	2D 3D TSV
US9416154	45	5′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases	Merck Sharp & Dohme Corp.	08/07/17	2D 3D TSV
US9428465	17	Acid ceramidase inhibitors and their use as medicaments	Fondazione Istituto Italiano Di Technologia	08/07/17	2D 3D TSV
US9409895	69	Autotaxin inhibitors	Novartis AG	08/07/17	2D 3D TSV
US9409908	443	Dihydropyridone p1 as factor XIa inhibitors	Bristol-Myers Squibb Company	08/07/17	2D 3D TSV
US9409888	53	Dimeric compounds	Hoffmann-La Roche Inc.	08/07/17	2D 3D TSV
US9422333	28	HCV protease inhibitors and uses thereof	Celgene Avilomics Research, Inc.	08/07/17	2D 3D TSV
US9409917	118	Heterocyclic amide derivatives as P2X7 receptor antagonists	ACTELION PHARMACEUTICALS LTD.	08/07/17	2D 3D TSV
US9421177	72	Imidamide sphingosine kinase inhibitors	University of Virginia Patent Foundation	08/07/17	2D 3D TSV
US9409907	205	Inhibitor compounds	Cancer Research Technology Limited	08/07/17	2D 3D TSV
US9416123	85	Kinase modulators for the treatment of cancer	Synovo GmbH	08/07/17	2D 3D TSV
US9428466	9	Methods for reducing uric acid levels using barbiturate derivatives	TBA	08/07/17	2D 3D TSV
US9416139	72	Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof	SUNSHINE LAKE PHARMA CO., LTD.	08/07/17	2D 3D TSV
US9409915	90	Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators	Janssen Pharmaceutica NV	08/07/17	2D 3D TSV
US9422307	17	2,4,7-substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY	08/01/17	2D 3D TSV
US9422324	8	6-substituted demethyl-estradiol derivatives as selective ER-β agonists	Endece LLC	08/01/17	2D 3D TSV
US9422312	21	Azabenzimidazole derivatives	Boehringer Ingelheim International GmbH	08/01/17	2D 3D TSV
US9422273	40	Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response	ALLERGAN, INC.	08/01/17	2D 3D TSV
US9422243	55	3-phenyl-isoquinolin-1(2H)-one derivatives as PARP-1 inhibitors	NERVIANO MEDICAL SCIENCES S.R.L. a corporation	07/31/17	2D 3D TSV
US9403813	270	Azetidine amide derivatives as orexin receptor antagonists	ACTELION PHARMACEUTICALS LTD.	07/31/17	2D 3D TSV
US9403843	72	Cysteine protease inhibitors and uses thereof	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK; THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS	07/31/17	2D 3D TSV
US9422263	19	Fluoro-substituted 3,5-dicyano-4-(1H-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof	BAYER PHARMA AKTIENGESELLSCHAFT	07/31/17	2D 3D TSV
US9422261	11	Heterocyclic resorcinol derivatives, preparation of same and cosmetic uses thereof	PIERRE FABRE DERMO-COSMETIQUE	07/31/17	2D 3D TSV
US9422231	5	Method for inhibiting Trypanosoma cruzi	HOWARD UNIVERSITY	07/31/17	2D 3D TSV
US9403808	195	Pyrazine derivatives	Hoffmann-La Roche Inc.	07/31/17	2D 3D TSV
US9409882	96	Pyridine derivatives	Hoffmann-La Roche Inc.	07/31/17	2D 3D TSV
US9409866	620	Pyridine-2-amides useful as CB2 agonists	HOFFMANN-LA ROCHE INC.	07/31/17	2D 3D TSV
US9409924	26	Selective glycosidase inhibitors and uses thereof	Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.	07/31/17	2D 3D TSV
US9403767	182	Substituted 4-aminocyclohexane derivatives	GRUENENTHAL GMBH	07/31/17	2D 3D TSV
US9403801	81	Substituted heteroaryl compounds and methods of use	CALITOR SCIENCES, LLC; SUNSHINE LAKE PHARMA CO., LTD.	07/31/17	2D 3D TSV
US9394309	198	Substituted phenylimidazopyrazoles and their use	Bayer Pharma Aktiengesellschaft; Bayer Intellectual Property GmbH	07/31/17	2D 3D TSV
US9416127	72	Triazole carboxamides and uses thereof	Hoffmann-La Roche Inc.	07/31/17	2D 3D TSV
US9394311	136	Triazolo compounds as PDE10 inhibitors	Hoffmann-La Roche Inc.	07/31/17	2D 3D TSV
US9403810	48	Carboxamide derivatives	Novartis AG	07/25/17	2D 3D TSV
US9409931	8	3-O-acyl-ingenol analogues	LEO LABORATORIES LIMITED	07/24/17	2D 3D TSV
US9408863	13	5′-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases	Merck Sharp & Dohme Corp.	07/24/17	2D 3D TSV
US9409845	22	Alpha-(3,5-dimethoxybenzylidene)-alpha′-hydrocarbyl methylene cyclic ketone and preparation method thereof	PHARMAXYN LABORATORIES LTD.	07/24/17	2D 3D TSV
US9394297	934	Amides as pim inhibitors	AMGEN INC.	07/24/17	2D 3D TSV
US9403846	28	Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds	Pfizer Inc.	07/24/17	2D 3D TSV
US9403833	17	Carboxamide derivatives	Novartis AG	07/24/17	2D 3D TSV
US9409900	4	Compound for increasing kinase active and application thereof	FUJIAN HAIXI PHARMACEUTICALS, INC.; BETTA PHARMACUETICALS CO., LTD.	07/24/17	2D 3D TSV
US9416126	394	Compounds inhibiting leucine-rich repeat kinase enzyme activity	Merck Sharp & Dohme Corp.	07/24/17	2D 3D TSV
US9403803	15	Indole-3-carboxamides as kinase inhibitors	Allergan, Inc.	07/24/17	2D 3D TSV
US9403768	24	Indolines	Hoffmann-La Roche Inc.	07/24/17	2D 3D TSV
US9409868	44	Inhibitors of rho associated protein kinases (ROCK) and methods of use	H. Lee Moffin Cancer Center and Research Institute, Inc.	07/24/17	2D 3D TSV
US9409858	37	Selective histone deactylase 6 inhibitors	H. Lee Moffitt Cancer Center and Research Institute, Inc.; Board of Trustees of the University of Illinois	07/24/17	2D 3D TSV
US9408850	74	Substituted indazole derivatives active as kinase inhibitors	NERVIANO MEDICAL SCIENCES S.R.L.	07/24/17	2D 3D TSV
US9403827	32	Substituted purinone compounds	NOVARTIS AG	07/24/17	2D 3D TSV
US9403831	42	Triazolopyrazine derivative and use thereof	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY; HANDOK INC.	07/24/17	2D 3D TSV
US9416103	25	Use of the aminoalkylindole JWH-073-M4 and related compounds as neutral CB1 receptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases	The Board of Trustees of the University of Arkansas; The University of Kansas	07/24/17	2D 3D TSV
US9394275	191	Diamide compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity	Theravance Respiratory Company, LLC	07/18/17	2D 3D TSV
US9394273	118	Therapeutic prostaglandin receptor agonists	ALLERGAN, INC.	07/18/17	2D 3D TSV
US9403797	2	5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use	Cancer Research Technology Limited	07/17/17	2D 3D TSV
US9394291	20	Benzoxazinone amides as mineralocorticoid receptor modulators	AstraZeneca AB	07/17/17	2D 3D TSV
US9403774	6	Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors	Bristol-Myers Squibb Company	07/17/17	2D 3D TSV
US9394285	186	Indole and indazole compounds that activate AMPK	Pfizer Inc.	07/17/17	2D 3D TSV
US9394289	44	Inhibitors of c-fms kinase	Janssen Pharmaceutica NV	07/17/17	2D 3D TSV
US9403804	10	Inhibitors of c-fms kinase	Janssen Pharmaceutica NV	07/17/17	2D 3D TSV
US9388165	22	Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinase	HANMI PHARM. CO., LTD.	07/17/17	2D 3D TSV
US9402837	20	Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase	Amicus Therapeutics, Inc.	07/17/17	2D 3D TSV
US9409887	14	Mutant-selective EGFR inhibitors and uses thereof	Celgene Avilomics Research, Inc.	07/17/17	2D 3D TSV
US9388210	17	Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same	WASHINGTON UNIVERSITY	07/17/17	2D 3D TSV
US9394282	406	Pyrazole carboxamides as Janus kinase inhibitors	Merck Sharp & Dohme Corp.	07/17/17	2D 3D TSV
US9394290	90	Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases	UNIVERSITAET DES SAARLANDES CAMPUS SAARBRUECKEN	07/17/17	2D 3D TSV
US9394303	31	Small molecule inhibitors of MCL-1 and uses thereof	THE REGENTS OF THE UNIVERSITY OF MICHIGAN	07/17/17	2D 3D TSV
US9393232	171	Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones	BeiGene, Ltd.	07/17/17	2D 3D TSV
US9394263	237	Substituted hetero-azepinones	F. HOFFMANN-LA ROCHE AG	07/17/17	2D 3D TSV
US9394250	56	Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases	ONO PHARMACEUTICAL CO., LTD.	07/17/17	2D 3D TSV
US9402842	12	Synthesis and use of dual tyrosyl-DNA phosphodiesterase I (Tdp1)—topoisomerase I (Top1) inhibitors	Purdue Research Foundation	07/17/17	2D 3D TSV
US9394293	17	TRPV1 antagonists including dihydroxy substituent and uses thereof	Purdue Pharma L.P.	07/17/17	2D 3D TSV
US9394254	6	Antibiotic and anti-parasitic agents that modulate class II fructose 1,6-bisphosphate aldolase	The University of Denver and Regis University	07/10/17	2D 3D TSV
US9403822	5	Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases	ABBVIE INC.	07/10/17	2D 3D TSV
US9365589	82	C5, C6 oxacyclic-fused thiazine dioxide compounds as BACE inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	07/10/17	2D 3D TSV
US9402878	2	Depsipeptide and uses thereof	NovoBiotic Pharmaceuticals, LLC	07/10/17	2D 3D TSV
US9388139	97	Derivatives of celeboxib, use thereof and preparation thereof	German University; Southern Research Institute	07/10/17	2D 3D TSV
US9388149	69	Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases	GALDERMA RESEARCH & DEVELOPMENT	07/10/17	2D 3D TSV
US9394307	6	Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation	ChemoCentryx, Inc.	07/10/17	2D 3D TSV
US9388197	76	Heterocyclic amide derivatives as P2X7 receptor antagonists	ACTELION PHARMACEUTICALS LTD.	07/10/17	2D 3D TSV
US9388198	17	Heterocyclic amide derivatives as P2X7 receptor antagonists	ACTELION PHARMACEUTICALS LTD.	07/10/17	2D 3D TSV
US9394304	18	Imidazopyridine derivatives	Hoffmann-La Roche Inc.	07/10/17	2D 3D TSV
US9365582	24	Macrocyclic inhibitors of hepatitis C virus	Janssen Sciences Ireland UC	07/10/17	2D 3D TSV
US9388176	119	Method of treating conditiions with kinase inhibitors	ALLERGAN, INC.	07/10/17	2D 3D TSV
US9365572	65	PI3K and/or mTOR inhibitor	Xuanzhu Pharma Co., Ltd.	07/10/17	2D 3D TSV
US9403799	14	Pyrimidinyl-pyridazinone derivatives for treating a disease which is influenced by inhibition of met kinase	MERCK PATENT GMBH	07/10/17	2D 3D TSV
US9388199	44	Pyrrolidine derivatives and their use as complement pathway modulators	NOVARTIS AG	07/10/17	2D 3D TSV
US9388189	81	Pyrrolotriazinone derivatives as PI3K inhibitors	Almirall, S.A.	07/10/17	2D 3D TSV
US9388171	28	Serine/threonine kinase inhibitors	GENETECH, INC.; ARRAY BIOPHARMA INC.	07/10/17	2D 3D TSV
US9394276	16	Substituted 1,2,3,4-tetrahydro-2,6-naphthyridines as factor XIa inhibitors	Bristol-Myers Squibb Company	07/10/17	2D 3D TSV
US9388181	15	Substituted 1,2,3,4-tetrahydropyrido[3,4-E] pyrrolo[1,2-A]pyrimidines as kinase	Allergan, Inc.	07/10/17	2D 3D TSV
US9388140	120	Substituted benzimidazoles	Bayer Intellectual Property GmbH	07/10/17	2D 3D TSV
US9388162	146	Substituted morphinans and the use thereof	Purdue Pharma L.P.	07/10/17	2D 3D TSV
US9388136	35	Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof	Chroma Therapeutics Ltd	07/10/17	2D 3D TSV
USRE46024	22	Thyroid hormone analogs	Hoffmann-La Roche Inc.	07/10/17	2D 3D TSV
US9365562	126	1,3 substituted azetidine PDE10 inhibitors	Merck Sharp & Dohme Corp.	07/03/17	2D 3D TSV
US9364459	43	3-(indolyl)- or 3-(azaindolyl)- 4-arylmaleimide derivatives for use in the treatment of colon and gastric adenocarcinoma	Johannes Gutenberg-Universität Mainz; Universitätsmedizin der Johannes Gutenberg-Universität Mainz	07/03/17	2D 3D TSV
US9365508	26	Aroyl thiourea derivatives	University Court of the University of St Andrews; University Court of the University of Dundee	07/03/17	2D 3D TSV
US9365534	43	Arylated camphenes, processes for their preparation and uses thereof	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.	07/03/17	2D 3D TSV
US9365529	68	Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics	GALDERMA RESEARCH & DEVLOPMENT	07/03/17	2D 3D TSV
US9359371	77	Bicyclic substituted pyrimidine compounds	XUANZHU PHARMA CO., LTD.	07/03/17	2D 3D TSV
US9365511	26	Biphenyl-ethyl-pyrrolidine derivatives as histamine H3 receptor modulators for the treatment of cognitive disorders	ARENA PHARMACEUTICALS, INC.	07/03/17	2D 3D TSV
US9359372	60	Hexahydrodibenzo[a,g]quinolizine compound, preparation method thereof, pharmaceutical composition and use thereof	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES	07/03/17	2D 3D TSV
US9359361	20	Immune system modulators	JANUS BIOTHERAPEUTICS, INC.	07/03/17	2D 3D TSV
US9365575	25	Kinase inhibitors	Allergan, Inc.	07/03/17	2D 3D TSV
US9365853	7	Matriptase inhibitors and uses thereof against orthomyxoviridae infections	TBA	07/03/17	2D 3D TSV
US9365502	18	Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors	WASHINGTON UNIVERSITY	07/03/17	2D 3D TSV
US9365539	11	Prolylcarboxypeptidase inhibitors	Merck Sharp & Dohme Corp.	07/03/17	2D 3D TSV
US9365576	279	Pyrrolopyrrolidinone compounds	Novartis AG	07/03/17	2D 3D TSV
US9388137	9	Quaternized amines as sodium channel blockers	Purdue Pharma L.P.	07/03/17	2D 3D TSV
US9394283	2	Salt form of a human histone methyltransferase EZH2 inhibitor	Epizyme, Inc.; Eisai R&D Management Co., LTD.	07/03/17	2D 3D TSV
US9364482	134	Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases	Merck Sharp & Dohme Corp.	07/03/17	2D 3D TSV
US9394281	12	Substituted heteroaryl compounds and methods of use	CALITOR SCIENCES, LLC; SUNSHINE LAKE PHARMA CO., LTD.	07/03/17	2D 3D TSV
US9365546	8	Substituted pyridinone-pyridinyl compounds	CONFLUENCE LIFE SCIENCES INC.	07/03/17	2D 3D TSV
US9359399	71	Synthetic peptide amides	Cara Therapeutics, Inc.	07/03/17	2D 3D TSV
US9365563	228	TRPV1 antagonists including dihydroxy substituent and uses thereof	Purdue Pharma L.P.	07/03/17	2D 3D TSV
US9359338	366	Cyclopropanecarboxamido-substitute aromatic compounds as anti-tumor agents	CROWN BIOSCIENCE INC. (Taiwan)	06/27/17	2D 3D TSV
US9388160	4	Quinazoline derivatives as kinases inhibitors and methods of use thereof	Teligene Ltd	06/27/17	2D 3D TSV
US9388170	7	Substituted aminoquinazolines useful as kinases inhibitors	TBA	06/27/17	2D 3D TSV
US9353084	49	2-amino 3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treatment of Alzheimer's disease	H. Lundbeck A/S	06/26/17	2D 3D TSV
US9359337	12	Acetamide derivatives	Hoffmann-La Roche Inc.	06/26/17	2D 3D TSV
US9359341	11	Aldehyde derivative of substitute oxazolidinones	WANBURY LTD.	06/26/17	2D 3D TSV
US9353089	180	Compositions and methods for the treatment of malaria	Saint Louis University; Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences	06/26/17	2D 3D TSV
US9353101	64	Cyclic amine substituted heterocyclic CETP inhibitors	Merck Sharp & Dohme Corp.	06/26/17	2D 3D TSV
US9359348	11	Cyclopropyl imidazopyridine PDE10 inhibitors	Merck Sharp & Dohme Corp.	06/26/17	2D 3D TSV
US9365558	99	Dihydropyridinone MGAT2 inhibitors	Bristol-Myers Squibb Company	06/26/17	2D 3D TSV
US9359339	19	Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use	Merck Sharp & Dohme Corp.	06/26/17	2D 3D TSV
US9353093	63	Indole-1-carboxamides as kinase inhibitors	Allergan, Inc.	06/26/17	2D 3D TSV
US9353116	62	Methods and compositions for kinase inhibition	The Regents of the University of California	06/26/17	2D 3D TSV
US9353102	88	Non-annulated thiophenylamides	Hoffmann-La Roche Inc.	06/26/17	2D 3D TSV
US9353104	130	Substituted pyridizinone derivatives as PDE10 inhibitors	Merck Sharp & Dohme Corp.	06/26/17	2D 3D TSV
US9359345	12	Thiazole derivatives as inhibitors of Bruton's tyrosine kinase	HOFFMANN-LA ROCHE INC.	06/26/17	2D 3D TSV
US9393245	88	Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors	vTv Therapeutics LLC	06/26/17	2D 3D TSV
US9353061	28	3,5,N-trihydroxy-alkanamide and derivatives: method for making same and use thereof	ACADEMIA SINICA; NATIONAL TAIWAN UNIVERSITY	06/19/17	2D 3D TSV
US9346829	31	5-HT3 receptor antagonists	Takeda Phamaceutical Company Limited	06/19/17	2D 3D TSV
US9353081	132	Bicyclic dihydroquinoline-2-one derivatives	Hoffmann-La Roche Inc.	06/19/17	2D 3D TSV
US9353075	66	Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA)	The Regents of the University of California; Fondazione Istituto Italiano Di Technologia; Universita Degli Studi Di Parma; Universita Degli Studi Di Urbino “Carlo Bo”	06/19/17	2D 3D TSV
US9359301	14	Ethynyl derivatives	Hoffmann-La Roche Inc.	06/19/17	2D 3D TSV
US9346814	250	FAP inhibitors	Universiteit Antwerp; Fox Chase Cancer Center	06/19/17	2D 3D TSV
US9346821	66	Heterocyclic carboxylic acid ester derivative	AJINOMOTO CO., INC.	06/19/17	2D 3D TSV
US9353090	331	Heterocyclic carboxylic acids as activators of soluble guanylate cyclase	Boehringer Ingelheim International GmbH	06/19/17	2D 3D TSV
US9351965	152	Indazole derivatives useful as ERK inhibitors	Merck Sharp & Dohme Corp.	06/19/17	2D 3D TSV
US9359293	24	Methods of treatment using modulators of SIRT2	CORNELL UNIVERSITY	06/19/17	2D 3D TSV
US9346786	123	Pyrrolidine compounds	Hoffmann-La Roche Inc.	06/19/17	2D 3D TSV
US9353066	228	Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors	Merck Sharp & Dohme Corp.; Merck Canada Inc.	06/19/17	2D 3D TSV
US9359330	25	Substituted piperidines as sodium channel blockers	Purdue Pharma L.P.	06/19/17	2D 3D TSV
US9346815	934	5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof	Genentech, Inc.	06/12/17	2D 3D TSV
US9345742	42	Aminostatin derivatives for the treatment of arthrosis	MERCK PATENT GMBH	06/12/17	2D 3D TSV
US9346770	29	Compounds having activating effect on subtypes of peroxisome proliferator-activated receptors and its preparation method and uses	ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.	06/12/17	2D 3D TSV
US9353067	3	Heterocyclic compounds and uses thereof in the treatment of sexual disorders	ATIR Holding S.A.	06/12/17	2D 3D TSV
US9353115	11	Immune system modulators	JANUS BIOTHERAPEUTICS, INC.	06/12/17	2D 3D TSV
US9353083	4	Oxazetidine derivatives, process for preparing them and use in human medicine and in cosmetics	GALDERMA RESEARCH & DEVELOPMENT	06/12/17	2D 3D TSV
US9358227	12	Pharmaceutical uses of 6-amino quinazoline or 3-cyano quinoline derivatives	Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd.	06/12/17	2D 3D TSV
US9346839	11	Phosphonate derivatives and methods of use thereof in the treatment of Alzheimer's disease	University of Kansas	06/12/17	2D 3D TSV
US9351973	15	Pyrazolopyridyl compounds as aldosterone synthase inhibitors	Merck Sharp & Dohme Corp.	06/12/17	2D 3D TSV
US9346794	85	Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity	Boehringer Ingelheim International GmbH	06/12/17	2D 3D TSV
US9346795	186	Substituted sulfonamides useful as antiapoptotic Bcl inhibitors	Bristol-Myers Squibb Company	06/12/17	2D 3D TSV
US9353113	13	Tetrahydrocarboline derivative	ONO PHARMACEUTICAL CO., LTD.	06/12/17	2D 3D TSV
US9346827	11	5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use	Amgen Inc.	06/05/17	2D 3D TSV
US9346782	60	Alkyl linked quinolinyl modulators of RORγt	Janssen Pharmaceutica NV	06/05/17	2D 3D TSV
US9346818	42	Benzodioxole derivative and preparation method and use thereof	Zhejiang Hisun Pharmaceutical Co., Ltd.	06/05/17	2D 3D TSV
US9345700	53	Compositions and methods useful for treating diseases	Eutropics Pharmaceuticals, Inc.	06/05/17	2D 3D TSV
US9346798	678	Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors	AMGEN INC.	06/05/17	2D 3D TSV
US9346803	44	Indomethacin analogs for the treatment of castrate-resistant prostate cancer	Vanderbilt University; The Trustees of the University of Pennsylvania	06/05/17	2D 3D TSV
US9340574	25	Inhibitors of protein tyrosine phosphatases	Indiana University Research and Technology Corporation	06/05/17	2D 3D TSV
US9340549	193	Oxazolidinone compounds and derivatives thereof	AMGEN INC.	06/05/17	2D 3D TSV
US9346787	28	Piperidine compound or salt thereof	TAIHO PHARMACEUTICAL CO., LTD.	06/05/17	2D 3D TSV
US9339501	54	17a-hydroxylase/C17,20-lyase inhibitors	NOVARTIS AG	05/31/17	2D 3D TSV
US9346797	14	2-amino 6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors	H. Lundbeck A/S	05/31/17	2D 3D TSV
US9340500	154	Aromatic heterocyclic derivative having TRPV4-inhibiting activity	SHIONOGI & CO., LTD.	05/31/17	2D 3D TSV
US9340537	173	Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1	NOVATIS AG	05/31/17	2D 3D TSV
US9334269	337	Carboxamides as inhibitors of voltage-gated sodium channels	AMGEN INC.	05/31/17	2D 3D TSV
US9346793	15	Hydroxylated aminotriazole derivatives as ALX receptor agonists	Actelion Pharmaceuticals, LTD.	05/31/17	2D 3D TSV
US9340517	531	Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor	Mimetica PTY LTD	05/31/17	2D 3D TSV
US9334286	108	Pharmacologically active compounds	Cancer Research Technology Limited	05/31/17	2D 3D TSV
US9340530	84	Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonists	Merck Sharp & Dohme Corp.	05/31/17	2D 3D TSV
US9340507	111	Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity	Boehringer Ingelheim International GmbH	05/31/17	2D 3D TSV
US9353062	2	Substituted quinolines as bruton's tyrosine kinases inhibitors	HangzhouDeRenYuCheng Biotechnology Ltd	05/31/17	2D 3D TSV
US9334290	152	Substituted tetrahydrocarbazole and carbazole carboxamide compounds	Bristol-Myers Squibb Company	05/31/17	2D 3D TSV
US9340510	245	Tetrahydroisoquinoline derivatives, pharmaceutical compositions and uses thereof	Boehringer Ingelheim International GmbH	05/31/17	2D 3D TSV
US9346822	4	Thienopyrimidine compounds and use thereof	Takeda Pharmaceutical Company Limited	05/31/17	2D 3D TSV
US9340506	38	Acetamide derivatives as glucokinase activators, their process and medicinal applications	ADVINUS THERAPEUTICS LIMITED	05/22/17	2D 3D TSV
US9340573	28	Azaindolines	Hoffmann-La Roche Inc.	05/22/17	2D 3D TSV
US9340555	180	Compounds as tyrosine kinase modulators	Allergan, Inc.	05/22/17	2D 3D TSV
US9345793	20	Compounds for binding to the platelet specific glycoprotein IIB/IIIA and their use for imaging of thrombi	PIRAMAL IMAGING SA	05/22/17	2D 3D TSV
US9334279	129	Hepatitis C virus inhibitors	Bristol-Myers Squibb Company	05/22/17	2D 3D TSV
US9345740	24	IAP antagonists	Bristol-Myers Squibb Company	05/22/17	2D 3D TSV
US9340521	130	Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives	GREEN CROSS CORPORATION	05/22/17	2D 3D TSV
US9340542	20	Propellane-based compounds and the use thereof	Purdue Pharma L.P.	05/22/17	2D 3D TSV
US9340504	6	Pyridine and piperidine derivatives as novel sodium channel blockers	Purdue Pharma L.P.	05/22/17	2D 3D TSV
US9346810	249	Pyrrolopyrimidine compounds and uses thereof	HUTCHISON MEDIPHARMA LIMITED	05/22/17	2D 3D TSV
US9334288	34	Selective β-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents	The University of North Carolina at Chapel Hill	05/22/17	2D 3D TSV
US9345789	13	Specific inhibitors and active site probes for legumain	The Board of Trustees of the Leland Stanford Junior University	05/22/17	2D 3D TSV
US9328099	1336	Cyanomethylpyrazole carboxamides as janus kinase inhibitors	Merck Sharp & Dohme Corp.	05/18/17	2D 3D TSV
US9333195	34	Quinuclidine derivatives and medicinal compositions containing the same	ALMIRALL, S.A.	05/18/17	2D 3D TSV
US9334268	25	4-amino-imidazoquinoline compounds	HOFFMAN-LA ROCHE INC.	05/15/17	2D 3D TSV
US9340534	4	Compounds and methods for treating ocular diseases	ALLERGAN, INC.	05/15/17	2D 3D TSV
US9328106	297	Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use	GENENTECH, INC.	05/15/17	2D 3D TSV
US9339486	15	Heterocyclic modulators of cannabinoid receptors	The Cleveland Clinic Foundation	05/15/17	2D 3D TSV
US9333217	10	Inhibitors of human EZH2, and methods of use thereof	Epizyme, Inc.	05/15/17	2D 3D TSV
US9333205	6	Isoxazolo-quinazolines as modulators of protein kinase activity	NERVIANO MEDICAL SCIENCES S.R.L.	05/15/17	2D 3D TSV
US9333199	13	Methods of treatment of histamine H-4 receptor-related pruritus associated with nerve disorders	BRIDGE PHARMA, INC.	05/15/17	2D 3D TSV
US9340511	7	Process for making isoquinoline compounds	FibroGen, Inc.	05/15/17	2D 3D TSV
US9334271	32	Purine derivatives and their use in the treatment of disease	Novarits AG	05/15/17	2D 3D TSV
US9321790	119	Pyrimidinone derivatives as antimalarial agents	Sanofi	05/15/17	2D 3D TSV
US9334278	38	Pyrrolo[2,3-B]pyrazines as SYK inhibitors	Hoffmann-La Roche Inc.	05/15/17	2D 3D TSV
US9328096	800	Tropomyosin-related kinase inhibitors	Pfizer Inc.	05/15/17	2D 3D TSV
US9328120	34	6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders	Boehringer Ingelheim International GmbH	05/08/17	2D 3D TSV
US9321791	46	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions	Boehringer Ingelheim International GmbH	05/08/17	2D 3D TSV
US9326978	16	A3 adenosine receptor allosteric modulators	The United States of America, Represented by the Secretary, Dept. of Health and Human Services; Universiteit Leiden	05/08/17	2D 3D TSV
US9321760	243	Aminopyrimidine derivatives for use as modulators of kinase activity	Merck Patent GmbH	05/08/17	2D 3D TSV
US9333197	9	Apoptosis signal-regulating kinase inhibitor	Gilead Sciences, Inc.	05/08/17	2D 3D TSV
US9321756	823	Azole compounds as PIM inhibitors	AMGEN INC.	05/08/17	2D 3D TSV
US9328124	3	BACE inhibitors	Eli Lilly and Company	05/08/17	2D 3D TSV
US9321773	21	Compounds	Respivert, Ltd.	05/08/17	2D 3D TSV
US9328070	8	Ethynyl derivatives	Hoffmann-La Roche Inc.	05/08/17	2D 3D TSV
US9328118	159	Nitrogen-containing bicyclic aromatic heterocyclic compound	Astellas Pharma Inc.	05/08/17	2D 3D TSV
US9328123	5	Rotenone derivatives and a use thereof	Korea Atomic Energy Research Institute	05/08/17	2D 3D TSV
US9328111	39	Substituted cycloocta[5,6]pyrido[4,3,2-de]phthalazines as PARP inhibitors	BeiGene Ltd.	05/08/17	2D 3D TSV
US9328112	193	Tetracyclic CDK9 kinase inhibitors	AbbVie Inc.	05/03/17	2D 3D TSV
US9315520	135	2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides	Pfizer Inc.	05/01/17	2D 3D TSV
US9321748	59	Aminopyridine derived compounds as LRRK2 inhibitors	H. Lundbeck A/S; Vernalis (R&D) Ltd.	05/01/17	2D 3D TSV
US9321728	33	Beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY; HANDOK PHARMACEUTICALS CO., LTD.	05/01/17	2D 3D TSV
US9320741	14	Compositions and methods for treating neoplasia, inflammatory disease and other disorders	DANA-FARBER CANCER INSTITUTE, INC.	05/01/17	2D 3D TSV
US9321743	25	Compositions and methods of inhibiting N-acylethanolamine-hydrolyzing acid amidase	The Regents of the University of California; Universita Degli Studi Di Parma; Universita Degli Studi Di Urbino “Carlo Bo”	05/01/17	2D 3D TSV
US9321766	10	Kinase inhibitors	Allergan, Inc.	05/01/17	2D 3D TSV
US9321738	28	N-alkyltriazole compounds as LPAR antagonists	HOFFMAN-LA ROCHE INC.	05/01/17	2D 3D TSV
US9321752	10	Pyrazole derivative	GREEN TECH CO., LTD.	05/01/17	2D 3D TSV
US9321750	5	ROR modulators and their uses	INNOV17 LLC	05/01/17	2D 3D TSV
US9320722	81	Regulators of aldehyde dehydrogenase ALDH3A1 and related therapeutic methods	Indiana University Research and Technology Corporation	05/01/17	2D 3D TSV
US9320734	110	Small molecule inhibitors of the pleckstrin homology domain and methods for using same	Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona	05/01/17	2D 3D TSV
US20160326143	65	Compounds and uses	Astrazeneca Ab	04/27/17	2D 3D TSV
US9320732	21	1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase	Incyte Corporation; Incyte Holdings Corporation	04/24/17	2D 3D TSV
US9315514	32	1,3-dioxanomorphides and 1,3-dioxanocodides	Rhodes Technologies	04/24/17	2D 3D TSV
US9321747	21	Acid addition salt of substituted pyridine compound	DAIICHI SANKYO COMPANY, LIMITED; UBE INDUSTRIES, LTD.	04/24/17	2D 3D TSV
US9315498	174	Arlethynyl derivatives	HOFFMAN-LA ROCHE INC.	04/24/17	2D 3D TSV
US9315500	26	Bicyclic heteroaryl cycloalkyldiamine derivatives	NOVARTIS AG	04/24/17	2D 3D TSV
US9315489	98	Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1	Novartis AG	04/24/17	2D 3D TSV
US9315499	41	Cytomegalovirus inhibitor compounds	Boehringer Ingelheim International GmbH	04/24/17	2D 3D TSV
US9315519	6	Guanidine substituted tetrahydroisoquinoline compounds as factor XIa inhibitors	Bristol-Myers Squibb Company	04/24/17	2D 3D TSV
US9315518	40	Imidazopyridin-2-one derivatives	Merck Sharp & Dohme Corp.	04/24/17	2D 3D TSV
US9321721	8	Kinase inhibitors	Allergan, Inc.	04/24/17	2D 3D TSV
US9315493	18	Phenylpyridine derivative and drug containing same	KOWA COMPANY, LTD.	04/24/17	2D 3D TSV
US9315491	129	Pyrimidine compounds as mTOR and PI3K inhibitors	DEVELOPMENT CENTER FOR BIOTECHNOLOGY; DCB-USA LLC	04/24/17	2D 3D TSV
US9320737	32	Substituted imidazopyridazines	BAYER INTELLECTUAL PROPERTY GMBH	04/24/17	2D 3D TSV
US9315508	3	Treating diabetes with dipeptidyl peptidase-IV inhibitors	Merck sharp & Dohme Corp.	04/24/17	2D 3D TSV
US9303017	131	2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof	Georgetown University; Duke University	04/10/17	2D 3D TSV
US9303045	162	5-HT3 receptor antagonists	Takeda Pharmaceutical Company Limited	04/10/17	2D 3D TSV
US9303025	407	Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases	AbbVie Inc.	04/10/17	2D 3D TSV
US9314468	140	Chemokine receptor modulators	Altiris Therapeutics, Inc.	04/10/17	2D 3D TSV
US9314464	22	Compounds and compositions as protein kinase inhibitors	Novartis AG	04/10/17	2D 3D TSV
US9315463	30	Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities	Almirall, S.A.	04/10/17	2D 3D TSV
US9303015	151	Heteroaryl linked quinolinyl modulators of RORγt	JANSSEN PHARMACEUTICA NV	04/10/17	2D 3D TSV
US9315492	29	Heterocyclic group contained amino-methanol derivative, and salt, synthetic method and use thereof	Beijing Foreland Biopharma Co., Ltd.	04/10/17	2D 3D TSV
US9315438	10	Optically pure benzyl-4-chlorophenyl-C-glucoside derivative	XUANZHU PHARMA CO., LTD	04/10/17	2D 3D TSV
US9303023	145	Pyrazole and imidazole derivatives useful as orexin antagonists	ACTELION PHARMACEUTICALS LTD.	04/10/17	2D 3D TSV
US9303012	304	Pyridine-2-amides useful as CB2 agonists	HOFFMAN-LA ROCHE INC.	04/10/17	2D 3D TSV
US9303035	36	Substituted pyrazino[1′,2′:1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4′,5′:3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4′,5′:3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel	Novartis AG	04/10/17	2D 3D TSV
US9284322	30	Nicotinic receptor compounds	Research Triangle Institute	04/04/17	2D 3D TSV
US9296759	188	Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use	Amgen Inc.	04/03/17	2D 3D TSV
US9290488	165	Azetidine-substituted quinoxalines as opioid receptor like-1 modulators	Purdue Pharma L.P.	04/03/17	2D 3D TSV
US9271961	119	Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereof	The Trustees of the University of Pennsylvania	04/03/17	2D 3D TSV
US9296741	698	Bromodomain inhibitors	AbbVie Inc.	04/03/17	2D 3D TSV
US9296708	17	Chimeric small molecules for the recruitment of antibodies to cancer cells	YALE UNIVERSITY	04/03/17	2D 3D TSV
US9302996	148	Continuous arycyclic compound	MITSUBISHI TANABE PHARMA CORPORATION	04/03/17	2D 3D TSV
US9278100	149	Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors	Pharmacyclics LLC	04/03/17	2D 3D TSV
US9290476	160	Methylene linked quinolinyl modulators of RORγt	JANSSEN PHARMACEUTICA NV	04/03/17	2D 3D TSV
US9271963	95	Selective inhibitors of human corticosteroid synthases	UNIVERSITAT DES SAARLANDES	04/03/17	2D 3D TSV
US9278925	146	Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one	BAYER INTELLECTUAL PROPERTY GMBH	04/03/17	2D 3D TSV
US9302986	97	Substituted 3-haloallylamine inhibitors of ASSAO and uses thereof	BOEHRINGER INGELHEIM INTERNATIONAL GMBH	04/03/17	2D 3D TSV
US9303033	2239	Pyrazolopyrimidines and related heterocycles as CK2 inhibitors	SENHWA BIOSCIENCES, INC.	03/30/17	2D 3D TSV
US9302985	17	Benzyl sulfonamide derivatives as RORc modulators	Genentech, Inc.	03/21/17	2D 3D TSV
US9212182	776	Bicyclic sulfonamide compounds as sodium channel inhibitors	Amgen Inc.	03/21/17	2D 3D TSV
US9296681	36	Cycloalkylmethylamines	REVIVA PHARMACEUTICALS, INC.	03/21/17	2D 3D TSV
US9289400	6	D3 dopamine receptor agonists to treat dyskinesia in parkinson's disease	Drexel University; Rutgers, The State University of New Jersey	03/21/17	2D 3D TSV
US9284333	390	Fused pyrroledicarboxamides and their use as pharmaceuticals	Sanofi	03/21/17	2D 3D TSV
US9249087	156	HDAC inhibitors and therapeutic methods using the same	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS; THE CHILDREN'S HOSPITAL OF PHILADELPHIA	03/21/17	2D 3D TSV
US9290501	16	Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase	Albert Einstein College of Medicine, Inc.; Victoria Link Limited	03/21/17	2D 3D TSV
US9296757	92	Substituted benzothienopyrimidines	BAYER PHARMA AKTIENGESELLSCHAFT	03/21/17	2D 3D TSV
US9260435	16	Substituted imidazopyrazines as Akt kinase inhibitors	BAYER PHARMA AKTIENGESELLSCHAFT	03/21/17	2D 3D TSV
US9303018	23	Inhibitors of leukotriene production	Boehringer Ingelheim International GmbH	03/13/17	2D 3D TSV
US9302989	1657	NAMPT and rock inhibitors	AbbVie Inc.	03/13/17	2D 3D TSV
US9303019	12	Amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome	UNIVERSITE DE STRASBOURG	03/06/17	2D 3D TSV
US9296745	236	Diacylglycerol acyltransferase 2 inhibitors	Pfizer Inc.	03/06/17	2D 3D TSV
US9296734	722	Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use	Amgen Inc.	03/06/17	2D 3D TSV
US9296736	497	Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer	Amgen INC.	03/06/17	2D 3D TSV
US9296748	113	Pyridinones	Boehringer Ingelheim International GmbH	03/06/17	2D 3D TSV
US9302981	6	Synthesis, methods of using, and compositions of cycloalkylmethylamines	REVIVA PHARMACEUTICALS, Inc.	03/06/17	2D 3D TSV
US9303005	4	Use of dibenzofuranone derivatives to inhibit kinases	TBA	03/06/17	2D 3D TSV
US9296747	30	Piperidylpyrimidine derivatives as modulators of protein kinase inhibitors and of vascular endothelial growth factor receptor 2	Allergan, Inc.	02/28/17	2D 3D TSV
US9296703	2	Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors	University of Utah Research Foundation	02/28/17	2D 3D TSV
US9296728	26	Therapeutic compounds	Regents of the University of Minnesota	02/28/17	2D 3D TSV
US9284330	29	1,4-dihydro-naphthyridine derivative and pharmaceutical composition and use thereof	Jiangsu Simovay Pharmaceutical Co., Ltd.	02/27/17	2D 3D TSV
US9296693	133	Acyl piperidine inhibitors of soluble epoxide hydrolase	The Regents of the University of California	02/27/17	2D 3D TSV
US9284319	34	Heterocyclyl aminoimidazopyridazines	BAYER INTELLECTUAL PROPERTY GMBH	02/27/17	2D 3D TSV
US9283222	773	Inhibitors of poly(ADP-ribose)polymerase	AbbVie Inc.	02/27/17	2D 3D TSV
US9295672	37	Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof	Ambit Biosciences Corporation	02/27/17	2D 3D TSV
US9278978	83	6-Alkynyl Pyridine	Boehringer Ingelheim International GmbH	02/21/17	2D 3D TSV
US9278976	8	Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes	Merck Sharp & Dohme Corp.	02/21/17	2D 3D TSV
US9278981	551	Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1	Novartis AG	02/21/17	2D 3D TSV
US9284302	4	Cyclobutyl benzimidazoles as PDE 10 inhibitors	Merck Sharp & Dohme Corp.	02/21/17	2D 3D TSV
US9278968	106	Imidazopyridine compounds	Astellas Pharma Inc.	02/21/17	2D 3D TSV
US9284284	64	Oxazine derivatives and their use in the treatment of disease	NOVARTIS AG	02/21/17	2D 3D TSV
US9296775	3	Pyrazole compounds	ELI LILLY AND COMPANY	02/21/17	2D 3D TSV
US9284298	8	Pyrazolyl-pyrimidine derivatives as kinase inhibitors	NERVIANO MEDICAL SCIENCES S.R.L.	02/21/17	2D 3D TSV
US9283225	2	Pyrido-pyrimidine derivatives	Merck Patent GmbH	02/21/17	2D 3D TSV
US9284299	58	Substituted 1H-indazol-1-ol analogs as inhibitors of beta catenin/Tcf protein-protein interactions	University of Utah Research Foundation	02/21/17	2D 3D TSV
US9284317	29	Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitors	Bayer Intellectual Property GmbH	02/21/17	2D 3D TSV
US9284315	32	Three-ring PI3K and/or mTOR inhibitor	ZUANZHU PHARMA CO., LTD.	02/21/17	2D 3D TSV
US9290517	25	Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives	Merck Sharp & Dohme Corp.	02/14/17	2D 3D TSV
US9278963	124	Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors	Acetylon Pharmaceuticals, Inc.	02/14/17	2D 3D TSV
US9278960	315	Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use	Merck Sharp & Dohme Corp.	02/14/17	2D 3D TSV
US9278093	8	Aldosterone synthase inhibitors	Merck Sharp & Dohme Corp.; ElexoPharm GmbH	02/13/17	2D 3D TSV
US9278953	14	Antagonists of prostaglandin EP3 receptor	Pfizer Inc.	02/13/17	2D 3D TSV
US9278930	32	Methods for increasing the stabilization of hypoxia inducible factor-α	AERPIO THERAPEUTICS, INC.	02/13/17	2D 3D TSV
US9278944	131	Nitrogen-containing saturated heterocyclic compound	MITSUBISHI TANABE PHARMA CORPORATION; SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.	02/13/17	2D 3D TSV
US8772490	5	Optically active diazabicyclooctane derivatives and process for preparing the same	Meiji Seika Pharma Co., Ltd.	02/13/17	2D 3D TSV
US9278954	172	Pyrrolidine derivatives, pharmaceutical compositions and uses thereof	Boehringer Ingelheim International GmbH	02/13/17	2D 3D TSV
US9278914	5	SARMs and method of use thereof	University of Tennessee Research Foundation	02/13/17	2D 3D TSV
US9278918	32	Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors	Hoffmann-La Roche Inc.	02/13/17	2D 3D TSV
US9290482	8	Amino-substituted imidazopyridazines	BAYER PHARMA AKTIENGESELLSCHAFT	02/06/17	2D 3D TSV
US9290490	33	Aminopyrimidines as Syk inhibitors	Merck Sharp & Dohme Corp.	02/06/17	2D 3D TSV
US9290507	137	B-RAF kinase inhibitors	Boehringer Ingelheim International GmbH	02/06/17	2D 3D TSV
US9290481	13	Monocyclic heteroaryl cycloalkyldiamine derivatives	NOVARTIS AG	02/06/17	2D 3D TSV
US9290485	183	N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides	NOVARTIS AG	02/06/17	2D 3D TSV
US9290487	74	Pharmaceutical composition for treating diabetes	AJINOMOTO CO., INC.	02/06/17	2D 3D TSV
US9290459	353	Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity	Boehringer Ingelheim International GmbH	02/06/17	2D 3D TSV
US9290457	215	Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity	Boehringer Ingelheim International GmbH	02/06/17	2D 3D TSV
US9290505	22	Substituted imidazo[1,2-a]pyrazines as Syk inhibitors	Gilead Sciences, Inc.	02/06/17	2D 3D TSV
US9247759	464	Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof	Senomyx, Inc.	02/02/17	2D 3D TSV
US9290467	51	Cyclic amides	HOFFMANN—LA ROCHE INC.	01/30/17	2D 3D TSV
US9273046	116	Fused tricyclic compounds as Raf kinase inhibitors	BeiGene, LTD.	01/30/17	2D 3D TSV
US9290477	7	Inhibitors of β-secretase	Vitae Pharmaceuticals, Inc.	01/30/17	2D 3D TSV
US9290456	68	Pyridazinone compounds and their use as DAAO inhibitors	Takeda Pharmaceutical Company Limited	01/30/17	2D 3D TSV
US9290451	758	Pyridine derivatives as agonists of the CB2 receptor	Hoffmann-La Roche Inc.	01/30/17	2D 3D TSV
US9290463	5	Radiolabeled compounds and uses thereof	The Trustees of Columbia University in the City of New York	01/30/17	2D 3D TSV
US9290454	27	Substituted isoquinolines as CRTH2 receptor modulators	Merck Sharp & Dohme Corp.	01/30/17	2D 3D TSV
US9273053	82	Sulfur-containing heterocyclic derivative having Beta secretase inhibitory activity	Shionogi & Co., Ltd.	01/30/17	2D 3D TSV
US9273043	82	TRPV1 antagonists including dihydroxy substituent and uses thereof	Purdue Pharma L.P.; Shionogi & Co., Ltd.	01/30/17	2D 3D TSV
US9249124	141	Aurora kinase inhibitors and methods of making and using thereof	H. Lee Moffitt Cancer Center and Research Institute, Inc.	01/27/17	2D 3D TSV
US9273042	9	5-amino[1,4]thiazines as BACE 1 inhibitors	HOFFMANN-LA ROCHE INC.	01/25/17	2D 3D TSV
US9273014	82	Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof	Bristol-Myers Squibb Company	01/24/17	2D 3D TSV
US9266877	359	Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases	ABBVIE INC.	01/23/17	2D 3D TSV
US9271969	134	Compounds as inhibitors of diacylglycerol O-acyltransferase type 1 enzyme	KAINOS MEDICINE, INC.	01/23/17	2D 3D TSV
US9273021	6	Dibenzofuran derivatives as inhibitors of fructose 1,6-bisphosphatase and methods of use thereof	TRUSTEES OF BOSTON COLLEGE	01/23/17	2D 3D TSV
US9273052	5	Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof	Jiangsu Hansoh Pharmaceutical Co., Ltd.	01/23/17	2D 3D TSV
US9273029	119	Pyridine-and pyrazine derivatives	Merck Patent GmbH	01/23/17	2D 3D TSV
US9266890	24	Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders	Dana-Farber Cancer Institute, Inc.	01/23/17	2D 3D TSV
US9271981	7	Pyrrolo[2,3-D]pyrimidine compounds	Zoetis Services LLC	01/23/17	2D 3D TSV
US9266883	144	Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors	Novartis AG	01/23/17	2D 3D TSV
US9266891	61	Substituted [1,2,4]triazolo[4,3-A]pyrazines that are BRD4 inhibitors	Boehringer Ingelheim International GmbH	01/23/17	2D 3D TSV
US9273011	14	Substituted pyridazines for the treatment of pain	Inhibitaxin Limited	01/23/17	2D 3D TSV
US9273033	142	Substituted pyridone derivatives as PDE10 inhibitors	Merck Sharp & Dohme Corp.	01/23/17	2D 3D TSV
US9243038	35	Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof	President and Fellows of Harvard College	01/18/17	2D 3D TSV
US9233167	124	Oligomer-opioid agonist conjugates	Nektar Therapeutics	01/18/17	2D 3D TSV
US9233947	11	Sulfamides as TRPM8 modulators	Janssen Pharmaceutica, NV	01/18/17	2D 3D TSV
US9266876	244	4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives	Actelion Pharmaceuticals Ltd.	01/17/17	2D 3D TSV
US9266870	96	Heteroaromatic methyl cyclic amine derivative	TAISHO PHARMACEUTICAL CO., LTD	01/17/17	2D 3D TSV
US9266878	656	Phosphatidylinositol 3-kinase inhibitors	Gilead Calistoga LLC	01/17/17	2D 3D TSV
US9266880	8	Substituted azaindazole compounds	Bristol-Myers Squibb Company	01/17/17	2D 3D TSV
US9266869	118	Substituted dialkyl(oxido)-lambda4-sulfanylidene nicotinamide derivatives as kinase inhibitors	Allergan, Inc.	01/17/17	2D 3D TSV
US9266895	33	Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors	Principia Biopharma Inc.	01/17/17	2D 3D TSV
US9266881	22	Triazolopyridinone PDE10 inhibitors	Merck Sharp & Dohme Corp.	01/17/17	2D 3D TSV
US9266835	362	Quinoline derivatives useful as CB-1 inverse agonists	Janssen Pharmaceutica NV	01/16/17	2D 3D TSV
US9265773	422	Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases	Merck Sharp & Dohme Corp.; MSD Italia S.R.L.	01/16/17	2D 3D TSV
US9233921	34	Potent poxvirus inhibitor	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA	01/14/17	2D 3D TSV
US9266848	37	4-alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide compounds as selective TACE-inhibitors for the treatment of inflammatory diseases	GALDERMA RESEARCH & DEVELOPMENT	01/09/17	2D 3D TSV
US9260455	15	Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds	Pfizer Inc.	01/09/17	2D 3D TSV
US9265734	416	Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors	BIOMARIN PHARMACEUTICAL INC.	01/09/17	2D 3D TSV
US9266832	90	Compounds for the treatment of neurodegenerative diseases	Katholieke Universiteit Levun; K. U. Leuven R&D reMYND	01/09/17	2D 3D TSV
US9260439	575	Dihydropyrrolopyrimidine derivatives	PFIZER INC.	01/09/17	2D 3D TSV
US9260440	123	Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors	BeiGene, Ltd.	01/09/17	2D 3D TSV
US9266828	5	Inhibitors of Furin and other pro-protein convertases	SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE	01/09/17	2D 3D TSV
US9266853	8	Orally available viridiofungin derivative possessing anti-HCV activity	Chugai Seiyaku Kabushiki Kaisha	01/09/17	2D 3D TSV
US9260450	18	Therapeutic pyrazolyl thienopyridines	THESAN PHARMACEUTICALS, INC.	01/09/17	2D 3D TSV
US9266839	2	Trifluoromethyl pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof	Lycera Corporation	01/09/17	2D 3D TSV
US9233965	111	3,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1H)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof for diseases involving casein kinase 1 epsilon and/or casein kinase 1 delta	SANOFI	01/07/17	2D 3D TSV
US9249163	241	PDE10a inhibitors for the treatment of type II diabetes	JANSSEN PHARMACEUTICA NV.	12/31/16	2D 3D TSV
US9492405	97	Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas	The United States of America, as represented by the Secretary, Department of Health and Human Services; SRI International	12/31/16	2D 3D TSV
US9260415	17	Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality	Genentech, Inc.	12/28/16	2D 3D TSV
US9260413	5	Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders	Merck Sharp & Dohme Corp.	12/28/16	2D 3D TSV
US9259422	35	Orvinol and thevinol derivatives useful in the treatment of depression	The University of Bath	12/28/16	2D 3D TSV
US9260410	8	P38 MAP kinase inhibitors	Respivert Ltd.	12/28/16	2D 3D TSV
US9260425	412	Pyrazolo[3,4-c]pyridine compounds and methods of use	Genetech, Inc.	12/28/16	2D 3D TSV
US9259470	42	Serine/threonine kinase inhibitors	Array BioPharma Inc.; Genentech, Inc.	12/28/16	2D 3D TSV
US9260446	5	Synthetic methods for spiro-oxindole compounds	Xenon Pharmaceuticals Inc.	12/28/16	2D 3D TSV
US9260448	11	Thienopyrimidinone derivatives as mGluR1 antagonists	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY	12/28/16	2D 3D TSV
US9253997	33	Alkylamine derivative	AJINOMOTO CO., INC.	12/20/16	2D 3D TSV
US9255091	15	Benzothiazole-based pyridinium compounds	The University of Montana	12/20/16	2D 3D TSV
US9255107	8	Heteroaryl alkyne compound and use thereof	NANJING SANHOME PHARMACEUTICAL CO., LTD.	12/20/16	2D 3D TSV
US9255090	449	Heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators	ACTELION PHARMACEUTICALS LTD.	12/20/16	2D 3D TSV
US9255110	229	Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators	ROCHE PALO ALTO LLC; HOFFMANN-LA ROCHE INC.	12/20/16	2D 3D TSV
US9255096	26	Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitors	Allergan, Inc.	12/20/16	2D 3D TSV
US9255106	46	Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors	Shanghai Institute of Materia Medica, Chinese Academy of Sciences	12/20/16	2D 3D TSV
US9255103	59	Substituted pyrazolo[1,5-a]pyrazines as mGluR5 receptor modulators	Vanderbilt University	12/20/16	2D 3D TSV
US9255098	6	Xanthine derivative	Chengdu Easton Pharmaceutical Co., Ltd.	12/20/16	2D 3D TSV
US9260417	14	Therapeutic methods and compositions involving allosteric kinase inhibition	AMITECH THERAPEUTIC SOLUTIONS, INC.	12/15/16	2D 3D TSV
US9249085	61	Aniline derivatives, their preparation and their therapeutic application	FOVEA PHARMACEUTICALS	12/12/16	2D 3D TSV
US9249151	126	Bis-amido pyridines	Boehringer Ingelheim International GmbH	12/12/16	2D 3D TSV
US9248140	66	Chemical compounds	AstraZeneca AB	12/12/16	2D 3D TSV
US9249139	9	Indolizinone based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof	Council of Scientific & Industrial Research	12/12/16	2D 3D TSV
US9249125	371	Pyrazole derivatives as p38 MAP inhibitors	RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED	12/12/16	2D 3D TSV
US9249123	8	Pyridinones/pyrazinones, method of making, and method of use thereof	Genentech, Inc.; Gilead Connecticut, Inc.	12/12/16	2D 3D TSV
US9249096	30	Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors	Bristol-Myers Squibb Company	12/12/16	2D 3D TSV
US9243020	20	Selective glycosidase inhibitors and uses thereof	Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.	12/12/16	2D 3D TSV
US9255087	12	Substituted indazole derivatives active as kinase inhibitors	NERVIANO MEDICAL SCIENCES S.R.L.	12/12/16	2D 3D TSV
US9249114	74	Thiazole derivatives	Merck Patent GmbH	12/12/16	2D 3D TSV
US9227979	64	Fluorescent antagonists of the A3 adenosine receptor	The United States of America, as represented by The Secretary, Department of Health and Human Services; Universita Degli Studi Di Trieste; Universita Degli Studi Di Padova	12/08/16	2D 3D TSV
US9260454	41	Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals	SANOFI	12/08/16	2D 3D TSV
US9242977	42	Trk-inhibiting compound	ONO PHARMACEUTICAL CO., LTD.	12/06/16	2D 3D TSV
US9242988	7	2′-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases	Merck Sharp & Dohme Corp.	12/05/16	2D 3D TSV
US9242996	573	Aminoheteroaryl benzamides as kinase inhibitors	Novartis AG	12/05/16	2D 3D TSV
US9242973	532	Chromane compounds	COMENTIS, INC.	12/05/16	2D 3D TSV
US9242998	118	Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C	Merck Sharp & Dohme Corp.	12/05/16	2D 3D TSV
US9243002	192	Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C	Merck Sharp & Dohme Corp.	12/05/16	2D 3D TSV
US9221809	356	Aminopyrimidinones as interleukin receptor-associated kinase inhibitors	MERCK SHARP & DOHME CORP.	11/29/16	2D 3D TSV
US9242943	66	1,4 oxazines as BACE1 and/or BACE2 inhibitors	SIENA BIOTECH S.P.A.; HOFFMANN-LA ROCHE INC.	11/28/16	2D 3D TSV
US9242969	416	Biaryl amide compounds as kinase inhibitors	Novartis AG	11/28/16	2D 3D TSV
US9238625	33	Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives	REVIVA PHARMACEUTICALS, INC.	11/28/16	2D 3D TSV
US9242981	44	Fused pyrazole derivatives as novel ERK inhibitors	Merck Sharp & Dohme Corp.	11/28/16	2D 3D TSV
US9242975	27	Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors	Bristol-Myers Squibb Company	11/28/16	2D 3D TSV
US9242995	3	Isoxazolopyridine orexin receptor antagonists	MERCK SHARP & DOHME CORP.	11/28/16	2D 3D TSV
US9242970	930	Lactam derivatives useful as orexin receptor antagonists	ACTELION PHARMACEUTICALS LTD.	11/28/16	2D 3D TSV
US9242960	4	P38MAP kinase inhibitors	Respivert, Ltd.	11/28/16	2D 3D TSV
US9242982	7	Pyridopyrimidine based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof	COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH	11/28/16	2D 3D TSV
US9242957	72	Thiophene-2-carboximidamide based selective neuronal nitric oxide inhibitors	Northwestern University	11/28/16	2D 3D TSV
US9238651	72	1-H-pyrrolo[2,3-b]pyridine derivatives	MERCK PATENT GMBH	11/21/16	2D 3D TSV
US9238626	42	Beta-amyloid-directed multitarget compounds for the treatment of alzheimer's disease	UNIVERSITAT DE BARCELONA; PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE	11/21/16	2D 3D TSV
US9233979	458	Compounds that are ERK inhibitors	Merck Sharp & Dohme Corp.	11/21/16	2D 3D TSV
US9238629	88	Heteroaryl compounds and uses thereof	Celgene Avilomics Research, Inc.	11/21/16	2D 3D TSV
US9241942	494	IRE-1α inhibitors	MannKind Corporation	11/21/16	2D 3D TSV
US9238619	76	Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy	AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.	11/21/16	2D 3D TSV
US9233983	152	Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof	ADVINUS THERAPEUTICS LIMITED	11/21/16	2D 3D TSV
US9233981	33	Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds	Pfizer Inc.	11/21/16	2D 3D TSV
US9238658	49	Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors	Janssen Pharmaceutica NV	11/21/16	2D 3D TSV
US9238644	143	VEGFR3 inhibitors	CANCER THERAPEUTICS CRC PTY LIMITED	11/21/16	2D 3D TSV
US9187424	434	Aryl dihydropyridinones and piperidinone MGAT2 inhibitors	Bristol-Myers Squibb Company	11/15/16	2D 3D TSV
US9227969	101	Compounds and compositions as inhibitors of MEK	NOVARTIS AG	11/14/16	2D 3D TSV
US9233108	30	Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities	ALMIRALL, S.A.	11/14/16	2D 3D TSV
US9233953	161	Derivatives of 4-(piperazinylcarbonyl)thiane-1, 1-dione which inhibit GlyT1	Boehringer Ingelheim International GmbH	11/14/16	2D 3D TSV
US9226927	15	Gamma secretase inhibitors	MERCK SHARP & DOHME CORP.	11/14/16	2D 3D TSV
US9233086	100	Inhibition of WDR5 interaction with its binding partners	THE REGENTS OF THE UNIVERSITY OF MICHIGAN	11/14/16	2D 3D TSV
US9233968	97	Kinase inhibitors	Allergan, Inc.	11/14/16	2D 3D TSV
US9227975	60	Method of treatment using substituted imidazo[1,2B]pyridazine compounds	Array BioPharma, Inc.	11/14/16	2D 3D TSV
US9227977	14	Phosphoinositide 3-kinase inhibitors	Respivert Ltd.	11/14/16	2D 3D TSV
US9227973	16	Pyridine CGRP receptor antagonists	Merck Sharp & Dohme Corp.	11/14/16	2D 3D TSV
US9233111	72	Pyrrolo pyrimidine derivatives	NOVARTIS AG	11/14/16	2D 3D TSV
US9227956	98	Substituted amide compounds	Pfizer Inc.	11/14/16	2D 3D TSV
US9233946	59	Sulfonamide compounds	KANCERA AB	11/14/16	2D 3D TSV
US9227970	43	Triazolopyridine compounds	Hoffmann-La Roche, Inc.	11/14/16	2D 3D TSV
US9227982	56	4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitors	NOVARTIS AG	11/08/16